[
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the expiration date of this contract?",
        "thought":"The context provides the date of execution for the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. as May 8, 2014. It also mentions that if the Agreement is renewed for the First Additional Term, it would commence on July 23, 2016, and expire on July 22, 2019. Therefore, the expiration date of the contract is July 22, 2019, which is relevant to the question.",
        "response":"The expiration date of the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. is July 22, 2019.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: \/s\/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: \/s\/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS",
            ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019",
            ". Between January 1, 2018 and the date of this Agreement, there have been no transactions, or series of related transactions, or Contracts, that would be required to be reported prior to the date hereof by the Company pursuant to Item 404 of Regulation S-K promulgated by the SEC (each, and \u201cAffiliate Arrangement\u201d) that have not been disclosed in the Company SEC Documents.   Section 4.22       Material Customers; Material Vendors.   (a)               Section 4"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the renewal term for this contract?",
        "thought":"The context specifies that the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. automatically renews for an additional three-year period unless either party provides written notice of non-renewal at least ninety days before the expiration of the initial term. The terms 'Company' and 'Endorser' refer to Birch First Global Investments Inc. and Mount Knowledge Holdings Inc., respectively. This directly answers the question regarding the renewal term of the contract.",
        "response":"The renewal term for the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. is an additional three (3) years, unless either party gives written notice of non-renewal at least ninety (90) days before the expiration of the initial term.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination",
            "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: \/s\/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: \/s\/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the notice period required to terminate the renewal?",
        "thought":"The context outlines the terms of the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. It specifies that the agreement can be renewed automatically unless either party provides written notice of non-renewal at least ninety (90) days before the expiration of the initial term. Additionally, it states that either party may terminate the agreement at the end of any term with thirty (30) days written notice, which is relevant to the termination of the renewal.",
        "response":"The notice period required to terminate the renewal of the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. is ninety (90) days prior to the expiration of the initial term.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination",
            "This Agreement may be terminated by either party at the expiration of its term or any renewal term upon thirty (30) days written notice to the other party"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the governing law for this contract?",
        "thought":"The context provides information about the parties involved in the Marketing Affiliate Agreement, specifically Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. However, it does not explicitly mention the governing law for the contract. Therefore, I cannot determine the governing law based on the provided context.",
        "response":"I don't know.",
        "retrieved_contexts":[
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)",
            "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: \/s\/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: \/s\/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS",
            "Section 3.26 Brokers 36 Section 3.27 Affiliate Arrangements 36 Section 3.28 Acknowledgement of No Other Representations or Warranties 36   Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND SUB   Section 4.01 Organization 36 Section 4.02 Authority 37 Section 4.03 No Conflict; Required Filings and Consents 37 Section 4.04 Information Supplied 38 Section 4.05 Litigation 39 Section 4.06 Capitalization and Operations of Sub 39 Section 4.07 Financing 39 Section 4"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; Is there an anti-assignment clause in this contract?",
        "thought":"The context provides two conflicting clauses regarding assignment in the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. The first clause allows either party to assign the agreement to an affiliate without consent, while the second clause states that neither party can assign the agreement without prior written consent from the other party. This indicates that there is an anti-assignment clause present, but it is limited by the allowance for assignment to affiliates.",
        "response":"Yes, the Marketing Affiliate Agreement contains an anti-assignment clause stating that neither party may assign the agreement without prior written consent from the other party, although there is an exception for assignments to affiliates.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)",
            "12.      Assignment. Either party may, at its election, assign this Agreement or          any of its rights or delegate any of its obligations hereunder, in          whole or in part, to any person, firm or corporation owning or          acquiring all or a substantial portion of its assets, to any person,          firm or corporation that is related to it as an affiliate,\n\n                                    7\n\n10",
            ".9 No Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties (whether by operation of Law or otherwise) without the prior written consent of the other parties. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; Is there a minimum commitment required under this contract?",
        "thought":"The context provides details about the parties involved in the Marketing Affiliate Agreement, specifically Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. However, it does not explicitly mention any minimum commitment required under the contract. Therefore, while the parties and the agreement are identified, the relevant information regarding minimum commitments is absent.",
        "response":"The context does not specify any minimum commitment required under the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.",
        "retrieved_contexts":[
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)",
            "., there is no investment banker, broker, finder or other financial intermediary that has been retained by or is authorized to act on behalf of the Company or any of its Subsidiaries who will be entitled to any fee or commission from the Company or any of its Subsidiaries in connection with the Transactions.   Section 4.21       Affiliate Arrangements",
            "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: \/s\/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: \/s\/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What licenses are granted under this contract?",
        "thought":"The context provided is a Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. However, the specific licenses granted under this contract are not detailed in the excerpt. Therefore, I cannot determine the exact licenses granted based on the available information.",
        "response":"I don't know.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: \/s\/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: \/s\/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS",
            "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)",
            ", and (ii) Licensor may assign its rights and obligations in this Agreement to its Affiliates or subsidiaries and either party may assign this Agreement in its entirety to any purchaser of all or substantially all of its business or assets pertaining to the line of business to which this Agreement relates or to any Affiliate of the party without the other party's approval"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What are the audit rights under this contract?",
        "thought":"The context provides the names of the parties involved in the Marketing Affiliate Agreement, Birch First Global Investments Inc. and Mount Knowledge Holdings Inc., but does not specify any details regarding audit rights. The terms 'audit rights' typically refer to the ability of one party to review the records or operations of another party to ensure compliance with the agreement, but this specific information is not included in the provided context. Therefore, I cannot provide a definitive answer regarding the audit rights under this contract.",
        "response":"I don't know.",
        "retrieved_contexts":[
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "(c) \"Affiliate(s)\" shall mean an entity controlling, controlled by or under common control with a party. \"Control,\" for purposes of this definition, means direct or indirect ownership or control of more than 50% of the voting interests of the subject entity.\n\n(d) \"Confidential Information\" shall have the meaning specified in Section 14(a) [Confidential Information].\n\n(e) \"Indemnified Party\" shall have the meaning specified in Section 13.",
            "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: \/s\/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: \/s\/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS",
            "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; Is there a cap on liability under this contract?",
        "thought":"The context provides information about the parties involved in the Marketing Affiliate Agreement, specifically Birch First Global Investments Inc. (the 'Company') and Mount Knowledge Holdings Inc. However, it does not contain any details regarding liability caps or limitations within the contract itself. Therefore, it cannot be determined from the provided context whether there is a cap on liability under this agreement.",
        "response":"The context does not specify any cap on liability under the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.",
        "retrieved_contexts":[
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: \/s\/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: \/s\/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS",
            "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)",
            "., there is no investment banker, broker, finder or other financial intermediary that has been retained by or is authorized to act on behalf of the Company or any of its Subsidiaries who will be entitled to any fee or commission from the Company or any of its Subsidiaries in connection with the Transactions.   Section 4.21       Affiliate Arrangements"
        ]
    },
    {
        "user_input":"Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the duration of any warranties provided in this contract?",
        "thought":"The context outlines the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc., specifying that neither party provides any warranties except as stated in the agreement. It also mentions the duration of the agreement itself, which is three years with an option to renew for an additional three years. However, it explicitly states that all implied warranties are disclaimed, indicating that there are no warranties provided in the contract.",
        "response":"The Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc. does not provide any warranties, as both parties disclaim all implied or statutory warranties. The agreement itself is effective for three years, with an option to renew for an additional three years.",
        "retrieved_contexts":[
            "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2",
            "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15\/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and\/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S",
            "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: \/s\/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: \/s\/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5\/20\/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS",
            "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE",
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the expiration date of this contract?",
        "thought":"The context specifies that the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. has an Effective Date of July 11, 2006. It indicates that if the agreement is renewed for the First Additional Term, it would commence on July 23, 2016, and expire on July 22, 2019. Therefore, the expiration date of the contract is July 22, 2019.",
        "response":"The expiration date of the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. is July 22, 2019.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ".   If either party terminates this Agreement prior to its expiration, Rogers shall be entitled to continue to distribute and exhibit all Licensed Programs then being distributed and exhibited on the ROD Service, in each case, for a period of sixty (60) days from the effective date of termination or the expiry of the relevant License Period, whichever is earlier, and, in such event, Rogers shall continue to be bound by its payment obligations set forth herein in respect of such Licensed Programs",
            ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry",
            ", such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended",
            ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the renewal term for this contract?",
        "thought":"The context specifies that the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. has an Initial Term that ends on June 30, 2010, and includes a Renewal Term of two years at Rogers' option. The term 'Renewal Term' refers to the subsequent period that can be activated by Rogers after the Initial Term. Therefore, the renewal term for this contract is two years.",
        "response":"The renewal term for the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. is two years, which can be exercised at Rogers' option following the Initial Term.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry",
            ".   If either party terminates this Agreement prior to its expiration, Rogers shall be entitled to continue to distribute and exhibit all Licensed Programs then being distributed and exhibited on the ROD Service, in each case, for a period of sixty (60) days from the effective date of termination or the expiry of the relevant License Period, whichever is earlier, and, in such event, Rogers shall continue to be bound by its payment obligations set forth herein in respect of such Licensed Programs",
            ", such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended",
            ".     The term of this Agreement (the \"Initial Term\") shall commence as of the Effective Date and, unless earlier terminated in accordance with this Agreement, shall terminate on June 30, 2010. At Rogers' option, this Agreement shall renew for a subsequent term of two (2) years on the terms and conditions herein (the \"Renewal Term\")"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the notice period required to terminate the renewal?",
        "thought":"The context specifies that either party, Rogers Cable Communications Inc. or EuroMedia Holdings Corp. (referred to as Licensor), can terminate the Video-on-Demand Content License Agreement with a notice period of sixty (60) days. This directly addresses the question regarding the notice period required for termination of the renewal. The terms 'Rogers' and 'Licensor' are equivalent to the parties mentioned in the question, confirming the relevant information.",
        "response":"The notice period required to terminate the renewal of the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. is sixty (60) days' prior written notice.",
        "retrieved_contexts":[
            ", such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended",
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry",
            ".   If either party terminates this Agreement prior to its expiration, Rogers shall be entitled to continue to distribute and exhibit all Licensed Programs then being distributed and exhibited on the ROD Service, in each case, for a period of sixty (60) days from the effective date of termination or the expiry of the relevant License Period, whichever is earlier, and, in such event, Rogers shall continue to be bound by its payment obligations set forth herein in respect of such Licensed Programs",
            ".   Notwithstanding any other provision of this Agreement, Rogers may terminate this Agreement, at any time, upon sixty (60) days' prior written notice to Licensor.     19. MUTUAL TERMINATION RIGHTS"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the governing law for this contract?",
        "thought":"The context provided does not explicitly mention the governing law for the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. The governing law typically refers to the jurisdiction whose laws will govern the interpretation and enforcement of the contract, but this information is absent in the retrieved context. Therefore, I cannot determine the governing law based on the available information.",
        "response":"I don't know.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory",
            ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry",
            "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program\/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and\/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks\/Company Servers x Full Television Broadcast Rights",
            ". or the Territory on a VOD basis, or any other basis that permits the downloading of such Licensed Programs and the subsequent viewing of such Licensed Programs by a residential subscriber, on terms (including, without limitation, license fees, copyright royalty payments, encoding fees and obligations, and marketing support) that are more favourable than those contained in this Agreement, then Rogers has the right to incorporate, or substitute, as the case may be"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there a most favored nation clause in this contract?",
        "thought":"The context mentions a 'most favored nation' clause in relation to contracts that grant preferential pricing or exclusive rights to other parties. However, it does not explicitly state whether such a clause exists in the Video-on-Demand Content License Agreement between Rogers and EuroMedia. The mention of a 'most favored nation' clause implies that it could be a consideration in the agreement, but without direct confirmation, we cannot definitively state its presence.",
        "response":"The context implies that a 'most favored nation' clause could be relevant to the agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp., but it does not explicitly confirm its existence in the contract.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ":   (i)                 a Contract granting a \u201cmost favored nation\u201d or most favored customer pricing to any Person, or any Contract providing for the grant of exclusive material sales, distribution, marketing or other exclusive rights, rights of first refusal, rights of first negotiation or similar rights and\/or terms to any Person, or materially limiting the right of the Company or any of its Subsidiaries to engage in any line of business or in any geographic area",
            "1. RIGHTS GRANTED   Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory",
            "(b) In the event that Licensor grants to another VOD or Pay-Per-View (\"PPV\") service provider in the U.S. or the Territory the right to distribute or exhibit any Licensed Program on an earlier availability date, then Licensor shall also grant to Rogers the right to distribute and exhibit such Licensed Program on such earlier availability date, on the terms provided herein"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Can this contract be terminated for convenience, and under what conditions?",
        "thought":"The context outlines the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. (referred to as 'Rogers') and EuroMedia Holdings Corp. (referred to as 'Licensor'). It specifies that either party can terminate the agreement with sixty (60) days' prior written notice, indicating that termination for convenience is permissible. The conditions for termination include the requirement of written notice and the continuation of certain obligations post-termination.",
        "response":"Yes, the Video-on-Demand Content License Agreement can be terminated for convenience by either Rogers or Licensor with sixty (60) days' prior written notice to the other party.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry",
            ".   If either party terminates this Agreement prior to its expiration, Rogers shall be entitled to continue to distribute and exhibit all Licensed Programs then being distributed and exhibited on the ROD Service, in each case, for a period of sixty (60) days from the effective date of termination or the expiry of the relevant License Period, whichever is earlier, and, in such event, Rogers shall continue to be bound by its payment obligations set forth herein in respect of such Licensed Programs",
            ".   Either Rogers or Licensor may, at its option and without prejudice to any other remedies available to it, immediately terminate this Agreement by giving written notice thereof to the other party for any one or more of the following causes",
            ", such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there an anti-assignment clause in this contract?",
        "thought":"The context provided does not explicitly mention an anti-assignment clause in the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. The terms 'anti-assignment clause' refers to a provision that restricts the ability of one party to transfer its rights or obligations under the contract to another party, which is not addressed in the retrieved context. Therefore, I cannot confirm the presence of such a clause based on the available information.",
        "response":"I don't know.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory",
            ". or the Territory on a VOD basis, or any other basis that permits the downloading of such Licensed Programs and the subsequent viewing of such Licensed Programs by a residential subscriber, on terms (including, without limitation, license fees, copyright royalty payments, encoding fees and obligations, and marketing support) that are more favourable than those contained in this Agreement, then Rogers has the right to incorporate, or substitute, as the case may be",
            "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program\/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and\/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks\/Company Servers x Full Television Broadcast Rights",
            "1. RIGHTS GRANTED   Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Does this contract include any revenue or profit-sharing arrangements?",
        "thought":"The context outlines a Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp., detailing the rights and obligations regarding the distribution of Licensed Programs. It mentions that Rogers can recover costs against future Retail Revenues but does not explicitly state any revenue or profit-sharing arrangements between the parties. Therefore, while there are provisions for revenue management, the absence of a minimum License Fee or retail viewing fee suggests that there is no direct profit-sharing mechanism outlined in the Agreement.",
        "response":"The Video-on-Demand Content License Agreement does not explicitly include any revenue or profit-sharing arrangements between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. It allows Rogers to recover costs from future Retail Revenues but does not establish a profit-sharing structure.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory",
            ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program",
            ". or the Territory on a VOD basis, or any other basis that permits the downloading of such Licensed Programs and the subsequent viewing of such Licensed Programs by a residential subscriber, on terms (including, without limitation, license fees, copyright royalty payments, encoding fees and obligations, and marketing support) that are more favourable than those contained in this Agreement, then Rogers has the right to incorporate, or substitute, as the case may be",
            "1. RIGHTS GRANTED   Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there a minimum commitment required under this contract?",
        "thought":"The context indicates that there is no minimum License Fee or retail viewing fee required for any Licensed Program under the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. This implies that while there may be costs associated with the distribution of content, there is no minimum financial commitment stipulated in the contract itself. Therefore, the absence of a minimum fee suggests flexibility in financial obligations for Rogers.",
        "response":"There is no minimum commitment required under the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp., as the agreement explicitly states that there shall be no minimum License Fee or retail viewing fee for any Licensed Program.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program\/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and\/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks\/Company Servers x Full Television Broadcast Rights",
            "CONTENT LICENSE AGREEMENT",
            ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program",
            ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What licenses are granted under this contract?",
        "thought":"The context outlines the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. (referred to as 'Rogers') and EuroMedia Holdings Corp. (referred to as 'Licensor'). It specifies that the Licensor grants Rogers a non-exclusive license to distribute and exhibit all entertainment programming for which the Licensor holds VOD distribution rights in Canada. This implies that Rogers can provide these Licensed Programs to its subscribers on a VOD basis, subject to certain conditions.",
        "response":"Under the Video-on-Demand Content License Agreement, Licensor grants Rogers a non-exclusive license to distribute and exhibit all Licensed Programs in Canada to its residential subscribers on a Video-on-Demand basis.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            "1. RIGHTS GRANTED   Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis",
            "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program\/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and\/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks\/Company Servers x Full Television Broadcast Rights",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory",
            ". For clarity, the VOD service that Rogers provides to such subscribers shall hereinafter be referred to as the \"ROD Service\".     2. LICENSED PROGRAMS.     (a) Subject to Section 3, Licensor shall forthwith provide to Rogers a comprehensive list (including title, length of program, license period and availability date) of all currently available Licensed Programs"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Does this contract include an unlimited or all-you-can-eat license?",
        "thought":"The context describes a Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp., detailing the rights granted to Rogers for distributing licensed programs. The terms indicate that there is no minimum license fee or retail viewing fee, which suggests a flexible arrangement, but it does not explicitly state that the license is unlimited or all-you-can-eat. Therefore, while the license is described as 'perpetual' and 'unlimited runs,' it does not confirm an all-you-can-eat model as typically understood in licensing terms.",
        "response":"The Video-on-Demand Content License Agreement between Rogers and EuroMedia indicates a 'perpetual' and 'unlimited runs' license, but it does not explicitly confirm an 'all-you-can-eat' model. The absence of a minimum license fee or retail viewing fee implies flexibility in usage, yet the specific nature of the license regarding unlimited access is not clearly defined.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program\/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and\/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks\/Company Servers x Full Television Broadcast Rights",
            ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program",
            ": x Free: Terrestrial, Cable, Satellite x Pay: Terrestrial, Cable, Satellite x Direct Satellite IP Distribution Systems Licensed Territory x Worldwide \u00a8 Other: _______________________________________________ License Term Perpetual, unlimited runs x Other: 2 years Commencing: November 15, 2012 Run Dates Within ConvergTV determined parameters",
            "1. RIGHTS GRANTED   Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What are the audit rights under this contract?",
        "thought":"The context outlines the audit rights under the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. (referred to as 'Rogers') and EuroMedia Holdings Corp. (referred to as 'Licensor'). Specifically, it states that Rogers has the right to inspect and audit Licensor's books and records to ensure compliance with the obligations set forth in the agreement, with a notice period and during regular business hours. This right to audit is valid during the term of the agreement and for twelve months thereafter, indicating a clear mechanism for Rogers to verify compliance.",
        "response":"Under the Video-on-Demand Content License Agreement, Rogers has the right to audit Licensor's books and records for compliance with the agreement, with reasonable prior written notice and during regular business hours. This audit right is effective during the term of the agreement and for twelve months following its expiration or termination.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            "Each Party shall cause any Subsidiary or other Affiliate (including, without limitation, a Subsidiary or other Affiliate of the Online Group or Skype Group, as applicable) to grant to the other Party the audit rights granted hereunder with respect to such other Party.",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory",
            ". During the Term, and for a period of twelve (12) months thereafter, Rogers (and its representatives) shall have the right, upon reasonable prior written notice to Licensor, and during regular business hours, to inspect and\/or audit Licensor's books and records to confirm compliance with Licensor's obligations under this Section. This Section shall survive the expiry or other termination of this Agreement for a period of twelve (12) months.   -8-",
            "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program\/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and\/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks\/Company Servers x Full Television Broadcast Rights"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there uncapped liability under this contract?",
        "thought":"The context outlines the indemnification obligations of Rogers Cable Communications Inc. towards EuroMedia Holdings Corp. under the Video-on-Demand Content License Agreement. It specifies that Rogers is liable for claims arising from breaches of the agreement and other specified circumstances, but does not explicitly state that there is uncapped liability. The absence of a minimum license fee or retail viewing fee suggests that liability may not be unlimited, but the exact nature of liability is not clearly defined in the provided excerpt.",
        "response":"The contract does not explicitly state that there is uncapped liability; however, Rogers is liable for certain claims and damages as outlined in the indemnification clause. The lack of a minimum license fee or retail viewing fee may imply limitations on liability, but this is not definitively stated in the agreement.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            "(b) Rogers shall indemnify Licensor and its affiliates from and against any and all claims, damages, liabilities, costs and expenses (including, without limitation, reasonable legal fees) arising out of or caused by:     (i) any breach by Rogers of any material term of this Agreement; and     (ii) any claim by a Rogers customer, except a claim related to the content of any Licensed Program, trailer and\/or other promotional materials provided by Licensor to Rogers hereunder",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory",
            ". or the Territory on a VOD basis, or any other basis that permits the downloading of such Licensed Programs and the subsequent viewing of such Licensed Programs by a residential subscriber, on terms (including, without limitation, license fees, copyright royalty payments, encoding fees and obligations, and marketing support) that are more favourable than those contained in this Agreement, then Rogers has the right to incorporate, or substitute, as the case may be",
            ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program"
        ]
    },
    {
        "user_input":"Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there a cap on liability under this contract?",
        "thought":"The context provided does not explicitly mention a cap on liability under the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. It discusses indemnification and liabilities related to breaches and claims but does not specify any limitations or caps on those liabilities. Therefore, the absence of such information implies that there may not be a defined cap on liability in this contract.",
        "response":"The context does not specify a cap on liability under the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp. It only discusses indemnification and liabilities without indicating any limitations. Therefore, it implies that there may not be a defined cap on liability.",
        "retrieved_contexts":[
            "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")",
            "(b) Rogers shall indemnify Licensor and its affiliates from and against any and all claims, damages, liabilities, costs and expenses (including, without limitation, reasonable legal fees) arising out of or caused by:     (i) any breach by Rogers of any material term of this Agreement; and     (ii) any claim by a Rogers customer, except a claim related to the content of any Licensed Program, trailer and\/or other promotional materials provided by Licensor to Rogers hereunder",
            ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program",
            ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and\/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory",
            ":     (i) any breach by Licensor of any material term of this Agreement;     (ii) the content of any Licensed Program, trailer and\/or other promotional materials provided by Licensor to Rogers hereunder (including, without limitation, any libelous, slanderous or obscene material, violations of copyright, trade- mark rights or other intellectual property rights, personality right, right of privacy or literary or dramatic right)"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; What is the renewal term for this contract?",
        "thought":"The context specifies that the License Term is perpetual and includes unlimited runs, but also mentions 'Other: 2 years'. This suggests that while the agreement may have a perpetual aspect, there is a defined initial term of 2 years. Therefore, the renewal term is implied to be after the initial 2-year period, but the context does not explicitly state the conditions for renewal.",
        "response":"The renewal term for the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd. is implied to follow an initial term of 2 years, but the specific conditions for renewal are not explicitly stated in the provided context.",
        "retrieved_contexts":[
            ": x Free: Terrestrial, Cable, Satellite x Pay: Terrestrial, Cable, Satellite x Direct Satellite IP Distribution Systems Licensed Territory x Worldwide \u00a8 Other: _______________________________________________ License Term Perpetual, unlimited runs x Other: 2 years Commencing: November 15, 2012 Run Dates Within ConvergTV determined parameters",
            ". The Producer shall have thirty (30) days from the payment date to dispute the amount of any revenue share payout or any such claim or dispute is hereby waived by the Producer.   4. Program Exclusivity For The License Term Within The Licensed Territory",
            "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd",
            ": (i) any information contained in this Agreement",
            ".     (a) For the License Term and within the Licensed Territory, Producer hereby grants to ConvergTV a right and license to Distribute the program, file or video listed on the Deal Terms above (the \"Program\") consisting of (check one) \u00a8 episodes (series) or x one-offs, for unlimited runs for the License Term through ConvergTV channels and\/or other distribution outlets, in accordance with the License Rights"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; What is the governing law for this contract?",
        "thought":"The provided context does not explicitly mention the governing law for the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd. It primarily discusses the binding nature of the agreement, audit rights, and the validity of provisions, but lacks any reference to the jurisdiction or legal framework that governs the contract. Therefore, I cannot determine the governing law based on the available information.",
        "response":"I don't know.",
        "retrieved_contexts":[
            ". Subject to the restrictions against assignment as herein contained, this Agreement shall be binding upon and inure to the benefit of the Parties, their predecessors, assigns, successors in interest, personal representatives, their past and present attorneys, principals, employees, independent contractors, officers, directors, shareholders, parents, issue, subsidiaries, agents, servants, estates, heirs, administrators, executors, conservators, trustees, legatees",
            "18. Audit. Each of the Parties may, at its own expense, audit the other Party's compliance with this Agreement, including but not limited to, auditing the other Party's representations and warranties.   19. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall be deemed to be one and the same instrument",
            ". There are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.   14.. Notices",
            ";    (d) there are no agreements, contracts, commitments or licenses, nor shall Producer enter into any agreements, contracts, commitments or grant any licenses, which would prevent the fulfillment of this Agreement or impair or conflict with the rights granted hereunder",
            ". If any term, provision, covenant or condition of this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the provisions shall remain in full force and effect and shall in no way be affected, impaired or invalidated."
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; Does this contract include an exclusivity agreement?",
        "thought":"The context mentions 'Program Exclusivity For The License Term Within The Licensed Territory,' which implies that there is an exclusivity aspect to the agreement. However, the specific details of the exclusivity, such as its scope or limitations, are not provided in the retrieved context. Therefore, while the mention of exclusivity suggests that it is part of the agreement, the exact nature of that exclusivity is not fully clarified in the provided text.",
        "response":"Yes, the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd. includes an exclusivity agreement as indicated by the phrase 'Program Exclusivity For The License Term Within The Licensed Territory.'",
        "retrieved_contexts":[
            ". There are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.   14.. Notices",
            ": (i) any information contained in this Agreement",
            "13. Entire Agreement . This Agreement, which includes the Deal Terms and any and all exhibits, schedules or attachments to this Agreement, contains the entire agreement of the Parties, and supersedes any prior written or oral agreements between them concerning the subject matter contained herein",
            ";    (d) there are no agreements, contracts, commitments or licenses, nor shall Producer enter into any agreements, contracts, commitments or grant any licenses, which would prevent the fulfillment of this Agreement or impair or conflict with the rights granted hereunder",
            ". The Producer shall have thirty (30) days from the payment date to dispute the amount of any revenue share payout or any such claim or dispute is hereby waived by the Producer.   4. Program Exclusivity For The License Term Within The Licensed Territory"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; Does this contract include any revenue or profit-sharing arrangements?",
        "thought":"The context mentions a 'revenue share payout' which indicates that there is a financial arrangement related to revenue between the parties involved in the agreement. The term 'Producer' likely refers to Fulucai Productions Ltd. as they are the party responsible for revenue disputes. Therefore, the context implies that the contract does include revenue-sharing arrangements, specifically regarding payouts.",
        "response":"Yes, the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd. includes revenue-sharing arrangements, as indicated by the mention of a 'revenue share payout' that the Producer can dispute.",
        "retrieved_contexts":[
            ": (i) any information contained in this Agreement",
            ";    (d) there are no agreements, contracts, commitments or licenses, nor shall Producer enter into any agreements, contracts, commitments or grant any licenses, which would prevent the fulfillment of this Agreement or impair or conflict with the rights granted hereunder",
            ". The Producer shall have thirty (30) days from the payment date to dispute the amount of any revenue share payout or any such claim or dispute is hereby waived by the Producer.   4. Program Exclusivity For The License Term Within The Licensed Territory",
            ". There are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.   14.. Notices",
            ". The terms \"License Term\", \"Licensed Rights\", and \"Licensed Territory\" shall have the meaning specified in the Deal Terms above, which such Deal Terms are part of this Agreement and are hereby incorporated herein by reference"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; Does the licensee's affiliates have any licensing rights under this contract?",
        "thought":"The context indicates that ConvergTV has the right to distribute the program on its channels and affiliates, which implies that the licensee's affiliates may have distribution rights under the agreement. However, the context does not explicitly state that the affiliates have independent licensing rights; rather, it suggests that any rights are derived from ConvergTV's license. Therefore, while affiliates can distribute, it does not confirm they have separate licensing rights under the contract.",
        "response":"The licensee's affiliates can distribute the program through ConvergTV's channels, but they do not have independent licensing rights under the contract; their rights are contingent upon ConvergTV's license.",
        "retrieved_contexts":[
            ". The Producer shall have thirty (30) days from the payment date to dispute the amount of any revenue share payout or any such claim or dispute is hereby waived by the Producer.   4. Program Exclusivity For The License Term Within The Licensed Territory",
            ".    (b) Producer further grants to ConvergTV the right and license to Distribute the Program on any ConvergTV channel, and\/or other distribution outlets, that exists today or that is created or developed in the future and this right includes the right to Distribute on any channels of a ConvergTV affiliate and\/or other distribution outlets without limitation",
            ". During the License Term (which is identified in the Deal Terms), Producer agrees that ConvergTV has the exclusive right to exercise the rights granted to it under this Agreement with respect to the Program, including those in Section 1, within the Licensed Territory.",
            ";    (d) there are no agreements, contracts, commitments or licenses, nor shall Producer enter into any agreements, contracts, commitments or grant any licenses, which would prevent the fulfillment of this Agreement or impair or conflict with the rights granted hereunder",
            ". The terms \"License Term\", \"Licensed Rights\", and \"Licensed Territory\" shall have the meaning specified in the Deal Terms above, which such Deal Terms are part of this Agreement and are hereby incorporated herein by reference"
        ]
    },
    {
        "user_input":"Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; What are the audit rights under this contract?",
        "thought":"The context specifies that each party, ConvergTV, Inc. and Fulucai Productions Ltd., has the right to audit the other party's compliance with the Content Distribution and License Agreement. This implies that both parties can verify adherence to the terms of the contract, including representations and warranties. The audit rights are mutual and can be exercised at each party's own expense.",
        "response":"Under the Content Distribution and License Agreement, both ConvergTV, Inc. and Fulucai Productions Ltd. have the right to audit each other's compliance with the contract, including verifying representations and warranties, at their own expense.",
        "retrieved_contexts":[
            "18. Audit. Each of the Parties may, at its own expense, audit the other Party's compliance with this Agreement, including but not limited to, auditing the other Party's representations and warranties.   19. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall be deemed to be one and the same instrument",
            ": (i) any information contained in this Agreement",
            ". Subject to the restrictions against assignment as herein contained, this Agreement shall be binding upon and inure to the benefit of the Parties, their predecessors, assigns, successors in interest, personal representatives, their past and present attorneys, principals, employees, independent contractors, officers, directors, shareholders, parents, issue, subsidiaries, agents, servants, estates, heirs, administrators, executors, conservators, trustees, legatees",
            ". There are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.   14.. Notices",
            "5. Producer's Representations and Warranties"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the expiration date of this contract?",
        "thought":"The context provided includes a Content License Agreement dated February 10, 2014, between PSiTech Corporation and Empirical Ventures, Inc. However, there is no mention of an expiration date for this contract within the retrieved context. Therefore, I cannot determine the expiration date based on the available information.",
        "response":"The expiration date of the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. is not specified in the provided context.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd",
            ".   6.3 Effect of Expiration or Termination. Upon any expiration or termination of this Agreement:   (a) All licenses granted under this Agreement shall also terminate, and Licensee shall immediately delete from its systems and servers all Licensed Content, Licensor's Marks and any other materials provided by Licensor. Upon Licensor's written request, Licensee shall promptly provide Licensor with written certification of such deletion",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            "(b) where applicable, each party shall return to the other party, within thirty (30) days from such Termination Date, all intellectual property, technology or other property in its possession used in connection with this Agreement that is proprietary to the other party;\n\n              (c) Confidential Information shall be returned in accordance with the terms of Section 11;"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the renewal term for this contract?",
        "thought":"The context specifies that the Content License Agreement between PSiTech Corporation (the Licensor) and Empirical Ventures, Inc. (the Licensee) includes a renewal term of one (1) additional three (3) year period. This means that after the initial term, the contract automatically renews unless either party provides written notice of non-renewal at least ninety (90) days prior to the expiration of the initial term. The terms 'Licensor' and 'Licensee' refer to PSiTech Corporation and Empirical Ventures, Inc., respectively, in the context of the agreement.",
        "response":"The renewal term for the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. is one (1) additional three (3) year period, unless either party gives written notice of non-renewal at least ninety (90) days before the expiration of the initial term.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination",
            ": (i) in perpetuity with respect to Titles for which the licenses granted in Section 2(a) [License Grant] are perpetual; and (ii) for the duration of the applicable license term specified in Schedule A with respect to Titles for which the license term specified in Schedule A extends beyond the expiration or termination of this Agreement",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the notice period required to terminate the renewal?",
        "thought":"The context outlines the termination rights under the Content License Agreement between PSiTech Corporation (the Licensor) and Empirical Ventures, Inc. (the Licensee). It specifies that either party can terminate the agreement upon written notice if the other materially breaches the agreement and fails to cure the breach within specified timeframes. However, the context does not explicitly mention a notice period required for terminating the renewal of the agreement itself, only for breaches.",
        "response":"The context does not provide specific information regarding the notice period required to terminate the renewal of the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            ".   (a) Either party may terminate this Agreement, effective upon written notice to the other party, if the other partymaterially breaches this Agreement, and such breach is incapable of cure or, if capable of cure, (i) fails to commence a plan of action approved by Licensor to cure such breach within thirty (30) days, or (ii) fails to cure such breach within ninety (90) days after receiving written notice thereof, in either case after receiving notice of the breach",
            ". Provided, however, that if the breach giving rise to the termination right under this Section 6.2is non-payment of License Fees or Royalties, the cure period shall be ten (10) days",
            "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES",
            ". Either party may terminate this Agreement upon written notice if the other party materially breaches this Agreement and fails to cure such breach within thirty (30) days after the date that it receives written notice of such breach from the non-breaching party."
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the governing law for this contract?",
        "thought":"The context provided does not explicitly mention the governing law for the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. It primarily outlines the parties involved and some terms of the agreement but lacks any reference to the jurisdiction or legal framework that governs the contract. Therefore, I cannot determine the governing law based on the available information.",
        "response":"I don't know.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "CONTENT LICENSE AGREEMENT",
            "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:",
            "; (b) Contracts pursuant to which the Company grants any Person any license, sublicense, consent, waiver, covenant not to sue or other right with respect to any Intellectual Property material to the business of the Company as of the date of this Agreement; (c) co-existence agreements and settlement agreements relating to any Owned Intellectual Property or Exclusive Intellectual Property",
            "i. The execution, delivery and performance of this Agreement have been duly authorized by all necessary corporate action on the part of Licensee and this Agreement constitutes a valid and legally binding agreement of Licensee enforceable against Licensee in accordance with its terms;\n\nii. It will use the Titles solely as permitted under this Agreement;\n\niii. It has the full right, capacity and authority to enter into this Agreement and to perform all of its obligations hereunder; and"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Does this contract include an exclusivity agreement?",
        "thought":"The context explicitly states that the Agreement includes a clause on non-exclusivity, indicating that the Licensee, Empirical Ventures, Inc., is not restricted from entering into similar agreements with other parties. This implies that the contract does not include an exclusivity agreement, as exclusivity would prevent the Licensee from engaging with third parties. Therefore, the terms 'non-exclusivity' and 'exclusivity agreement' are directly related, with the former negating the latter.",
        "response":"The Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. does not include an exclusivity agreement, as it explicitly states that the Licensee is free to enter into similar agreements with third parties.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "13\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\n(c) Non-Exclusivity. Nothing in this Agreement limits or restricts Licensee from entering into any similar agreements with any third party.",
            ", exclusive or non-exclusive) licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business and non-exclusive licenses granted or received in the Ordinary Course of Business consistent with past practice), or (B) is restricted in its rights, or permits other Persons, to use or register any material Intellectual Property Rights or Key Marks, including any license agreements, coexistence agreements",
            ";   (iii)            each Contract that (A) grants any exclusive rights to any Third Party, including any exclusive license or supply or distribution agreement or other exclusive rights or which, pursuant to its terms, could have such effect after the Closing solely as a result of the consummation of the transactions contemplated hereby, (B) grants any rights of first refusal or rights of first negotiation with respect to any product, service or Company Owned IP",
            ". This Agreement grants no rights of ownership, licenses, and\/or any other intellectual property rights, nor does it create any agency, partnership, joint venture or any other relationship not expressly stated herein."
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
        "thought":"The context specifies that any merger, consolidation, or reorganization involving the Licensee (Empirical Ventures, Inc.) is considered a transfer of rights and obligations under the Agreement, requiring prior written consent from the Licensor (PSiTech Corporation). This indicates that a change of control, such as a merger or acquisition, would necessitate Licensor's approval to maintain compliance with the Agreement. Therefore, the relevant terminology here is 'change of control' which aligns with the 'merger, consolidation or reorganization' mentioned in the context.",
        "response":"In the event of a change of control of Empirical Ventures, Inc. (the Licensee), it is deemed a transfer of rights and obligations under the Content License Agreement, requiring prior written consent from PSiTech Corporation (the Licensor). This implies that without such consent, the Licensee remains obligated under the Agreement.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "CONTENT LICENSE AGREEMENT",
            ". For purposes of the preceding sentence, and without limiting its generality, any merger, consolidation or reorganization involving Licensee (regardless of whether Licensee is a surviving or disappearing entity) will be deemed to be a transfer of rights, obligations or performance under this Agreement for which Licensor's prior written consent is required. No delegation or other transfer will relieve Licensee of any of its obligations or performance under this Agreement",
            ".   6.3 Effect of Expiration or Termination. Upon any expiration or termination of this Agreement:   (a) All licenses granted under this Agreement shall also terminate, and Licensee shall immediately delete from its systems and servers all Licensed Content, Licensor's Marks and any other materials provided by Licensor. Upon Licensor's written request, Licensee shall promptly provide Licensor with written certification of such deletion",
            ". Neither this Agreement nor the licenses granted hereunder convey any ownership right in any of the Licensed Content, Licensor's Marks or other materials provided by or on behalf of Licensor under this Agreement. Except for the express licenses granted in this Agreement, all right, title and interest in and to the Licensed Content and Licensor's Marks are and will remain with Licensor and its licensors.   4. Licensee Obligations.   4.1 Content Display"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Is there an anti-assignment clause in this contract?",
        "thought":"The context contains multiple references to assignment clauses within the Content License Agreement between PSiTech Corporation (Licensor) and Empirical Ventures, Inc. (Licensee). Specifically, Section 9 and Section 10.5 both state that neither party may assign their rights or obligations under the Agreement without prior written consent from the other party, indicating the presence of an anti-assignment clause. Additionally, the first context reinforces that any assignment in violation of this clause is void, further confirming its existence.",
        "response":"Yes, the Content License Agreement contains an anti-assignment clause, as neither party may assign their rights or obligations without prior written consent from the other party.",
        "retrieved_contexts":[
            ". Any purported assignment, delegation or transfer in violation of this Section 11.7 is void from the outset and shall be of no force or effect. Licensor may freely assign or otherwise transfer all or any of its rights, or delegate or otherwise transfer all or any of its obligations or performance, under this Agreement without Licensee's consent. This Agreement is binding upon and inures to the benefit of the parties hereto and their respective permitted successors and assigns.",
            ".9 No Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties (whether by operation of Law or otherwise) without the prior written consent of the other parties. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns",
            "10.5    Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned or delegated, in whole or in part, by operation of law or otherwise by any of the parties hereto without the prior written consent of the other parties, and any such assignment without such prior written consent shall be null and void",
            ". This Agreement grants no rights of ownership, licenses, and\/or any other intellectual property rights, nor does it create any agency, partnership, joint venture or any other relationship not expressly stated herein.",
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
        "thought":"The Content License Agreement between PSiTech Corporation (Licensor) and Empirical Ventures, Inc. (Licensee) explicitly states that no royalties or fees are owed by the Licensee, indicating a lack of traditional revenue-sharing. However, it does mention 'profit participation rights' for specific projects as detailed in Schedule A6, which implies that there are certain arrangements for sharing profits related to those projects. Therefore, while there is no general revenue sharing, there are specific profit-sharing provisions for designated projects.",
        "response":"The Content License Agreement does not include general revenue sharing, as no royalties or fees are owed by the Licensee. However, it does imply that there are specific profit participation rights for certain projects as outlined in Schedule A6.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "No royalty or fees of any kind shall be owed by Licensee under this Agreement. The consideration for the licenses granted by Licensor to Licensee under this Agreement is the issuance of the IP Common Shares as defined in the Amended and Securities Purchase Agreement, dated as of December 21, 2015, by and among the Licensee and the Licensor (the \"Share Consideration\").\n\n11. Use of Licensor Marks.",
            "CONTENT LICENSE AGREEMENT",
            ", payments and obligations arising out of the activities contemplated by this Agreement, and Licensee shall have no responsibility or liability for any such royalties or fees",
            "(e) Profit Participation. For content listed in Schedule A6 of Schedule A (each a \"Project\"), Licensor will only grant Licensee certain profit participation rights, for certain durations, as detailed and set forth in Schedule A6 of Schedule A. Licensee will not have distribution rights or any other rights to the content in Schedule A6 of Schedule A under Section 2(a) [License Grant]- (d)"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What licenses are granted under this contract?",
        "thought":"The context provided discusses a Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc., but it does not specify the exact licenses granted under this contract. It mentions licensing arrangements and payments related to intellectual property but lacks specific details on the licenses themselves. Therefore, while the context implies that licenses are involved, it does not explicitly state what those licenses are.",
        "response":"The context does not specify the exact licenses granted under the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; it only implies that licensing arrangements exist.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "CONTENT LICENSE AGREEMENT",
            "(vii)          is (A) a license agreement pursuant to which the Company or any Company Subsidiary is licensed by a third party to use any Intellectual Property or Intellectual Property Rights for which the Company or any Company Subsidiary is required to make annual payments in excess of $2,000,000 (other than any \u201ccommercially available off-the-shelf software package,\u201d or other software licensed pursuant to a software \u201cshrink wrap",
            ", option to license, or any other similar rights with respect to any Company Product or any material Intellectual Property Rights, in each case, which payments are in an amount having an expected value in excess of $50,000,000 in the fiscal year ending December 31, 2020",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Are the licenses granted under this contract non-transferable?",
        "thought":"The context clearly states that the Licensee, Empirical Ventures, Inc., is prohibited from assigning or transferring its rights or obligations under the Content License Agreement without prior written consent from the Licensor, PSiTech Corporation. This indicates that the licenses granted under this contract are indeed non-transferable by the Licensee. The Licensor, however, retains the right to assign or transfer its rights without the Licensee's consent, which does not affect the Licensee's non-transferability obligation.",
        "response":"The licenses granted under the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc. are non-transferable by the Licensee without the Licensor's prior written consent.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            ". Any purported assignment, delegation or transfer in violation of this Section 11.7 is void from the outset and shall be of no force or effect. Licensor may freely assign or otherwise transfer all or any of its rights, or delegate or otherwise transfer all or any of its obligations or performance, under this Agreement without Licensee's consent. This Agreement is binding upon and inures to the benefit of the parties hereto and their respective permitted successors and assigns.",
            ". Neither this Agreement nor the licenses granted hereunder convey any ownership right in any of the Licensed Content, Licensor's Marks or other materials provided by or on behalf of Licensor under this Agreement. Except for the express licenses granted in this Agreement, all right, title and interest in and to the Licensed Content and Licensor's Marks are and will remain with Licensor and its licensors.   4. Licensee Obligations.   4.1 Content Display",
            "CONTENT LICENSE AGREEMENT",
            ". Licensee shall not assign or otherwise transfer any of its rights, or delegate or otherwise transfer any of its obligations or performance, under this Agreement, in each case whether voluntarily, involuntarily, by operation of law or otherwise, without Licensor's prior written consent"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What are the audit rights under this contract?",
        "thought":"The context outlines the audit rights under the Content License Agreement between PSiTech Corporation (the Licensor) and Empirical Ventures, Inc. (the Licensee). It specifies that either party can conduct an audit once per contract year with five days' notice, allowing them to inspect relevant records. Additionally, it details the financial responsibilities related to the audit costs, particularly if discrepancies are found.",
        "response":"Under the Content License Agreement, both PSiTech Corporation (Licensor) and Empirical Ventures, Inc. (Licensee) have the right to conduct an audit once per contract year with five days' notice. The Licensor may inspect the Licensee's records related to the Licensed Products, and if discrepancies of 5% or more are found, the Licensee must reimburse the audit costs.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            "18.02 Audit Rights",
            ". Audit Rights:   (a) The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm",
            "Each Party shall cause any Subsidiary or other Affiliate (including, without limitation, a Subsidiary or other Affiliate of the Online Group or Skype Group, as applicable) to grant to the other Party the audit rights granted hereunder with respect to such other Party.",
            ".   Licensor may take copies and abstracts of materials audited. Licensor will pay the cost of such audits unless an audit reveals a discrepancy in payment or reporting of five percent (5%) or more, in which case the Licensee shall reimburse the Licensor for the reasonable cost of the audit. Licensee shall immediately upon notice from Licensor pay Licensor the amount of any underpayment revealed by the audit, including interest calculated in accordance with Section 5"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Is there uncapped liability under this contract?",
        "thought":"The Content License Agreement between PSiTech Corporation (Licensor) and Empirical Ventures, Inc. (Licensee) explicitly states that neither party shall be liable for indirect, incidental, or consequential damages. Additionally, Section 9.2 caps each party's liability to the aggregate amounts paid to the Licensor in the twelve months preceding a claim, indicating that there is a limitation on liability rather than uncapped liability. Therefore, the context implies that there is no uncapped liability under this contract.",
        "response":"Under the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc., there is a cap on liability, limiting it to the amounts paid to the Licensor in the preceding twelve months, thus indicating no uncapped liability exists.",
        "retrieved_contexts":[
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            ". NEITHER PARTY SHALL BE LIABLE UNDER OR IN CONNECTION WITH THIS AGREEMENT FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, LIQUIDATED, SPECIAL OR EXEMPLARY DAMAGES OR PENALTIES, INCLUDING WITHOUT LIMITATION, LOSSES OF BUSINESS, REVENUE OR ANTICIPATED PROFITS, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY",
            "9.2 Cap on Monetary Damages. EACH PARTY'S LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT WILL NOT EXCEED AN AMOUNT EQUAL TO THE AGGREGATE AMOUNTS PAID OR PAYABLE TO LICENSOR IN THE TWELVE (12) MONTHS PRECEDING THE COMMENCEMENT OF THE CLAIM.   9.3 Exceptions. The provisions of Section 9.1 and Section 9.2 will not apply to limit the Licensee's indemnification obligations under Section 8.2, or in the case of Licensee's gross negligence or wilful misconduct.   10. Confidentiality",
            ". (e) Notwithstanding anything to the contrary in this Agreement, the representations and warranties contained in this Section 4.17, together with Section 4.10(a)(vi), are the only representations and warranties being made by the Company in this Agreement with respect to Intellectual Property rights or the violation of any Person\u2019s privacy or personal information. Section 4.18  Insurance Coverage"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Is there a cap on liability under this contract?",
        "thought":"The context clearly states that each party's liability under the Content License Agreement is capped at the aggregate amounts paid or payable to the Licensor in the twelve months preceding the claim. This indicates a limitation on liability, which is relevant to the question. Additionally, it specifies exceptions to this cap, such as indemnification obligations and cases of gross negligence or willful misconduct, which further clarifies the scope of liability under the contract.",
        "response":"Yes, there is a cap on liability under the Content License Agreement between PSiTech Corporation (Licensor) and Empirical Ventures, Inc. (Licensee), which limits each party's liability to the total amounts paid to the Licensor in the twelve months prior to the claim.",
        "retrieved_contexts":[
            "9.2 Cap on Monetary Damages. EACH PARTY'S LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT WILL NOT EXCEED AN AMOUNT EQUAL TO THE AGGREGATE AMOUNTS PAID OR PAYABLE TO LICENSOR IN THE TWELVE (12) MONTHS PRECEDING THE COMMENCEMENT OF THE CLAIM.   9.3 Exceptions. The provisions of Section 9.1 and Section 9.2 will not apply to limit the Licensee's indemnification obligations under Section 8.2, or in the case of Licensee's gross negligence or wilful misconduct.   10. Confidentiality",
            "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY",
            ". NEITHER PARTY SHALL BE LIABLE UNDER OR IN CONNECTION WITH THIS AGREEMENT FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, LIQUIDATED, SPECIAL OR EXEMPLARY DAMAGES OR PENALTIES, INCLUDING WITHOUT LIMITATION, LOSSES OF BUSINESS, REVENUE OR ANTICIPATED PROFITS, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.",
            ".     (c) This Section shall survive the termination or expiration of this Agreement.     16. LIMITATION OF LIABILITY.   Except with respect to any claim or liability arising from an infringement of any third party intellectual property right, in no event shall either party be liable for any special, indirect, consequential, punitive or incidental damages of any kind. This Section shall survive the termination or expiration of this Agreement.     17. COPYRIGHT ROYALTY PAYMENTS"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; What is the expiration date of this contract?",
        "thought":"The question asks for the expiration date of the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. The context provides the Effective Date of the Agreement as December 21, 2015, but does not specify an expiration date or duration of the contract. Therefore, it implies that the expiration date is not provided in the context.",
        "response":"The expiration date of the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. is not specified in the provided context.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd",
            "CONTENT LICENSE AGREEMENT",
            ", such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; What is the governing law for this contract?",
        "thought":"The context provided includes a Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. However, it does not specify the governing law for this contract. Without explicit information regarding the governing law in the context, I cannot determine the applicable legal jurisdiction for the agreement.",
        "response":"I don't know.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "CONTENT LICENSE AGREEMENT",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd",
            "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program\/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and\/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks\/Company Servers x Full Television Broadcast Rights"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "thought":"The context mentions rights of first refusal and rights of first negotiation in relation to exclusive rights granted to third parties. The Content License Agreement between Beijing Sun Seven Stars Culture Development Limited (Licensor) and You On Demand Holdings, Inc. (Licensee) does not explicitly state whether it includes these rights, but it does reference them in a broader context. Therefore, while the contract may imply the existence of such rights, it does not definitively confirm their inclusion.",
        "response":"The Content License Agreement does imply the possibility of rights of first refusal or rights of first negotiation, but it does not explicitly confirm their inclusion within the contract.",
        "retrieved_contexts":[
            ";   (iii)            each Contract that (A) grants any exclusive rights to any Third Party, including any exclusive license or supply or distribution agreement or other exclusive rights or which, pursuant to its terms, could have such effect after the Closing solely as a result of the consummation of the transactions contemplated hereby, (B) grants any rights of first refusal or rights of first negotiation with respect to any product, service or Company Owned IP",
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "CONTENT LICENSE AGREEMENT",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            ", right of first negotiation, option to purchase, option to license, or any other similar rights with respect to any Company Product or any material Intellectual Property Rights"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Is there an anti-assignment clause in this contract?",
        "thought":"The context provides information about the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited (Licensor) and You On Demand Holdings, Inc. (Licensee). It specifies that neither party can assign or delegate their rights or obligations under the Agreement without prior written consent from the other party, indicating the presence of an anti-assignment clause. This clause is relevant to the question as it directly addresses the issue of assignment in the contract.",
        "response":"Yes, the Content License Agreement contains an anti-assignment clause, which states that neither party may assign or delegate their rights or obligations without the prior written consent of the other party.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "CONTENT LICENSE AGREEMENT",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            ". Any purported assignment, delegation or transfer in violation of this Section 11.7 is void from the outset and shall be of no force or effect. Licensor may freely assign or otherwise transfer all or any of its rights, or delegate or otherwise transfer all or any of its obligations or performance, under this Agreement without Licensee's consent. This Agreement is binding upon and inures to the benefit of the parties hereto and their respective permitted successors and assigns.",
            "10.5    Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned or delegated, in whole or in part, by operation of law or otherwise by any of the parties hereto without the prior written consent of the other parties, and any such assignment without such prior written consent shall be null and void"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
        "thought":"The Content License Agreement between Beijing Sun Seven Stars Culture Development Limited (Licensor) and You On Demand Holdings, Inc. (Licensee) explicitly states that no royalties or fees are owed by the Licensee under this Agreement. Instead, the consideration for the licenses is the issuance of IP Common Shares, which indicates that there is no revenue or profit-sharing arrangement in the traditional sense, as the Licensee does not owe any payments based on revenue or profits generated from the licensed content.",
        "response":"The Content License Agreement does not include any revenue or profit-sharing arrangements, as it specifies that no royalties or fees are owed by You On Demand Holdings, Inc. to Beijing Sun Seven Stars Culture Development Limited; the consideration is solely the issuance of IP Common Shares.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            "CONTENT LICENSE AGREEMENT",
            "No royalty or fees of any kind shall be owed by Licensee under this Agreement. The consideration for the licenses granted by Licensor to Licensee under this Agreement is the issuance of the IP Common Shares as defined in the Amended and Securities Purchase Agreement, dated as of December 21, 2015, by and among the Licensee and the Licensor (the \"Share Consideration\").\n\n11. Use of Licensor Marks.",
            ", payments and obligations arising out of the activities contemplated by this Agreement, and Licensee shall have no responsibility or liability for any such royalties or fees"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; What are the audit rights under this contract?",
        "thought":"The question asks about the audit rights specified in the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited (Licensor) and You On Demand Holdings, Inc. (Licensee). The relevant section from the context indicates that each party is required to ensure that their subsidiaries or affiliates grant audit rights to the other party. This implies that both parties have the right to conduct audits on each other's subsidiaries or affiliates as part of the agreement.",
        "response":"Under the Content License Agreement, each party, Beijing Sun Seven Stars Culture Development Limited (Licensor) and You On Demand Holdings, Inc. (Licensee), has the right to audit the other party's subsidiaries or affiliates, ensuring compliance with the terms of the agreement.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            "CONTENT LICENSE AGREEMENT",
            "18.02 Audit Rights",
            "Each Party shall cause any Subsidiary or other Affiliate (including, without limitation, a Subsidiary or other Affiliate of the Online Group or Skype Group, as applicable) to grant to the other Party the audit rights granted hereunder with respect to such other Party."
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Is there uncapped liability under this contract?",
        "thought":"The Content License Agreement specifies that neither party shall be liable for indirect, incidental, consequential, or special damages, which implies a limitation on liability. However, it does not explicitly state that liability is uncapped; instead, it outlines specific exclusions for certain types of damages. Therefore, the agreement suggests that there is capped liability concerning indirect damages, but it does not clarify the extent of liability for direct damages or breaches of specific sections.",
        "response":"The Content License Agreement between Beijing Sun Seven Stars Culture Development Limited (Licensor) and You On Demand Holdings, Inc. (Licensee) implies that there is capped liability for indirect damages, as it excludes liability for such damages. However, the agreement does not explicitly state that liability is uncapped, leaving the extent of liability for direct damages or specific breaches unclear.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            "CONTENT LICENSE AGREEMENT",
            ". NEITHER PARTY SHALL BE LIABLE UNDER OR IN CONNECTION WITH THIS AGREEMENT FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, LIQUIDATED, SPECIAL OR EXEMPLARY DAMAGES OR PENALTIES, INCLUDING WITHOUT LIMITATION, LOSSES OF BUSINESS, REVENUE OR ANTICIPATED PROFITS, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
        ]
    },
    {
        "user_input":"Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Is there a cap on liability under this contract?",
        "thought":"The question asks about a cap on liability in the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited (Licensor) and You On Demand Holdings, Inc. (Licensee). The context specifies a limitation of liability clause that states neither party shall be liable for indirect, incidental, consequential, liquidated, special, or exemplary damages, which implies that there is a limitation on liability but does not explicitly mention a cap. Therefore, while there is a limitation, it does not define a specific monetary cap on liability.",
        "response":"The Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc. includes a limitation of liability clause that states neither party shall be liable for indirect, incidental, or consequential damages, implying a limitation on liability but not specifying a monetary cap.",
        "retrieved_contexts":[
            "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").",
            "CONTENT LICENSE AGREEMENT",
            "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: \/s\/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: \/s\/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3\/30\/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]",
            ".     (c) This Section shall survive the termination or expiration of this Agreement.     16. LIMITATION OF LIABILITY.   Except with respect to any claim or liability arising from an infringement of any third party intellectual property right, in no event shall either party be liable for any special, indirect, consequential, punitive or incidental damages of any kind. This Section shall survive the termination or expiration of this Agreement.     17. COPYRIGHT ROYALTY PAYMENTS",
            ". NEITHER PARTY SHALL BE LIABLE UNDER OR IN CONNECTION WITH THIS AGREEMENT FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, LIQUIDATED, SPECIAL OR EXEMPLARY DAMAGES OR PENALTIES, INCLUDING WITHOUT LIMITATION, LOSSES OF BUSINESS, REVENUE OR ANTICIPATED PROFITS, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES."
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What is the expiration date of this contract?",
        "thought":"The context specifies that the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc. has a term of three years from the effective date. However, it does not provide the specific effective date, which is necessary to determine the exact expiration date of the contract. Therefore, while the term is clear, the expiration date cannot be determined without additional information regarding the effective date.",
        "response":"The Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc. has a term of three years, but the specific expiration date cannot be determined without knowing the effective date.",
        "retrieved_contexts":[
            "Section 1.01. Term. The term of this Agreement shall be effective as of the date first stated above and shall continue for a term of three (3) years, unless terminated earlier in accordance with the provisions of this Agreement (the \"Term\"); provided, however, that PrimeCall may elect to terminate this Agreement, upon thirty (30) days' written notice, at any time from and after the time that collectively RSL Communications, Ltd",
            "4\n\ndate shall be no earlier than ten (10) days after the date of such notice.",
            "Section 5.01. Payment Terms. Any amounts due hereunder shall be calculated and paid in U.S. dollars on a monthly basis within twenty-five (25) business days following the receipt of the reports detailed in Sections 3.06  [Reporting] and 4.02  [Reporting] hereof or any other invoices provided for herein. All payments shall be made via wire transfer in accordance with written instructions from the parties.\n\n                                   ARTICLE VI  [Termination]",
            ". In the event that either PrimeCall or DeltaThree materially breaches any of its duties or obligations hereunder, which breach shall not be cured within thirty (30) days after written notice is given to the breaching party specifying the breach, then either PrimeCall or DeltaThree, as the case may be, may, by giving written notice thereof to the other, terminate this Agreement as of a date specified in such notice of termination, which",
            "10\n\nSource: DELTATHREE INC, S-1\/A, 11\/2\/1999"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What is the governing law for this contract?",
        "thought":"The context explicitly states the governing law for the Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc. as the laws of the State of New York. This is found in Section 9.11, which directly addresses the governing law clause. Therefore, the relevant information indicates that New York law applies to the contract.",
        "response":"The governing law for the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc. is the laws of the State of New York, as specified in Section 9.11 of the Agreement.",
        "retrieved_contexts":[
            ". Each party will, at any time and from time to time after the date hereof, upon the request of the other, do, execute, acknowledge and deliver, or shall cause to be done, executed, acknowledged and delivered, all such other instruments as may be reasonably required in connection with the performance of this Agreement and each shall take all such further actions as may be reasonably required to carry out or further effect the transactions contemplated by this Agreement",
            "Section 9.05  [No Modification Except in Writing]. No Modification Except in Writing. This Agreement shall not be changed, modified, or amended except by a writing signed by the party to be charged and this Agreement may not be discharged except by performance in accordance with its terms or by a writing signed by the party to be charged.",
            "ARTICLE VII  [Limited Warranty]\n\n                                Limited Warranty",
            ", (ii) such termination shall not constitute a waiver of any right to receive payments that are due and owing pursuant to this Agreement and (iii) the provisions of Article VII  [Limited Warranty] shall continue in full force and effect",
            "Section 9.11  [Governing Law]. Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without giving effect to the conflict of laws principles thereof. For purposes of this\n\nSource: DELTATHREE INC, S-1\/A, 11\/2\/1999"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
        "thought":"The question asks about the implications of a change of control of either party in the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc. The relevant context is found in Section 9.09, which discusses assignment and indicates that DeltaThree cannot assign the agreement without PrimeCall's consent, while PrimeCall can assign it under certain conditions. This implies that a change of control for DeltaThree would require PrimeCall's approval, whereas PrimeCall has more flexibility in such situations.",
        "response":"In the event of a change of control of DeltaThree, PrimeCall's prior written consent is required for any assignment of the Agreement, as stated in Section 9.09. Conversely, PrimeCall may assign the Agreement to an affiliate or in connection with a merger without such restrictions. Therefore, the implications of a change of control differ significantly between the two parties.",
        "retrieved_contexts":[
            ". Each party will, at any time and from time to time after the date hereof, upon the request of the other, do, execute, acknowledge and deliver, or shall cause to be done, executed, acknowledged and delivered, all such other instruments as may be reasonably required in connection with the performance of this Agreement and each shall take all such further actions as may be reasonably required to carry out or further effect the transactions contemplated by this Agreement",
            "Section 9.05  [No Modification Except in Writing]. No Modification Except in Writing. This Agreement shall not be changed, modified, or amended except by a writing signed by the party to be charged and this Agreement may not be discharged except by performance in accordance with its terms or by a writing signed by the party to be charged.",
            "Section 9.09  [Assignment]. Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall. PrimeCall may assign this Agreement to any affiliate of PrimeCall or in connection with a merger or consolidation of PrimeCall or a sale of all or substantially all of PrimeCall's business",
            "Section 9.08  [Severability]. Severability. If any provision of this Agreement or the application of any provision hereof to any person or circumstances is held invalid, the remainder of this Agreement and the application of such provision to other persons or circumstances shall not be affected unless the provision held invalid shall substantially impair the benefits of the remaining portions of this Agreement.\n\n                                       8",
            ". In the event of the termination of this Agreement, all rights and obligations of PrimeCall and DeltaThree shall terminate as of the effective date of such termination, except that (i) such termination shall not constitute a waiver of any rights that either PrimeCall or DeltaThree may have by reason of a breach of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; Is there an anti-assignment clause in this contract?",
        "thought":"The context includes a specific section on assignment (Section 9.09) that states DeltaThree cannot assign the agreement without PrimeCall's prior written consent, indicating an anti-assignment clause. Additionally, it mentions that PrimeCall can assign the agreement under certain conditions, which further clarifies the restrictions on assignment. Therefore, the presence of an anti-assignment clause is confirmed as it restricts DeltaThree's ability to assign the agreement without consent.",
        "response":"Yes, there is an anti-assignment clause in the Co-Branding and Services Agreement, as DeltaThree cannot assign the agreement without the prior written consent of PrimeCall.",
        "retrieved_contexts":[
            "Section 9.04  [Independent Contractors]. Independent Contractors. At all times the parties hereto shall be considered independent contractors and this Agreement shall not create any agency, partnership or employment relationship between the parties. Except as specifically set forth herein, neither party shall have the right to act for or on behalf of or in the name of the other party.",
            "Section 9.09  [Assignment]. Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall. PrimeCall may assign this Agreement to any affiliate of PrimeCall or in connection with a merger or consolidation of PrimeCall or a sale of all or substantially all of PrimeCall's business",
            "Section 9.05  [No Modification Except in Writing]. No Modification Except in Writing. This Agreement shall not be changed, modified, or amended except by a writing signed by the party to be charged and this Agreement may not be discharged except by performance in accordance with its terms or by a writing signed by the party to be charged.",
            ". Except as provided in the preceding sentence, this Agreement may not be assigned by PrimeCall without the prior written consent of DeltaThree.",
            "Section 9.11  [Governing Law]. Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without giving effect to the conflict of laws principles thereof. For purposes of this\n\nSource: DELTATHREE INC, S-1\/A, 11\/2\/1999"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What licenses are granted under this contract?",
        "thought":"The context outlines a 'Limited License' granted between RSL COM PrimeCall, Inc. and deltathree.com, Inc. for the use of each other's proprietary marks specifically for the sale, distribution, marketing, and promotion of calling cards. It also emphasizes that this license is subject to quality standards and requires prior consent for any use outside the agreed terms. Therefore, the licenses granted under this contract are limited to the specified use of proprietary marks with conditions attached.",
        "response":"Under the Co-Branding and Services Agreement, RSL COM PrimeCall, Inc. and deltathree.com, Inc. grant each other a limited license to use their proprietary marks solely for the sale, distribution, marketing, and promotion of calling cards, subject to quality standards and prior consent for any other use.",
        "retrieved_contexts":[
            "Section 2.03  [Limited License]. Limited License. Throughout the Term of this Agreement, the parties hereby agree to grant to each other a limited license to use each other's proprietary marks solely in connection with the sale, distribution, marketing and promotion of each party's calling cards by the other party. Both parties hereto shall exercise such license in compliance with the quality and other standards established by the party owning such marks",
            "Section 9.09  [Assignment]. Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall. PrimeCall may assign this Agreement to any affiliate of PrimeCall or in connection with a merger or consolidation of PrimeCall or a sale of all or substantially all of PrimeCall's business",
            ". Each party will, at any time and from time to time after the date hereof, upon the request of the other, do, execute, acknowledge and deliver, or shall cause to be done, executed, acknowledged and delivered, all such other instruments as may be reasonably required in connection with the performance of this Agreement and each shall take all such further actions as may be reasonably required to carry out or further effect the transactions contemplated by this Agreement",
            "ARTICLE VII  [Limited Warranty]\n\n                                Limited Warranty",
            ". Except as set forth herein, neither party shall use the other party's proprietary marks without the prior, express, written consent of the other party. All rights to either party's proprietary marks shall remain with the owner of the marks."
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; Is there a cap on liability under this contract?",
        "thought":"The context outlines a limited warranty clause that specifies both parties, RSL PrimeCall, Inc. and deltathree.com, Inc., are not liable for special, incidental, or consequential damages. It also states that the liability of each party is capped at the direct damages of the other party. This indicates that there is indeed a cap on liability under the Co-Branding and Services Agreement.",
        "response":"Yes, there is a cap on liability under the Co-Branding and Services Agreement, as both RSL PrimeCall, Inc. and deltathree.com, Inc. have their liability limited to the direct damages of the other party.",
        "retrieved_contexts":[
            "ARTICLE VII  [Limited Warranty]\n\n                                Limited Warranty",
            ". IN NO EVENT SHALL DELTATHREE BE LIABLE TO PRIMECALL FOR ANY SPECIAL, INCIDENTIAL OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, LOSS OF PROFITS, REVENUES OR DATA WHETHER BASED ON BREACH OF CONTRACT, TORT OR OTHERWISE, WHETHER OR NOT PRIMECALL HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. THE LIABILITY OF DELTATHREE FOR DAMAGES OR ALLEGED DAMAGES HEREUNDER, WHETHER IN CONTRACT, TORT OR ANY OTHER LEGAL THEORY, IS LIMITED TO, AND WILL NOT EXCEED, PRIMECALL'S DIRECT DAMAGES.",
            ". IN NO EVENT SHALL PRIMECALL BE LIABLE TO DELTATHREE FOR ANY SPECIAL, INCIDENTIAL OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, LOSS OF PROFITS, REVENUES OR DATA WHETHER BASED ON BREACH OF CONTRACT, TORT OR OTHERWISE, WHETHER OR NOT DELTATHREE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. THE LIABILITY OF PRIMECALL FOR DAMAGES OR ALLEGED DAMAGES HEREUNDER, WHETHER IN CONTRACT, TORT OR ANY OTHER LEGAL THEORY, IS LIMITED TO, AND WILL NOT EXCEED, DELTATHREE'S DIRECT DAMAGES.",
            ", (ii) such termination shall not constitute a waiver of any right to receive payments that are due and owing pursuant to this Agreement and (iii) the provisions of Article VII  [Limited Warranty] shall continue in full force and effect",
            "(and without limiting the availability of legal or equitable, including injunctive, remedies under any other provisions of this Agreement), each of PrimeCall and DeltaThree agrees that in the event of any such breach, the other party hereto shall be entitled to injunctive relief in addition to such other legal and equitable remedies that may be available. In addition, PrimeCall and DeltaThree each agree that the provisions of Section 8"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What is the renewal term for this contract?",
        "thought":"The context specifies that the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. has an Initial Term of two years, followed by automatic Renewal Terms of twelve months each. The terminology 'Initial Term' refers to the initial two-year period, while 'Renewal Terms' refers to the successive twelve-month periods that follow unless terminated by either party. Therefore, the renewal term for this contract is twelve months.",
        "response":"The renewal term for the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. is twelve (12) months, following the initial two-year term.",
        "retrieved_contexts":[
            ". This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term. As used in this agreement, \"Term\" shall mean the Initial Term and the Renewal Terms, if any.",
            "10.1 Initial Term. This Agreement will become effective as of the Effective Date and, unless sooner terminated pursuant to Sections 3.1  [Advertising and Promotion] or 10.2  [Termination for Breach], shall remain effective for two (2) years from and after the Effective Date (the \"Initial Term\")",
            "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE",
            "10.2 Termination for Breach. In the event of a material breach of this Agreement by either party, the non-breaching party may terminate this Agreement if such breach is not cured within thirty (30) days from receipt of written notice of such breach sent to the address of the breaching party as specified herein. Such termination shall be in addition to any and all other actions or remedies the parties may seek at law or equity with respect to a breach of this Agreement.",
            "15.4 Notice. Any notice under this Agreement will be in writing and delivered by personal delivery, express courier, confirmed facsimile, confirmed e-mail or certified or registered mail, return receipt requested, and will be deemed given upon personal delivery, one (1) day after deposit with express courier, upon confirmation of receipt of facsimile or e-mail or five (5) days after deposit in the mail"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What is the notice period required to terminate the renewal?",
        "thought":"The context specifies that the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. will automatically renew for additional terms unless either party provides written notice at least sixty (60) days prior to the end of the Initial Term. The relevant terminology here includes 'Initial Term' and 'Renewal Terms,' which clarify the duration and conditions for termination. Therefore, the notice period required to terminate the renewal is explicitly stated as sixty (60) days.",
        "response":"The notice period required to terminate the renewal of the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. is sixty (60) days prior to the end of the Initial Term.",
        "retrieved_contexts":[
            ". This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term. As used in this agreement, \"Term\" shall mean the Initial Term and the Renewal Terms, if any.",
            "10.1 Initial Term. This Agreement will become effective as of the Effective Date and, unless sooner terminated pursuant to Sections 3.1  [Advertising and Promotion] or 10.2  [Termination for Breach], shall remain effective for two (2) years from and after the Effective Date (the \"Initial Term\")",
            "10.2 Termination for Breach. In the event of a material breach of this Agreement by either party, the non-breaching party may terminate this Agreement if such breach is not cured within thirty (30) days from receipt of written notice of such breach sent to the address of the breaching party as specified herein. Such termination shall be in addition to any and all other actions or remedies the parties may seek at law or equity with respect to a breach of this Agreement.",
            "15.4 Notice. Any notice under this Agreement will be in writing and delivered by personal delivery, express courier, confirmed facsimile, confirmed e-mail or certified or registered mail, return receipt requested, and will be deemed given upon personal delivery, one (1) day after deposit with express courier, upon confirmation of receipt of facsimile or e-mail or five (5) days after deposit in the mail",
            "(g) within sixty (60) days after such Termination Date, Women.com shall make-good to eDiets any and all payments made to Women.com under this Agreement for advertising inventory not yet delivered or run, provided that eDiets has paid for such inventory; and"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What is the governing law for this contract?",
        "thought":"The context provided does not explicitly state the governing law for the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. It discusses obligations, enforceability, and general provisions but lacks specific information regarding the jurisdiction or governing law applicable to the contract. Therefore, it cannot be determined from the given context what the governing law is.",
        "response":"The context does not specify the governing law for the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc.",
        "retrieved_contexts":[
            "by such party of its obligations and duties hereunder, do not and will not violate any agreement to which such party is a party or by which it is bound, (c) when executed and delivered by such party, this Agreement will constitute the legal, valid and binding obligation of such party, enforceable against such party in accordance with its terms and (d) such party will perform its obligations hereunder in compliance with applicable law and regulations.",
            "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is",
            "12.1 General. Each party represents and warrants to the other that: (a) such party has the full corporate right, power, and authority to enter into this Agreement and perform the acts required of it hereunder, (b) the execution of this Agreement by such party, and the performance\n\n                                       10",
            ". This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns",
            "15.7 Severability. In the event that any of the provisions of this Agreement are held to be unenforceable, the remaining portions of the Agreement will remain in full force and effect.\n\n         15.8 Entire Agreement. This Agreement is the complete and exclusive agreement between the parties with respect to the subject matter hereof, superseding that certain Letter of\n\n                                       14"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Are there any exceptions to competitive restrictions in this contract?",
        "thought":"The context discusses exclusivity and competitive restrictions in the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. It mentions that Women.com will not engage with competitive companies in specific areas, implying that there are restrictions on competition. However, it does not explicitly outline any exceptions to these competitive restrictions, only mentioning liability and agency terms.",
        "response":"The context does not provide explicit exceptions to the competitive restrictions in the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. It only implies that Women.com is restricted from entering relationships with competitive companies in specified areas.",
        "retrieved_contexts":[
            "5.       EXCLUSIVITY.",
            ".com will not enter into a relationship with a Competitive Company that involves any of the following; (i) custom developed mini or micro web sites; (ii) content integration; (iii) discounts offered only to Women.com members on the Member Central page of the Women.com Sites; (iv) editorial endorsement (such as",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY",
            "15.5 No Agency. The parties are independent contractors and will have no power or authority to assume or create any obligation or responsibility on behalf of each other. This Agreement will not be construed to create or imply any partnership, agency or joint venture.",
            "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "thought":"The provided context does not mention any rights of first refusal, right of first offer, or right of first negotiation. It primarily discusses the nature of the relationship between the parties, the term of the agreement, and general provisions such as severability and assignment. Therefore, it implies that such rights are not included in the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc.",
        "response":"The Co-Branding Agreement does not include any right of first refusal, right of first offer, or right of first negotiation, as these terms are not mentioned in the provided context.",
        "retrieved_contexts":[
            "15.5 No Agency. The parties are independent contractors and will have no power or authority to assume or create any obligation or responsibility on behalf of each other. This Agreement will not be construed to create or imply any partnership, agency or joint venture.",
            "10.1 Initial Term. This Agreement will become effective as of the Effective Date and, unless sooner terminated pursuant to Sections 3.1  [Advertising and Promotion] or 10.2  [Termination for Breach], shall remain effective for two (2) years from and after the Effective Date (the \"Initial Term\")",
            "15.7 Severability. In the event that any of the provisions of this Agreement are held to be unenforceable, the remaining portions of the Agreement will remain in full force and effect.\n\n         15.8 Entire Agreement. This Agreement is the complete and exclusive agreement between the parties with respect to the subject matter hereof, superseding that certain Letter of\n\n                                       14",
            "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE",
            "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What happens in the event of a change of control of one of the parties in this contract?",
        "thought":"The context defines 'Change in Control' as a merger or consolidation or sale of assets, which is relevant to the question about the implications of such a change in the Co-Branding Agreement. It also specifies that assignment of the Agreement is permitted to a successor in the event of a Change in Control, provided the successor is not a competitor. Therefore, the context implies that if a Change in Control occurs, the Agreement can be assigned to a successor without needing the other party's consent, as long as the successor is not a competitor.",
        "response":"In the event of a Change in Control, which refers to a merger, consolidation, or sale of assets, the Co-Branding Agreement can be assigned to a successor without the need for the other party's consent, provided the successor is not a competitor. This means that the rights and obligations under the Agreement can continue with the new entity assuming control.",
        "retrieved_contexts":[
            ". For purposes of this Agreement, \"Change in Control\" means a merger or consolidation of the party with, or any sale of all or substantially all of the assets of such party to, any other person, corporation or entity, unless as a result of such merger",
            "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is",
            "controlled by, under common control with, or controls a party. For purposes hereof, the terms \"control\", \"controlled by\" or \"under common control with\" refer to the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of an entity, whether through the ownership of voting securities, by contract or otherwise. Any attempt to assign this Agreement other than as permitted above will be null and void",
            "10.2 Termination for Breach. In the event of a material breach of this Agreement by either party, the non-breaching party may terminate this Agreement if such breach is not cured within thirty (30) days from receipt of written notice of such breach sent to the address of the breaching party as specified herein. Such termination shall be in addition to any and all other actions or remedies the parties may seek at law or equity with respect to a breach of this Agreement.",
            "(b) where applicable, each party shall return to the other party, within thirty (30) days from such Termination Date, all intellectual property, technology or other property in its possession used in connection with this Agreement that is proprietary to the other party;\n\n              (c) Confidential Information shall be returned in accordance with the terms of Section 11;"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Are there any price restrictions or controls specified in this contract?",
        "thought":"The context does not explicitly mention any price restrictions or controls related to the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. However, it does indicate that eDiets must offer a minimum discount of 20% on products or services and that Women.com can increase the Payment Schedule by no more than 20% once a year. These terms imply some level of price control, but they do not constitute outright restrictions.",
        "response":"The Co-Branding Agreement implies that eDiets.com must provide a minimum discount of 20% on products or services, and Women.com can increase the Payment Schedule by up to 20% annually. However, there are no explicit price restrictions stated in the contract.",
        "retrieved_contexts":[
            "11.8 The terms and conditions of this Agreement will be deemed to be the Confidential Information of each party and will not be disclosed without the written consent of the other party.\n\n12.      WARRANTY.",
            ", \"Indemnifiable Sums\") that the other party may incur as a result of third party claims arising from circumstances that constitute a breach or alleged breach of such party's warranties set forth in Section 12 or otherwise explicitly set forth in this Agreement",
            "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE",
            "eDiets shall offer in any membership offer provided pursuant to this Agreement a minimum discount of 20% on the fair market value of any products or services.\n\nPlacement within Women.com Newsletters:",
            ".com shall have the right, upon no fewer than sixty (60) days prior written notice to eDiets, to increase the amount of the Payment Schedule; provided, that (i) Women.com may not increase the Payment Schedule more than once in any period of twelve (12) consecutive months; and (ii) such increase may not exceed twenty percent (20%) of the then current Payment Schedule."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there a minimum commitment required under this contract?",
        "thought":"The context provides information about the duration of the agreement, specifically mentioning an 'Initial Term' of two years. However, it does not explicitly state any minimum commitment required under the contract beyond this term. Therefore, while the two-year term implies a commitment, it does not clarify if there are additional minimum commitments required.",
        "response":"The Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. specifies an 'Initial Term' of two years, which implies a commitment for that duration, but does not explicitly outline any additional minimum commitments required under the contract.",
        "retrieved_contexts":[
            "15.5 No Agency. The parties are independent contractors and will have no power or authority to assume or create any obligation or responsibility on behalf of each other. This Agreement will not be construed to create or imply any partnership, agency or joint venture.",
            "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE",
            "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is",
            "10.1 Initial Term. This Agreement will become effective as of the Effective Date and, unless sooner terminated pursuant to Sections 3.1  [Advertising and Promotion] or 10.2  [Termination for Breach], shall remain effective for two (2) years from and after the Effective Date (the \"Initial Term\")",
            ". This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What licenses are granted under this contract?",
        "thought":"The context provided discusses various aspects of the Co-Branding Agreement but does not explicitly mention the specific licenses granted under the contract between Women.com Networks, Inc. and eDiets.com, Inc. The mention of licenses is limited to the termination of rights and licenses, which implies that both parties retain rights to their respective tools and methodologies. However, without specific details on the licenses granted, I cannot provide a definitive answer regarding the licenses under this contract.",
        "response":"I don't know.",
        "retrieved_contexts":[
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY",
            "8.5 Tools. To the extent either party, directly or indirectly, utilizes any software, HTML and\/or Java scripts, proprietary tools and\/or methodologies (collectively the \"Tools\") in performing under this Agreement, such party and its licensors retain all right, title and interest in and to any such Tools.\n\n9.       TRADEMARK OWNERSHIP AND LICENSE.",
            "10.3 Effect of Termination. Upon the termination, expiration or earlier termination of this Agreement in accordance with its terms (the \"Termination Date\"):\n\n              (a) the rights and licenses granted by each party to the other pursuant to this Agreement shall automatically terminate;",
            "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is",
            "For the purposes of this Agreement, \"Affiliate\" shall mean another entity that controls, is controlled by or is under common control with such party; provided, however, that such entity is not a human being. For purposes of this definition, the terms \"controls,\" \"is controlled by,\" or \"is under common control with,\" refer to the power to direct the policies and day-to-day operations of an entity, whether by virtue of ownership of a voting securities, contract, or otherwise."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Are the licenses granted under this contract non-transferable?",
        "thought":"The context indicates that neither party may assign the Agreement without written consent, which implies that the licenses granted under this contract are non-transferable unless specific conditions are met. The mention of 'assignment' suggests that the licenses cannot be transferred to another entity without the other party's approval, reinforcing the non-transferability of the licenses. Therefore, the licenses granted under the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. are indeed non-transferable unless exceptions apply.",
        "response":"The licenses granted under the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. are non-transferable without written consent from the other party, as indicated by the assignment clause in the contract.",
        "retrieved_contexts":[
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY",
            "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is",
            "10.3 Effect of Termination. Upon the termination, expiration or earlier termination of this Agreement in accordance with its terms (the \"Termination Date\"):\n\n              (a) the rights and licenses granted by each party to the other pursuant to this Agreement shall automatically terminate;",
            "8.       OWNERSHIP.\n\n         8.1 eDiets Content. Nothing in this Agreement shall effect a transfer of ownership in the eDiets Content from eDiets to Women.com, and eDiets shall retain all rights of copyright, trademark or other intellectual property rights in such eDiets Content that it possessed prior to providing such eDiets Content to Women.com, subject only to the licenses expressly granted by eDiets to Women.com by this Agreement. eDiets retains all rights with respect to eDiets",
            "8.5 Tools. To the extent either party, directly or indirectly, utilizes any software, HTML and\/or Java scripts, proprietary tools and\/or methodologies (collectively the \"Tools\") in performing under this Agreement, such party and its licensors retain all right, title and interest in and to any such Tools.\n\n9.       TRADEMARK OWNERSHIP AND LICENSE."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there uncapped liability under this contract?",
        "thought":"The context outlines a limitation of liability clause that specifies neither party will be liable for special, incidental, indirect, or consequential damages, except for breaches of certain sections. This implies that there is a cap on liability for most damages, but it does not apply to indemnification obligations. Therefore, while there is limited liability under the contract, the indemnification obligations may suggest potential uncapped liability in those specific instances.",
        "response":"Under the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc., there is generally limited liability for damages, but this limitation does not apply to indemnification obligations, which could imply uncapped liability in those cases.",
        "retrieved_contexts":[
            "14.      LIMITATION OF LIABILITY",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY",
            ". THE LIMITATIONS ON LIABILITY FOR DAMAGES SET FORTH IN THIS AGREEMENT SHALL BE INAPPLICABLE TO EACH PARTY'S CONTRACTUAL OBLIGATION TO INDEMNIFY THE OTHER PARTY AS SET FORTH IN SECTIONS 2.6 AND 13.",
            "13.1 Breach of Warranty. Subject to Section 13.3  [Indemnification Requirements and Procedures], eDiets and Women",
            "13.4 Limitations on Indemnification. Notwithstanding the terms of Sections 13.1  [Breach of Warranty] and 13"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there a cap on liability under this contract?",
        "thought":"The context discusses limitations on liability between Women.com Networks, Inc. and eDiets.com, Inc. under their Co-Branding Agreement. It specifies that certain damages are excluded from liability, except for breaches of specific sections, and that indemnification obligations are not subject to these limitations. Therefore, while there is a cap on liability for certain types of damages, indemnification obligations are not capped, which is crucial for understanding the full scope of liability under the contract.",
        "response":"Yes, there is a cap on liability for special, incidental, indirect, or consequential damages under the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc., except for indemnification obligations and breaches of specific sections.",
        "retrieved_contexts":[
            "14.      LIMITATION OF LIABILITY",
            ". THE LIMITATIONS ON LIABILITY FOR DAMAGES SET FORTH IN THIS AGREEMENT SHALL BE INAPPLICABLE TO EACH PARTY'S CONTRACTUAL OBLIGATION TO INDEMNIFY THE OTHER PARTY AS SET FORTH IN SECTIONS 2.6 AND 13.",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY",
            "13.4 Limitations on Indemnification. Notwithstanding the terms of Sections 13.1  [Breach of Warranty] and 13",
            "13.1 Breach of Warranty. Subject to Section 13.3  [Indemnification Requirements and Procedures], eDiets and Women"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there a covenant not to sue included in this contract?",
        "thought":"The context provided discusses indemnification and limitations on liability but does not explicitly mention a covenant not to sue. The terms 'indemnification' and 'limitations on liability' are related to the parties' responsibilities and potential claims against each other, but they do not equate to a covenant not to sue. Therefore, the context does not provide sufficient information to confirm the existence of a covenant not to sue in the Co-Branding Agreement.",
        "response":"The context does not indicate the presence of a covenant not to sue in the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc.",
        "retrieved_contexts":[
            ". Each party, as Indemnitee, may participate, at its own cost, in the defense of any indemnifiable claim with counsel of its own choosing. Each party agrees not to settle any indemnifiable claim without the prior written consent of the other party, which consent shall not be unreasonably withheld or delayed.",
            ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY",
            "13.      INDEMNIFICATION.",
            ". This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns",
            ". THE LIMITATIONS ON LIABILITY FOR DAMAGES SET FORTH IN THIS AGREEMENT SHALL BE INAPPLICABLE TO EACH PARTY'S CONTRACTUAL OBLIGATION TO INDEMNIFY THE OTHER PARTY AS SET FORTH IN SECTIONS 2.6 AND 13."
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What is the expiration date of this contract?",
        "thought":"The context provides information about the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' series, but it does not specify the expiration date of the contract. The absence of an expiration date in the provided text implies that this information is not available in the context.",
        "response":"The expiration date of the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' series is not mentioned in the provided context.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "a.       Integrity Trademarks. Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein",
            "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What is the governing law for this contract?",
        "thought":"The context provided does not explicitly state the governing law for the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. However, since both parties are Delaware corporations, it is common for contracts involving such entities to be governed by Delaware law unless otherwise specified. Therefore, while the context does not provide a definitive answer, it implies that Delaware law may govern this contract.",
        "response":"The governing law for the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. is likely Delaware law, as both parties are Delaware corporations, although the context does not explicitly state this.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "EXHIBIT 10.4\n\n                              CO-BRANDING AGREEMENT",
            "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution.",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Is there a most favored nation clause in this contract?",
        "thought":"The context mentions 'most favored nation' obligations and restrictions in relation to the Product Development and Co-Branding Agreement, indicating that such clauses may exist. However, it does not explicitly confirm the presence of a 'most favored nation' clause in the agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' Series.",
        "response":"The context implies that there may be 'most favored nation' obligations in the Product Development and Co-Branding Agreement, but it does not definitively state that such a clause exists in the contract between Integrity Incorporated and Time Life, Inc.",
        "retrieved_contexts":[
            ":   (i)                 a Contract granting a \u201cmost favored nation\u201d or most favored customer pricing to any Person, or any Contract providing for the grant of exclusive material sales, distribution, marketing or other exclusive rights, rights of first refusal, rights of first negotiation or similar rights and\/or terms to any Person, or materially limiting the right of the Company or any of its Subsidiaries to engage in any line of business or in any geographic area",
            ", (C) contains any provision that requires the purchase of all or any portion of the Company\u2019s or any of its Subsidiaries\u2019 requirements from any Third Party or (D) grants \u201cmost favored nation\u201d rights, except in the case of each of clauses (A), (B), (C) and (D) for such rights and provisions that are not material to the Company and its Subsidiaries, taken as a whole",
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            ", (B) contains material exclusivity or \u201cmost favored nation\u201d obligations or restrictions or (C) contains any other provisions that restrict the ability of the Company or any of its Subsidiaries to sell, market, distribute, promote, manufacture, develop, commercialize, or test or research any Company Product, directly or indirectly through Third Parties, in any material respect, or that would so limit or purport to limit the ability of Parent or any of its Affiliates to sell, market, distribute",
            ", (B) contains material exclusivity or \u201cmost favored nation\u201d obligations or restrictions or (C) contains any other provisions that restrict the ability of the Company or any of its Subsidiaries to sell, market, distribute, promote, manufacture, develop, commercialize, or test or research any Company Product, directly or indirectly through third parties, in any material respect, or that would so limit or purport to limit the ability of Parent or any of its Affiliates to sell, market, distribute"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract include an exclusivity agreement?",
        "thought":"The context provided does not explicitly mention an exclusivity agreement between Integrity Incorporated and Time Life, Inc. It discusses the rights granted to Time Life regarding the use of Integrity's trademarks but does not indicate whether these rights are exclusive or if there are any restrictions on Integrity's ability to work with other parties. Therefore, it only implies that there may be a co-branding relationship, but does not confirm exclusivity.",
        "response":"The Product Development and Co-Branding Agreement does not explicitly state that it includes an exclusivity agreement between Integrity Incorporated and Time Life, Inc.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")",
            "a.       Integrity Trademarks. Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein",
            "EXHIBIT 10.4\n\n                              CO-BRANDING AGREEMENT"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract include any revenue or profit-sharing arrangements?",
        "thought":"The context indicates that the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. includes a provision for royalties to be paid to Time Life based on sales of recorded products. This implies a revenue-sharing arrangement, as Integrity will pay Time Life a percentage of its net receipts or a fixed amount per unit sold. Therefore, the contract does include revenue or profit-sharing arrangements.",
        "response":"Yes, the contract includes revenue-sharing arrangements, as Integrity will pay Time Life royalties based on sales of recorded products.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution.",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")",
            ".       On sales of recorded products pursuant to this Agreement (less                   any returns) Integrity will pay to TL royalties in the amount                   of [**]\/1\/ ($[**]\/1\/) for each and every unit of the product                   sold by Integrity in the United States pursuant to this                   Agreement, and [**]\/1\/ the foregoing rate or [**]\/1\/ percent                   ([**]\/1\/%) of Integrity's net receipts, whichever is less"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Is there a minimum commitment required under this contract?",
        "thought":"The context provided does not explicitly mention a minimum commitment required under the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. It focuses on shared expenses and marketing aspects without detailing any minimum obligations or commitments. Therefore, it implies that the information regarding minimum commitments is either not included or not specified in the provided context.",
        "response":"The context does not specify a minimum commitment required under the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. It only discusses shared expenses and marketing, implying that such details may not be included in the provided information.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution.",
            "EXHIBIT 10.4\n\n                              CO-BRANDING AGREEMENT"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract include any volume restrictions?",
        "thought":"The context provided does not explicitly mention any volume restrictions related to the sales or distribution of products under the 'Songs 4 Worship' series. It focuses on the sharing of expenses and the royalty structure for sales of printed products, but does not indicate any limitations on the quantity of products that can be sold. Therefore, it can be inferred that there are no stated volume restrictions in the contract.",
        "response":"The Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. does not explicitly mention any volume restrictions regarding the sales of products under the 'Songs 4 Worship' series.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution.",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")",
            ".       On sales of printed products (song books) pursuant to this                   Agreement (less any returns) Integrity will pay to TL                   royalties in the amount of [**]\/1\/ ($[**]\/1\/) for each and                   every unit of the product sold by Integrity in the United                   States pursuant to this Agreement, and [**]\/1\/ the foregoing                   rate or [**]\/1\/ percent ([**]\/1\/%) of Integrity's net                   receipts, whichever is less"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract provide for joint intellectual property ownership?",
        "thought":"The context explicitly states that if any intellectual property rights are created or developed jointly by Integrity Incorporated and Time Life, Inc. as a result of their collaboration under the Agreement, those rights shall be owned jointly. This indicates that the contract does provide for joint intellectual property ownership. The terminology 'jointly' in this context refers to both parties sharing ownership of any intellectual property developed together.",
        "response":"Yes, the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. provides for joint intellectual property ownership if any such rights are created or developed jointly as a result of their collaboration.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "a.       Integrity Trademarks. Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")",
            "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:",
            "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What licenses are granted under this contract?",
        "thought":"The context outlines a Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for the 'Songs 4 Worship' series. It specifies that Integrity grants Time Life the right to use its 'Integrity Music' name and logo, which constitutes a license for branding purposes. However, the context does not provide detailed information on other specific licenses that may be granted under this contract.",
        "response":"Under the Product Development and Co-Branding Agreement, Integrity Incorporated grants Time Life, Inc. a license to use the 'Integrity Music' name and logo in connection with the products produced during the term of the agreement. This implies a branding license but does not specify additional licenses granted.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "a.       Integrity Trademarks. Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")",
            "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What are the audit rights under this contract?",
        "thought":"The context provided does not explicitly mention audit rights under the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. Therefore, I cannot determine the specific audit rights from the available information. The terms 'Integrity' and 'TL' refer to the parties involved in the agreement, but no relevant details about audit rights are included in the context.",
        "response":"I don't know.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")",
            "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution.",
            "a.       Integrity Trademarks. Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein"
        ]
    },
    {
        "user_input":"Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Is there a covenant not to sue included in this contract?",
        "thought":"The context provided does not explicitly mention a covenant not to sue between Integrity Incorporated and Time Life, Inc. in the Product Development and Co-Branding Agreement for the 'Songs 4 Worship' Series. The absence of such a clause in the excerpt suggests that it may not be included, but without the full text of the agreement, this cannot be definitively confirmed. Therefore, it only implies that a covenant not to sue may not be present based on the available information.",
        "response":"The context does not explicitly state that there is a covenant not to sue included in the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. It only implies that such a covenant may not be present, as it is not mentioned in the provided excerpt.",
        "retrieved_contexts":[
            "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"",
            "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n\/1\/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS",
            "EXHIBIT 10.4\n\n                              CO-BRANDING AGREEMENT",
            "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution.",
            "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d\/b\/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What is the expiration date of this contract?",
        "thought":"The context outlines the terms of the Co-Branding and Endorsement Licensing Agreement, including its Initial Term and subsequent Additional Terms. The Initial Term starts on July 23, 2013, and ends on July 22, 2016, followed by the First Additional Term from July 23, 2016, to July 22, 2019, and the Second Additional Term from July 23, 2019, to July 22, 2022. Therefore, the expiration date of the contract is July 22, 2022, which is the end of the Second Additional Term.",
        "response":"The expiration date of the Co-Branding and Endorsement Licensing Agreement is July 22, 2022, which marks the end of the Second Additional Term.",
        "retrieved_contexts":[
            ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019",
            ".0 in each Contract Year of the Second Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022.   2",
            "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\"",
            ". The period from July 23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"",
            "Section (2)   Guaranteed Minimum Royalty during the First Additional Term:   In the event that the Renewal Threshold is achieved in the Third Contract Year, during the First Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Four   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2016; October 1, 2016; February 1, 2017 Five   $2,500,000   $833,333"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What is the renewal term for this contract?",
        "thought":"The context provides information about the renewal terms of the Co-Branding and Endorsement Licensing Agreement. It specifies that the First Additional Term begins on July 23, 2016, and ends on July 22, 2019, while the Second Additional Term starts on July 23, 2019, and concludes on July 22, 2022. Therefore, the renewal term for this contract is three years for both the First Additional Term and the Second Additional Term.",
        "response":"The renewal term for the Co-Branding and Endorsement Licensing Agreement is three years for both the First Additional Term, which runs from July 23, 2016, to July 22, 2019, and the Second Additional Term, which runs from July 23, 2019, to July 22, 2022.",
        "retrieved_contexts":[
            ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019",
            "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\"",
            ".0 in each Contract Year of the Second Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022.   2",
            "Section (3)   Guaranteed Minimum Royalty during the Second Additional Term:   In the event that the Second Renewal Threshold is achieved in the Sixth Contract Year, during the Second Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Seven   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2019; October 1, 2019; February 1, 2020 Eight   $5,000,000   $1,666,666",
            "Section (2)   Guaranteed Minimum Royalty during the First Additional Term:   In the event that the Renewal Threshold is achieved in the Third Contract Year, during the First Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Four   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2016; October 1, 2016; February 1, 2017 Five   $2,500,000   $833,333"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What is the governing law for this contract?",
        "thought":"The context provided does not explicitly mention the governing law for the Co-Branding and Endorsement Licensing Agreement. It discusses assignment of rights, performance of the agreement, and terms of the contract, but lacks any reference to the jurisdiction or legal framework that governs the contract. Therefore, I cannot determine the governing law based on the available information.",
        "response":"I don't know.",
        "retrieved_contexts":[
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under",
            "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\"",
            ".   (b) This Agreement may be terminated by the AS Parties only",
            ", then MusclePharm shall continue to be obligated to compensate Lender with the full compensation amount of this Agreement for such Contract Year"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Are there any exceptions to competitive restrictions in this contract?",
        "thought":"The context mentions that the Endorser's non-competition obligation is not required in the event of a material breach of the Agreement by MusclePharm. This implies that if MusclePharm fails to uphold its contractual obligations, Arnold Schwarzenegger (the Endorser) may not be bound by the competitive restrictions outlined in the contract. Therefore, the exception to the competitive restrictions is tied to MusclePharm's breach of the Agreement.",
        "response":"Yes, there is an exception to the competitive restrictions in the Co-Branding and Endorsement Licensing Agreement; specifically, Arnold Schwarzenegger's non-competition obligation does not apply if MusclePharm materially breaches the Agreement.",
        "retrieved_contexts":[
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016",
            "; it being understood that the parties may mutually decide not to deploy the full Marketing Budget in any Contract Year if in the good faith determination by the parties that the deployment of the full Marketing Budget is unnecessary to achieve its projected revenue targets in connection with the sale of the Licensed Products",
            ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under",
            ". Endorser's non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm",
            ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a non-compete clause in this contract?",
        "thought":"The context mentions an 'Endorser's non-competition obligation' but specifies that this obligation is not required if MusclePharm commits a material breach of the Agreement. This implies that there is a non-compete clause, but it is conditional based on MusclePharm's actions. Therefore, while a non-compete clause exists, its enforceability is contingent upon MusclePharm's compliance with the Agreement.",
        "response":"Yes, there is a non-compete clause in the Co-Branding and Endorsement Licensing Agreement, but it is not enforceable if MusclePharm breaches the Agreement.",
        "retrieved_contexts":[
            ". Endorser's non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm",
            ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under",
            ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include an exclusivity agreement?",
        "thought":"The context explicitly states that during the term of the Agreement, the Endorser (Arnold Schwarzenegger) and the Lender (MusclePharm Corporation) agree not to enter into any other endorsement agreements for dietary supplements, which indicates an exclusivity arrangement. The term 'exclusivity' in this context refers to the restriction on the Endorser's ability to endorse competing products. Therefore, the contract does include an exclusivity agreement as it prohibits the Endorser from endorsing other dietary supplements during the Agreement's term.",
        "response":"Yes, the Co-Branding and Endorsement Licensing Agreement includes an exclusivity agreement, as it prohibits Arnold Schwarzenegger from entering into other endorsement agreements for dietary supplements during the term of the Agreement.",
        "retrieved_contexts":[
            ":   Neither party may, without the other party's prior written consent, make any news release or public announcement of the existence or value of this Agreement or its terms and conditions, or in any other manner advertise or publish its value, or its terms and conditions and neither party shall issue any press release or other public announcement which includes the name of the other party without such party's prior written consent, such consent not to be unreasonably withheld or delayed",
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            "; provided however, nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement",
            ". Notwithstanding anything contained herein, irrespective of the expiratation or termination of this Agreement, the AS Parties shall always be entitled to retain and shall never be obligated to return any monies paid and\/or stock issued to Lender and\/or Endorser pursuant to this Agreement",
            "16. Exclusivity; Non-Competition:   (a) During the term of this Agreement, or any extensions of this Agreement, Endorser and the Lender hereby agree and warrant that it will not enter into any other endorsement agreement for the use of Endorser's name, image and\/or likeness for advertising, marketing and\/or endorsement of any other dietary supplements during the Term of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "thought":"The provided context outlines the financial terms and duration of the Co-Branding and Endorsement Licensing Agreement but does not mention any rights of first refusal, right of first offer, or right of first negotiation. The terms discussed focus on guaranteed minimum royalties and the contract's duration without addressing negotiation rights. Therefore, the context does not provide relevant information regarding the specific rights in question.",
        "response":"The contract does not explicitly mention any right of first refusal, right of first offer, or right of first negotiation based on the provided context.",
        "retrieved_contexts":[
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016",
            ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8",
            ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under",
            "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\"",
            ". Representations, Warranties and Covenants"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
        "thought":"The context outlines that MusclePharm Corporation can assign its rights and obligations under the Co-Branding and Endorsement Licensing Agreement without the consent of Arnold Schwarzenegger and the other parties in the event of a change of control transaction, provided that the new acquirer meets certain financial criteria and assumes the obligations in writing. This indicates that a change of control does not automatically terminate the agreement but allows for assignment under specific conditions. The other parties, referred to as the AS Parties, retain the right to terminate the agreement only under certain circumstances, such as a material breach by MusclePharm.",
        "response":"In the event of a change of control of MusclePharm Corporation, it may assign its rights and obligations under the agreement without the consent of Arnold Schwarzenegger and the other parties, provided the acquirer has similar financial resources and assumes the obligations in writing. This implies that the agreement remains in effect unless terminated for other reasons, such as a material breach by MusclePharm.",
        "retrieved_contexts":[
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction",
            ".   (v)  In the event Musclepharm is in material breach or default of this Agreement, the AS Parties may give written notice to Musclepharm of intent to terminate, and such notice shall set forth in reasonable detail the facts, circumstances or events causing the alleged breach or default (\"MusclePharm Events of Default\"). Musclepharm shall have thirty (30) days' notice in which to cure the MusclePharm Events of Default to the reasonable and objective satisfaction of the terminating party",
            ".   (b) This Agreement may be terminated by the AS Parties only",
            "19. Modification of Agreement:   The parties may modify this Agreement hereto only by a written supplemental agreement executed by both parties.   20"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there an anti-assignment clause in this contract?",
        "thought":"The context explicitly states that neither party can assign or transfer their rights and obligations under the agreement without prior written consent from the other party, indicating the presence of an anti-assignment clause. Additionally, it mentions that MusclePharm can assign its rights in connection with a change of control transaction, which is a specific exception to the general rule. Therefore, the clause restricts assignments unless consent is obtained or specific conditions are met.",
        "response":"Yes, the Co-Branding and Endorsement Licensing Agreement contains an anti-assignment clause that prohibits either party from assigning their rights and obligations without prior written consent from the other party, with a specific exception for MusclePharm in the case of a change of control.",
        "retrieved_contexts":[
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under",
            ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction",
            ". Nothing in this Section 6(c) shall entitle MusclePharm to reduce Endorser's compensation pursuant to Section 7 and Section 8 of this Agreement (including, without limitation, with respect to any renewal Term, if any).   (d) Discretion to Utilize",
            ".   (b) This Agreement may be terminated by the AS Parties only"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
        "thought":"The context outlines a Co-Branding and Endorsement Licensing Agreement that includes a Guaranteed Minimum Royalty and a royalty structure based on Net Sales of Licensed Products. The term 'Royalty' refers to a percentage of sales, indicating a profit-sharing arrangement based on the performance of the products. Therefore, the contract does imply revenue sharing through the specified royalties on sales.",
        "response":"Yes, the contract includes revenue sharing arrangements as it stipulates a royalty of 10% on Net Sales of Licensed Products, indicating a profit-sharing mechanism.",
        "retrieved_contexts":[
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016",
            "7. Compensation:   (a) Cash:   (i) During the Term of this Agreement and during any sell-off period, MusclePharm shall pay Lender a royalty (the \"Royalty\") of 10% on Net Sales (as defined below) of Licensed Products sold through its wholesale Distribution Channels or retail Distribution Channels, as the case may be and 10% on Net Sales of the Training Video and any Products sold in connection with any Training Video as contemplated pursuant to the last sentence of Section 4(a)(i) above",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5",
            "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a minimum commitment required under this contract?",
        "thought":"The context provides details about a 'Guaranteed Minimum Royalty' that is required for each Contract Year under the agreement, indicating that there is indeed a minimum commitment involved. The terms 'Guaranteed Minimum Royalty' and 'Minimum Royalty' refer to the same concept of a financial commitment that must be met by the parties involved in the contract. This implies that the contract does require a minimum financial commitment from the parties.",
        "response":"Yes, the Co-Branding and Endorsement Licensing Agreement requires a minimum commitment in the form of a 'Guaranteed Minimum Royalty' for each Contract Year, as outlined in Exhibit 'C'.",
        "retrieved_contexts":[
            ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8",
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016",
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            "Section (2)   Guaranteed Minimum Royalty during the First Additional Term:   In the event that the Renewal Threshold is achieved in the Third Contract Year, during the First Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Four   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2016; October 1, 2016; February 1, 2017 Five   $2,500,000   $833,333",
            "; it being understood that the parties may mutually decide not to deploy the full Marketing Budget in any Contract Year if in the good faith determination by the parties that the deployment of the full Marketing Budget is unnecessary to achieve its projected revenue targets in connection with the sale of the Licensed Products"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include any volume restrictions?",
        "thought":"The context provided discusses the Guaranteed Minimum Royalty payments and restrictions on public announcements but does not mention any volume restrictions related to the Co-Branding and Endorsement Licensing Agreement. The terms 'volume restrictions' typically refer to limits on the quantity of products or services involved, which are not addressed in the provided sections. Therefore, the context does not imply any volume restrictions in the contract.",
        "response":"The contract does not explicitly mention any volume restrictions based on the provided context.",
        "retrieved_contexts":[
            "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016",
            ":   Neither party may, without the other party's prior written consent, make any news release or public announcement of the existence or value of this Agreement or its terms and conditions, or in any other manner advertise or publish its value, or its terms and conditions and neither party shall issue any press release or other public announcement which includes the name of the other party without such party's prior written consent, such consent not to be unreasonably withheld or delayed",
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8",
            "; (ii) any material inaccuracy or misrepresentation by MusclePharm in this Agreement; (iii) any advertisement and\/or promotion of MusclePharm, its Products, or Licensed Products, including but not limited to any use of the materials produced pursuant to this Agreement, as well as MusclePharm's advertising\/promotion campaign described above in this Agreement and\/or (iv) any breach of this Agreement and\/or in connection with this Agreement"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; How is intellectual property ownership assigned in this contract?",
        "thought":"The context indicates that MusclePharm retains certain intellectual property rights even after the termination of the agreement, while copyrights in works created based on the Trademarks and Name and Appearance Rights are assigned to the AS Parties (which includes Arnold Schwarzenegger). This suggests a division of intellectual property ownership where MusclePharm has ongoing rights, but specific creations are owned by the AS Parties. The mention of consent for assignment or transfer of rights emphasizes the importance of mutual agreement in any changes to ownership.",
        "response":"In the Co-Branding and Endorsement Licensing Agreement, MusclePharm retains certain intellectual property rights post-termination, while copyrights for works based on Trademarks and Name and Appearance Rights are assigned to Arnold Schwarzenegger and associated parties. This indicates a shared ownership structure where specific rights are allocated to different parties, and any transfer of rights requires mutual consent.",
        "retrieved_contexts":[
            ", nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement",
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            ".   (e) MusclePharm agrees that any copyrights in works created based upon the Trademarks and\/or Name and Appearance Rights shall become the rights of the AS Parties (as among them to be determined among them)",
            "; provided however, nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement",
            ". MusclePharm agrees that (i) with respect to the Compensation Shares, Lender shall be entitled to all rights and benefits under the registration rights agreement, dated as of March 28, 2013 (the \"Registration Rights Agreement\"), by and among MusclePharm and the investors party thereto as if it were an investor party thereto, mutatis mutandis"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What licenses are granted under this contract?",
        "thought":"The context discusses the rights and obligations of MusclePharm under the Co-Branding and Endorsement Licensing Agreement, specifically mentioning that MusclePharm has the authority to exploit the Licensed Products and must market them effectively. However, it does not explicitly list the specific licenses granted under the contract. The terms 'Licensed Products' refer to the products covered by the agreement, and the context implies that MusclePharm has the right to market and distribute these products, but does not provide a comprehensive list of licenses.",
        "response":"The Co-Branding and Endorsement Licensing Agreement implies that MusclePharm has the right to market and distribute the Licensed Products, but it does not explicitly enumerate the specific licenses granted under the contract.",
        "retrieved_contexts":[
            ":   (i) It has the full right, power and authority to enter into this Agreement and to perform its obligations hereunder; (ii) it has acquired all rights necessary to perform this Agreement and exploit the Licensed Products as contemplated herein; (iii) the Licensed Products, any element thereof, or any advertising, promotional or publicity materials supplied by Licensee or third parties hereunder will not contain any language or material which is obscene, libelous, slanderous or defamatory",
            ".   17. [RESERVED.]   18. Assignment:   The license granted by this Agreement is personal to MusclePharm. Except as set forth below, MusclePharm shall not assign or otherwise transfer, license, sublicense, or delegate any rights or obligations under this Agreement without the express prior written consent of the AS Parties",
            ". Each such royalty payment shall include an itemized statement showing the nature and source of such royalties, including (i) the number of units of Licensed Products sold (by country and customer); (ii) the total number of units returned for which credit was given and the total dollar amount of such credits, and (iii) the total gross sales and the total royalties due with respect to such gross sales, and each itemized statement shall be certified by a duly authorized officer of MusclePharm",
            ". MusclePharm shall use its commercially reasonable efforts to market and distribute the Licensed Products, and MusclePharm shall allocate between $3,000,000 and $5,000,000 in the First Contract Year and $5,000,000 in each subsequent Contract Year (including any renewal terms if any) toward the marketing of the Licensed Products (the \"Marketing Budget\")",
            ".   (b) MusclePharm represents, warrants and covenants that (i) it has the full right, power and authority to enter into this Agreement; (ii) it has acquired all rights necessary to perform this Agreement and exploit the Licensed Products as contemplated herein"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Are there any services to be provided after the termination of this contract?",
        "thought":"The context indicates that upon expiration or termination of the Co-Branding and Endorsement Licensing Agreement, the Endorser (Arnold Schwarzenegger) has no further obligation to provide any services. This aligns with the question regarding services post-termination, confirming that no services will be rendered after the contract ends. Additionally, it specifies that MusclePharm will not owe any further compensation to the Endorser except for royalties earned prior to termination, clarifying the financial implications of termination.",
        "response":"After the termination of the Co-Branding and Endorsement Licensing Agreement, Arnold Schwarzenegger (the Endorser) will have no further obligation to provide any services. MusclePharm Corporation will not be required to pay any additional compensation beyond royalties earned up to the termination date.",
        "retrieved_contexts":[
            ": Upon expiration or termination of the Agreement for pursuant to Section 9 herein, Endorser shall have no further obligation to render any services whatsoever",
            ". In the event of a termination by MusclePharm pursuant to paragraph 9(a)(i)-(ii), Musclepharm shall not be required to pay Endorser any further compensation except for Royalties earned up until such termination date, and provided, however, that if Musclepharm terminates this Agreement because of death, disability, physical injury, or other incapacity of Endorser, if Endorser has performed all services required by this Agreement for a particular Contract Year",
            "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\"",
            ". Representations, Warranties and Covenants",
            ", then MusclePharm shall continue to be obligated to compensate Lender with the full compensation amount of this Agreement for such Contract Year"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What are the audit rights under this contract?",
        "thought":"The context outlines the audit rights granted to the AS Parties (which include Arnold Schwarzenegger and Marine MP, LLC) under the Co-Branding and Endorsement Licensing Agreement with MusclePharm Corporation. It specifies that the AS Parties can inspect MusclePharm's records and facilities once per year with prior notice, and if discrepancies are found, MusclePharm must cover the audit costs. The terms 'AS Parties' refer to Arnold Schwarzenegger and Marine MP, LLC, while 'MusclePharm' refers to MusclePharm Corporation, which is the entity being audited.",
        "response":"Under the Co-Branding and Endorsement Licensing Agreement, the AS Parties have the right to audit MusclePharm's records and facilities once per year with five days' notice. If a shortfall of 5% or more is found, MusclePharm must reimburse the AS Parties for the audit costs, including attorney's fees. MusclePharm is required to maintain relevant records for at least three years after the agreement ends.",
        "retrieved_contexts":[
            ". Audit Rights:   (a) The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm",
            ". Each party shall be entitled to share such confidential information received by such party only with such party's representatives, legal and accounting advisors who shall agree to be bound by the confidentiality obligations set forth in this Section 26. During the term of this Agreement and for three (3) years thereafter, each party shall hold in strict confidence all such information",
            "(b) MusclePharm shall at all reasonable times during the Term (but no more than once during each Contract Year of the Term), and upon reasonable notice, permit the AS Parties to send their authorized representatives to inspect the facilities of MusclePharm or its agents in order to confirm that the production of the Licensed Products hereunder is in compliance with the quality standards set out herein and, at MusclePharm's expense",
            ".   (c) In the event a shortfall in the amount of five percent (5%) or more is discovered, MusclePharm shall reimburse the AS Parties for the cost of the audit including any reasonable attorney's fees incurred in connection therewith.   (d) MusclePharm agrees to preserve and keep accessible and available to the AS Parties all relevant books and records for a period of at least three (3) years following the expiration or termination of the Agreement.   12",
            ". Representations, Warranties and Covenants"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a cap on liability under this contract?",
        "thought":"The context indicates that the indemnification obligations of the AS Parties (Arnold Schwarzenegger and related entities) to MusclePharm are capped at the after-tax value of the Cash Consideration received by MusclePharm under the agreement. This implies that there is a limitation on liability related to indemnification, but it does not explicitly state a general cap on all liabilities under the contract. Therefore, while there is a specific cap on indemnification, it is unclear if this extends to other liabilities that may arise under the agreement.",
        "response":"Yes, there is a cap on indemnification liability under the Co-Branding and Endorsement Licensing Agreement, specifically limited to the after-tax value of the Cash Consideration received by MusclePharm. However, this does not necessarily imply a cap on all forms of liability under the contract.",
        "retrieved_contexts":[
            ". In no event shall the AS Parties' indemnification obligations to MusclePharm hereunder exceed the after-tax value of the Cash Consideration received by Lender under this Agreement.   (b) By MusclePharm",
            "; both those incurred in connection with the defense or prosecution of the indemnifiable claim and those incurred in connection with the enforcement of this provision), caused by, arising out of, or in any way connected with (i) any injury, death, or other harm or claim connected with, or claimed defect in, Products or Licensed Products provided, manufactured, produced, marketed, promoted, sold, and\/or distributed by MusclePharm (including any party affiliated with MusclePharm)",
            ". MusclePharm shall be responsible to provide for any appearances pursuant to this Agreement by Endorser appropriate certificates of insurance with coverage limits of at least Five Million Dollars (US$5,000,000) per occurrence endorsed to name the AS Parties as additional named insureds with respect to claims arising out of appearances by Endorser. MusclePharm shall be responsible to pay the deductible under any such insurance policies with respect to any claims made under such policies.",
            ". MusclePharm shall not be liable to pay any compensation for services performed after the expiration or termination",
            ":   MusclePharm shall, throughout the Term of the Agreement and for a period of not less than four years thereafter, obtain and maintain at its own cost and expense from a qualified insurance company licensed to do business in California and New York, a commercial general liability insurance policy including coverage for contractual liability (applying to the terms and conditions of this agreement), product liability, personal injury liability, and advertiser's liability"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What are the insurance requirements under this contract?",
        "thought":"The context outlines the insurance requirements that MusclePharm Corporation must adhere to under the Co-Branding and Endorsement Licensing Agreement. It specifies that MusclePharm is responsible for obtaining a commercial general liability insurance policy with specific coverage limits and must name the AS Parties (which includes Arnold Schwarzenegger) as additional insureds. The context also mentions the requirement for notification of any changes to the insurance policy, which is relevant to the contractual obligations.",
        "response":"Under the Co-Branding and Endorsement Licensing Agreement, MusclePharm Corporation must maintain a commercial general liability insurance policy with coverage of at least Five Million Dollars per occurrence, naming Arnold Schwarzenegger and other AS Parties as additional insureds. MusclePharm is also responsible for providing certificates of insurance for any appearances by the Endorser and must pay any deductibles related to claims. Additionally, the insurer must notify the AS Parties of any modifications or cancellations to the policy.",
        "retrieved_contexts":[
            ":   MusclePharm shall, throughout the Term of the Agreement and for a period of not less than four years thereafter, obtain and maintain at its own cost and expense from a qualified insurance company licensed to do business in California and New York, a commercial general liability insurance policy including coverage for contractual liability (applying to the terms and conditions of this agreement), product liability, personal injury liability, and advertiser's liability",
            ". MusclePharm shall be responsible to provide for any appearances pursuant to this Agreement by Endorser appropriate certificates of insurance with coverage limits of at least Five Million Dollars (US$5,000,000) per occurrence endorsed to name the AS Parties as additional named insureds with respect to claims arising out of appearances by Endorser. MusclePharm shall be responsible to pay the deductible under any such insurance policies with respect to any claims made under such policies.",
            ". Representations, Warranties and Covenants",
            ". Insurance",
            ". The policy shall provide for ten (10) days notice to the AS Parties from the insurer by Registered or Certified Mail, return receipt requested, in the event of any modification, cancellation, or termination thereof"
        ]
    },
    {
        "user_input":"Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a covenant not to sue included in this contract?",
        "thought":"The context provided discusses various representations, warranties, and covenants related to the agreement but does not explicitly mention a covenant not to sue. The terms 'covenant' and 'sue' are relevant to the question, but the absence of a specific mention of a covenant not to sue implies that such a provision may not be included in the contract. Therefore, the context does not provide a definitive answer regarding the existence of a covenant not to sue.",
        "response":"The context does not explicitly indicate the presence of a covenant not to sue in the Co-Branding and Endorsement Licensing Agreement among MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; it only implies that such a provision may not be included.",
        "retrieved_contexts":[
            ". Representations, Warranties and Covenants",
            ". Notwithstanding the foregoing, the following will not be a breach of this Agreement",
            ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and\/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and\/or obligations without such consent shall be void",
            ". No settlement will be entered into by the AS Parties without MusclePharm's prior written approval.",
            ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the expiration date of this contract?",
        "thought":"The context indicates that the Co-Branding Agreement has an Initial Term of five years from the execution date, followed by an Extended Term of three years unless terminated earlier. The expiration date of the contract would therefore be eight years from the initial execution date, unless a party provides notice of termination. However, the specific execution date is not provided in the context, making it impossible to determine the exact expiration date.",
        "response":"The Co-Branding Agreement has an Initial Term of five years and an Extended Term of three years, totaling eight years from the execution date; however, the exact expiration date cannot be determined without the execution date.",
        "retrieved_contexts":[
            ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof",
            "6.1 Term. The term of this Agreement shall continue for a period of five years following the initial date of execution of the Memorandum, unless terminated earlier pursuant to Section 6.2 or Section 2.8 (\"Initial Term\")",
            ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\").",
            ". Except as specifically stated herein, each capitalized term used in this Statement shall have the same meaning as is assigned to it in the Agreement. The effective date (\"Effective Date\") of this Statement is  ,  , 200 .   2. General Description of Services:",
            ". Provided that the respective Parties utilize their best efforts to provide such payments together with the respective Statements, no Party shall be deemed in breach hereof for delivering late payment until the date which is sixty (60) days following the last day of the respective applicable calendar quarter"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the renewal term for this contract?",
        "thought":"The context indicates that the Co-Branding Agreement has an Initial Term and an Extended Term. The Extended Term lasts for an additional three years following the Initial Term unless terminated by a party with proper notice. Therefore, the renewal term for this contract is three years after the Initial Term, provided no termination notice is given.",
        "response":"The renewal term for the Co-Branding Agreement is three years, referred to as the 'Extended Term,' which follows the Initial Term unless a party provides written notice of termination at least sixty days prior to its expiration.",
        "retrieved_contexts":[
            ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\").",
            "6.1 Term. The term of this Agreement shall continue for a period of five years following the initial date of execution of the Memorandum, unless terminated earlier pursuant to Section 6.2 or Section 2.8 (\"Initial Term\")",
            ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof",
            "8.3.1.3 the Party who delivers the Type One Notice gives notice to the other Parties of its intention to exercise its right to end the Non-Competition Period within 30 days of the expiry of the Type One Cure Period.; or   8.3.2 within thirty (30) days of the end of the Type Two Cure Period (defined below) where:",
            ".4 The Parties agree that notwithstanding any termination or expiration of this Agreement, the rights and licenses granted to any Company- Skype Branded Customers prior to termination or expiration of this Agreement pursuant to any EULA shall continue during the 24 months after such termination or expiration for the sole purpose of permitting such users to continue to access and utilize the Company-Skype Branded Application and the Company-Skype Toolbar"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the notice period required to terminate the renewal?",
        "thought":"The context specifies that a party must provide written notice of termination at least sixty (60) days prior to the expiration of the Initial Term or the Extended Term of the Co-Branding Agreement. This indicates that the notice period required for termination is consistent across both terms. Therefore, the relevant terminology here is 'notice of termination' and 'expiration of the Initial Term or Extended Term', which both point to the same requirement of sixty (60) days.",
        "response":"The notice period required to terminate the renewal of the Co-Branding Agreement is sixty (60) days prior to the expiration of the Initial Term or Extended Term.",
        "retrieved_contexts":[
            ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\").",
            ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof",
            "6.1 Term. The term of this Agreement shall continue for a period of five years following the initial date of execution of the Memorandum, unless terminated earlier pursuant to Section 6.2 or Section 2.8 (\"Initial Term\")",
            "8.3.1.3 the Party who delivers the Type One Notice gives notice to the other Parties of its intention to exercise its right to end the Non-Competition Period within 30 days of the expiry of the Type One Cure Period.; or   8.3.2 within thirty (30) days of the end of the Type Two Cure Period (defined below) where:",
            ", Online BVI or Skype may thereafter terminate this Agreement by delivery to the other parties 30 days written notice of termination"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the governing law for this contract?",
        "thought":"The context provided does not specify the governing law for the Co-Branding Agreement among Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited. It primarily discusses liability, representations, warranties, and assignment without mentioning any jurisdiction or governing law clause. Therefore, there is no relevant information to determine the governing law from the context provided.",
        "response":"I don't know.",
        "retrieved_contexts":[
            "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES",
            ", express or implied and whether negligently or innocently made) of any Person (whether a party to this Agreement or not) which is not expressly set out in this Agreement and the only remedy available in respect of any misrepresentation or untrue statement made to such party shall be a claim for breach of contract under this Agreement except to the extent that the misrepresentation or untrue statement is repeated in this Agreement in which case any remedies for misrepresentation shall be",
            "7.1 Mutual Representations and Warranties. Each of the parties to this Agreement warrant and represent that it has the full right and power to enter into this Agreement and that no contractual right of any third party will be violated, breached or negatively impacted by entering into this Agreement",
            "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void",
            ". Any party to this Agreement shall have the right to terminate this Agreement during the Term by giving notice to another party to this Agreement or to any party that is not an Affiliate of the terminating party (collectively, \"Defaulter\")"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there a most favored nation clause in this contract?",
        "thought":"The context provided does not mention a 'most favored nation clause' or any equivalent terminology that would indicate such a provision exists in the Co-Branding Agreement. The terms discussed relate to rights, assignments, and ownership but do not address pricing or preferential treatment clauses typically associated with a most favored nation clause. Therefore, there is no relevant information to confirm the presence of such a clause in the contract.",
        "response":"The context does not provide any information regarding a most favored nation clause in the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited.",
        "retrieved_contexts":[
            "., with HGC), or (b) to any agreement now existing or hereafter entered into with an entity that operates in multiple international markets, which may include the PRC, so long as such agreement applies to multiple territories, which may include the PRC in addition to other territories, and does not, directly or indirectly",
            ". Subject to any other provisions of this Agreement, the guarantees are in addition to and without prejudice to and not in substitution for any rights or security which parties may now or hereafter have or hold for the performance and observance of the obligations, commitments, undertakings and warranties of the parties under this Agreement.",
            "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void",
            "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership.",
            ". Any party to this Agreement shall have the right to terminate this Agreement during the Term by giving notice to another party to this Agreement or to any party that is not an Affiliate of the terminating party (collectively, \"Defaulter\")"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Are there any exceptions to competitive restrictions in this contract?",
        "thought":"The context mentions a Non-Competition Period and its termination, indicating that there are specific conditions under which the competitive restrictions may not apply. Section 8.3 states that the Non-Competition Period can end before the specified End Date, implying that once it terminates, the parties are no longer bound by the restrictions outlined in Section 8.1. Therefore, the exceptions to the competitive restrictions would be tied to the termination of the Non-Competition Period, allowing parties to engage in competitive activities thereafter.",
        "response":"Yes, there are exceptions to the competitive restrictions in the Co-Branding Agreement, specifically when the Non-Competition Period terminates prior to the End Date, as stated in Section 8.3. After this termination, the parties are no longer obligated to comply with the restrictions set out in Section 8.1.",
        "retrieved_contexts":[
            "8.2.2 with respect to the provisions of Section 8.1.2, during any period following the expiration of the Enterprise Non-Competition Period.\n\n8.3 Termination of Non-Competition Period. Notwithstanding any portion of the foregoing to the contrary, the Non-Competition Period shall terminate prior to the End Date, and for the avoidance of doubt, no party shall be obligated to comply with the restrictions set out in Section 8.1 after the termination of the Non-Competition Period:",
            "8. NON-COMPETITION\n\n8.1 Non-Competition.",
            "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES",
            ". Subject to any other provisions of this Agreement, the guarantees are in addition to and without prejudice to and not in substitution for any rights or security which parties may now or hereafter have or hold for the performance and observance of the obligations, commitments, undertakings and warranties of the parties under this Agreement.",
            ". THE PARTIES TO THIS AGREEMENT EXPRESSLY DISCLAIM, AND HEREBY EXPRESSLY WAIVE, ALL OTHER WARRANTIES AND ALL OTHER CONDITIONS, TERMS AND UNDERTAKINGS WHATSOEVER, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF MERCHANTABILITY, PERFORMANCE, QUALITY AND FITNESS FOR A PARTICULAR PURPOSE AND SUCH WARRANTIES, CONDITIONS, TERMS AND UNDERTAKINGS ARE EXCLUDED TO THE FULLEST EXTENT PERMITTED BY LAW"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there a non-compete clause in this contract?",
        "thought":"The context provides information about a Non-Competition Period defined in the Co-Branding Agreement, which explicitly states that for a period of five years from the Effective Date, no party or their affiliates can engage in business targeting primarily Consumers within the PRC. This indicates that there is indeed a non-compete clause in the contract, as it restricts certain business activities during the specified period. The terminology 'Non-Competition Period' directly correlates with the question regarding the existence of a non-compete clause.",
        "response":"Yes, the Co-Branding Agreement contains a non-compete clause, referred to as the 'Non-Competition Period,' which prohibits the parties from engaging in certain business activities targeting Consumers within the PRC for five years from the Effective Date.",
        "retrieved_contexts":[
            "8.2.2 with respect to the provisions of Section 8.1.2, during any period following the expiration of the Enterprise Non-Competition Period.\n\n8.3 Termination of Non-Competition Period. Notwithstanding any portion of the foregoing to the contrary, the Non-Competition Period shall terminate prior to the End Date, and for the avoidance of doubt, no party shall be obligated to comply with the restrictions set out in Section 8.1 after the termination of the Non-Competition Period:",
            "14.9 Independent Contractors. The parties to this Agreement acknowledge and agree that they are dealing with each other hereunder as independent contractors. Nothing contained in this Agreement shall be interpreted as constituting any party the joint venturer, employee or partner of the other party or as conferring upon any party the power of authority to bind another party in any transaction with third parties.",
            ". During the Enterprise Non-Competition Period, the Parties agree to use their commercially reasonable efforts to discuss mutually agreeable terms pursuant to which the Company would, and Online BVI would cause the Company to, promote, market and distribute in the PRC an enterprise co-branded Internet-based application in simplified Chinese that is focused on, and targeted primarily at, non-Consumers within the PRC",
            ". THE PARTIES TO THIS AGREEMENT EXPRESSLY DISCLAIM, AND HEREBY EXPRESSLY WAIVE, ALL OTHER WARRANTIES AND ALL OTHER CONDITIONS, TERMS AND UNDERTAKINGS WHATSOEVER, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF MERCHANTABILITY, PERFORMANCE, QUALITY AND FITNESS FOR A PARTICULAR PURPOSE AND SUCH WARRANTIES, CONDITIONS, TERMS AND UNDERTAKINGS ARE EXCLUDED TO THE FULLEST EXTENT PERMITTED BY LAW",
            ".1 Each Party agrees that, for a period of five years (\"Non-Competition Period\") from the Effective Date (\"End Date\"), no Party, nor any of their respective Affiliates, will enter into an agreement with any third party, or otherwise carry on any business, directly or indirectly, which is focused on, and targets, primarily Consumers within the PRC, and (i) in the case of Skype and Skype Holding"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What happens in the event of a change of control of one of the parties in this contract?",
        "thought":"The context provided discusses termination rights and assignment of the Agreement but does not explicitly mention the consequences of a change of control for any party involved. The term 'change of control' typically refers to a significant shift in ownership or management, which may affect the parties' obligations or rights under the Agreement. However, without specific provisions regarding change of control in the context, it is unclear what the exact implications would be.",
        "response":"The context does not specify what happens in the event of a change of control of one of the parties in the Co-Branding Agreement. Therefore, I cannot provide a definitive answer regarding the implications of such a change.",
        "retrieved_contexts":[
            ". Any party to this Agreement shall have the right to terminate this Agreement during the Term by giving notice to another party to this Agreement or to any party that is not an Affiliate of the terminating party (collectively, \"Defaulter\")",
            "and the Affected Party provides written notice to the breaching party detailing the Breach and requiring the breaching party to cure the Breach within thirty (30) days of the date of the notice, the Affected Party shall not be obligated to perform the relevant obligation or undertaking affected by the Breach so long as such Breach continues uncured where such non-performance or non-compliance would be deemed a material breach of this Agreement or the Deed",
            ". A party to this Agreement may change its address for purposes hereof by written notice to the other in accordance with the provisions of this Section 14.5. The addresses for the parties to this Agreement are as set forth in the preamble hereof, with attention in each case to the respective Chief Executive Officer.",
            "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void",
            "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there an anti-assignment clause in this contract?",
        "thought":"The context explicitly states that the Agreement may not be assigned by any party without the express written approval of the other parties, indicating the presence of an anti-assignment clause. The term 'assignment' refers to the transfer of rights or obligations under the contract, and the clause makes any unauthorized assignment null and void. Therefore, this clause restricts parties from transferring their interests in the Agreement without consent.",
        "response":"Yes, the Co-Branding Agreement contains an anti-assignment clause that prohibits any party from assigning their rights or obligations without the express written approval of the other parties.",
        "retrieved_contexts":[
            "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void",
            "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES",
            "14.9 Independent Contractors. The parties to this Agreement acknowledge and agree that they are dealing with each other hereunder as independent contractors. Nothing contained in this Agreement shall be interpreted as constituting any party the joint venturer, employee or partner of the other party or as conferring upon any party the power of authority to bind another party in any transaction with third parties.",
            ", express or implied and whether negligently or innocently made) of any Person (whether a party to this Agreement or not) which is not expressly set out in this Agreement and the only remedy available in respect of any misrepresentation or untrue statement made to such party shall be a claim for breach of contract under this Agreement except to the extent that the misrepresentation or untrue statement is repeated in this Agreement in which case any remedies for misrepresentation shall be",
            ". THE PARTIES ACKNOWLEDGE AND AGREE THAT NOTHING IN THIS SECTION 12.2 SHALL LIMIT A PARTY'S OBLIGATION TO PAY ANY AMOUNTS DUE AND OWING TO THE OTHER PARTY UNDER SECTION 5 ON OR BEFORE ANY DATE OF EXPIRATION OR TERMINATION HEREOF."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does this contract include any revenue or profit-sharing arrangements?",
        "thought":"The context indicates that there are revenue-sharing arrangements in the Co-Branding Agreement, specifically stating that Skype and the Company (which could refer to TOM Online) are entitled to receive 50% of all Adjusted Net Revenue. This implies a profit-sharing mechanism exists between the parties involved. The mention of 'Adjusted Net Revenue' and the specific percentages allocated to each party confirms that the contract includes revenue or profit-sharing arrangements.",
        "response":"Yes, the Co-Branding Agreement includes revenue-sharing arrangements, as both Skype and the Company are entitled to receive 50% of all Adjusted Net Revenue.",
        "retrieved_contexts":[
            ", the determination of the amounts of Gross Revenue under this Agreement",
            ". Notwithstanding the foregoing, Online BVI shall be entitled to receive 50% of all Adjusted Net Revenue, in lieu of the Company's right to be paid hereunder, in the event that (A) this Agreement remains in effect, (B) Online BVI assumes the obligations of the Company hereunder, and (C) (i) the Deed is terminated pursuant to the terms thereof, or (ii)) the Company is being or has been wound up, liquidated or dissolved",
            ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof",
            ", agree that \"Gross Revenue\" to the extent generated by that unaffiliated third party distributor or reseller will arise on the date payment with respect to that revenue is due from the unaffiliated third party distributor or reseller to the Company as opposed to the date upon which the applicable revenue is actually collected by the third party distributor or reseller and the operation of the provisions of Section 5 in respect of the revenue due from that unaffiliated third party distributor or",
            "5.2 Revenue Sharing. In consideration of the licenses and other agreements set forth herein, Skype shall be entitled to receive 50% of all Adjusted Net Revenue, and the Company shall be entitled to receive 50% of all Adjusted Net Revenue"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; How is intellectual property ownership assigned in this contract?",
        "thought":"The context outlines the ownership of intellectual property rights created jointly by the parties involved in the Co-Branding Agreement. It specifies that such rights are owned collectively by the parties, while also reserving individual rights not granted in the agreement. This implies that any improvements or jointly created intellectual property will be shared among the parties, rather than assigned to a single entity.",
        "response":"In the Co-Branding Agreement, any jointly created intellectual property rights are owned collectively by Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited. Each party retains rights not explicitly granted in the agreement, indicating a shared ownership model for jointly developed intellectual property.",
        "retrieved_contexts":[
            "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:",
            ", Intellectual Property deemed to be owned by the other Parties under Section 4",
            "4.2.3 Improvements; Jointly Created Intellectual Property.",
            "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership.",
            ".2(i), resulting from any party's respective use of the other party's Intellectual Property, then the Indemnifying Party may at its own election (and at its own expense) (i) replace substantially equivalent Intellectual Property for the infringing item, (ii) modify or fix the infringing item so that it no longer infringes but remains functionally equivalent, (iii) obtain for the benefit of the other party the right to continue using such item in accordance with this Agreement"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does this contract provide for joint intellectual property ownership?",
        "thought":"The context indicates that if intellectual property rights are created jointly by the parties involved in the Co-Branding Agreement, those rights will be owned collectively as specified in Section 4.2.3. This implies that the contract does provide for joint ownership of intellectual property developed through their collaboration. However, it also emphasizes that each party retains rights not expressly granted, which may affect the extent of joint ownership.",
        "response":"Yes, the Co-Branding Agreement provides for joint intellectual property ownership for any rights created or developed jointly by the parties as a result of their collaboration.",
        "retrieved_contexts":[
            "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:",
            "4.2.3 Improvements; Jointly Created Intellectual Property.",
            ", Intellectual Property deemed to be owned by the other Parties under Section 4",
            "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership.",
            "14.9 Independent Contractors. The parties to this Agreement acknowledge and agree that they are dealing with each other hereunder as independent contractors. Nothing contained in this Agreement shall be interpreted as constituting any party the joint venturer, employee or partner of the other party or as conferring upon any party the power of authority to bind another party in any transaction with third parties."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What licenses are granted under this contract?",
        "thought":"The context outlines the proprietary rights and license grants under the Co-Branding Agreement, specifically mentioning that licenses are granted subject to the terms and conditions of the agreement. It also indicates that each party retains rights not expressly granted, and that the use of intellectual property is restricted to what is specified in the licenses. However, the specific licenses granted under this contract are not detailed in the provided context.",
        "response":"The context does not specify the exact licenses granted under the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; it only implies that licenses are granted subject to the agreement's terms.",
        "retrieved_contexts":[
            "4. PROPRIETARY RIGHTS & LICENSE GRANTS\n\n4.1 Licenses.",
            "4.1.2 Company License. Subject to the terms and conditions of this Agreement:",
            "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES",
            "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership.",
            "4.1.3 Restrictions. Each Party may only use the Intellectual Property of the other Party as expressly set forth in the licenses provided in this Section 4."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does the licensor's affiliates have any licensing rights under this contract?",
        "thought":"The question asks whether the licensor's affiliates have licensing rights under the Co-Branding Agreement. The context defines 'Affiliate' and discusses rights and licenses granted under the agreement, particularly noting that all rights terminate upon expiration or termination of the agreement. However, the context does not explicitly state that affiliates have any licensing rights, only that each party reserves rights not granted in the agreement.",
        "response":"The context does not explicitly grant licensing rights to the licensor's affiliates under the Co-Branding Agreement, as it primarily discusses the termination of rights and the definition of 'Affiliate' without confirming any specific rights for them.",
        "retrieved_contexts":[
            "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES",
            "1.2 \"Affiliate\" means in relation to any Person, any Subsidiary or Holding Company, and any company in which such Person or any such Holding Company holds or Controls directly or indirectly not less than 30% of the issued share capital.",
            "4.1.2 Company License. Subject to the terms and conditions of this Agreement:",
            "4. PROPRIETARY RIGHTS & LICENSE GRANTS\n\n4.1 Licenses.",
            "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does the licensee's affiliates have any licensing rights under this contract?",
        "thought":"The context defines 'Affiliate' and discusses licensing rights under the Co-Branding Agreement. However, it does not explicitly state whether the licensee's affiliates have any licensing rights. The termination clause indicates that rights and licenses terminate upon expiration, which may imply that affiliates do not retain rights after termination unless specified otherwise.",
        "response":"The context does not explicitly grant licensing rights to the licensee's affiliates under the Co-Branding Agreement, and upon termination, all rights and licenses granted under the agreement immediately terminate.",
        "retrieved_contexts":[
            "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES",
            "1.2 \"Affiliate\" means in relation to any Person, any Subsidiary or Holding Company, and any company in which such Person or any such Holding Company holds or Controls directly or indirectly not less than 30% of the issued share capital.",
            ", provided that, in each case, the arrangement with the Third Party Affiliate Partner applies to multiple territories (which may include the PRC)",
            "4.1.2 Company License. Subject to the terms and conditions of this Agreement:",
            "4. PROPRIETARY RIGHTS & LICENSE GRANTS\n\n4.1 Licenses."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Are there any services to be provided after the termination of this contract?",
        "thought":"The context outlines the obligations of the parties upon termination of the Co-Branding Agreement, specifically mentioning that certain sections will survive termination, including duties related to rights and licenses. It implies that while all rights and licenses granted under the agreement will terminate, there are specific obligations that will continue for a period of two years after termination. Therefore, it suggests that there may be limited services or obligations that persist post-termination, but it does not explicitly state what those services are.",
        "response":"Upon termination of the Co-Branding Agreement, all rights and licenses will immediately terminate, but certain obligations, including those outlined in Sections 6.3 and others, will survive for a period of two years. This implies that while no new services will be provided, some obligations may continue to exist post-termination.",
        "retrieved_contexts":[
            "Source: TOM ONLINE INC, 20-F, 5\/1\/2006\n\n\n\n\n\n6.3 Duties Upon Termination. Subject to Section 6.5 and to the extent required for the Parties to give effect to Section 6.4, upon termination or expiration of this Agreement, the following shall occur:",
            ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof",
            "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES",
            "14.15 Survival. Sections 1, 4.2 (but not 4.2.3.2.4), 5.4, 6.3, 6.4, 6.5, 7, 11, 12, 13, and 14 and the obligation to pay any amount accrued but not yet paid shall survive termination or expiration of this Agreement.\n\n14.16 The parties agree that the provisions of this Agreement are personal to them and are not intended to confer any rights of enforcement on any third party. The Contracts (Rights of Third Parties) Act 1999 shall not apply to this Agreement or to any of its provisions.   28",
            ". Upon any such termination, the Parties will comply with the other provisions surviving termination hereunder, including, without limitation, Section 6.3."
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What are the audit rights under this contract?",
        "thought":"The context outlines the audit rights under the Co-Branding Agreement, specifying that each Party, including subsidiaries and affiliates, has the right to audit the records of the other Parties. It details the conditions under which audits can be conducted, including the frequency (not more than once per calendar quarter), the requirement for prior notice, and the involvement of certified public accountants. This directly addresses the question regarding the audit rights within the contract.",
        "response":"Under the Co-Branding Agreement, each Party, including subsidiaries and affiliates, has the right to audit the records of the other Parties not more than once per calendar quarter, with a minimum of fifteen days' notice. Audits can be conducted at the premises where the audited Party maintains its records, and must be performed by a certified public accountant. This implies that all Parties are entitled to verify calculations and financial records as stipulated in the agreement.",
        "retrieved_contexts":[
            "5.4 Audit Rights. The Parties (including Online BVI on behalf of the Online Group) agree to maintain records (i) of all information reasonably necessary to verify all calculations to be made under Section 8.3",
            "Each Party shall cause any Subsidiary or other Affiliate (including, without limitation, a Subsidiary or other Affiliate of the Online Group or Skype Group, as applicable) to grant to the other Party the audit rights granted hereunder with respect to such other Party.",
            ". Such audit shall be conducted at the premises where the audited Party maintains consolidated books of account; provided however, that the auditing Party may conduct all or any part of such audit at any of the audited Party's premises where any relevant books of account and\/or records are located. During such audits, the auditing Party shall have the right to take extracts and\/or make copies of the audited Party's records as it deems necessary",
            "The exercise by any Party in whole or in part, at any time of the right to inspect and\/or audit records and accounts or of any other right herein granted, or the acceptance by such Party of any statement or statements or the receipt and\/or deposit by such Party, of any payment tendered by or on behalf of an audited Party shall be without prejudice to any rights or remedies of the accepting Party and such acceptance",
            ". Not more than once per calendar quarter, each Party or its independent auditor (who shall be a certified public accountant) shall have the right, on not less than fifteen (15) calendar days prior notice and not during the first twenty (20) days after the close of any fiscal quarter of the other Parties, or within sixty (60) day of the close of such Parties' respective fiscal years, to audit the books of account and records of any and all such Parties"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there uncapped liability under this contract?",
        "thought":"The context provided discusses limitations on liability, specifically stating that no party shall be liable for special, indirect, consequential, incidental, punitive, or consequential damages. This implies that there may be limitations on liability, but it does not explicitly state whether there is uncapped liability under the Co-Branding Agreement. Therefore, the context does not provide a definitive answer regarding uncapped liability.",
        "response":"The Co-Branding Agreement does not explicitly indicate uncapped liability, as it limits liability for certain types of damages. However, the absence of specific language regarding uncapped liability means it is unclear if any uncapped liability exists under this contract.",
        "retrieved_contexts":[
            "12.2 Limitation of Liability.",
            "13. INDEMNIFICATION",
            ", and shall not be liable for such material breach",
            "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES",
            "13.1 Company Indemnification"
        ]
    },
    {
        "user_input":"Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there a cap on liability under this contract?",
        "thought":"The context provided discusses a limitation of liability clause, indicating that parties to the Co-Branding Agreement may have their liability capped under certain conditions. It specifies exceptions for willful misappropriation or infringement of intellectual property and obligations under Section 13, suggesting that liability is limited except in these cases. Therefore, the contract does imply a cap on liability, contingent on the circumstances outlined.",
        "response":"Yes, the Co-Branding Agreement includes a limitation of liability clause that caps liability for damages, except in cases of willful misappropriation or infringement of intellectual property, or obligations under Section 13.",
        "retrieved_contexts":[
            "12.2 Limitation of Liability.",
            "Source: TOM ONLINE INC, 20-F, 5\/1\/2006\n\n\n\n\n\n12. DISCLAIMER & LIMITATION OF LIABILITY",
            ".1 TO THE MAXIMUM EXTENT PERMISSIBLE UNDER APPLICABLE LAW, EXCEPT FOR THE WILFUL MISAPPROPRIATION OR INFRINGEMENT OF THE INTELLECTUAL PROPERTY OF A PARTY TO THIS AGREEMENT, OR THE OBLIGATIONS OF THE PARTIES TO THIS AGREEMENT PURSUANT TO SECTION 13, (A) THE LIABILITY OF ANY PARTY TO THIS AGREEMENT, IF ANY, FOR DAMAGES FOR ANY CLAIM OF ANY KIND WHATSOEVER AND REGARDLESS OF THE LEGAL THEORY, WITH REGARD TO THE RIGHTS GRANTED HEREUNDER OR THE SERVICES PERFORMED HEREUNDER",
            ", and shall not be liable for such material breach",
            "13. INDEMNIFICATION"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; What is the expiration date of this contract?",
        "thought":"The Development Agreement between Howmedica Osteonics Corp. (referred to as Stryker) and Conformis, Inc. specifies an Effective Date of September 30, 2019. However, the expiration date of the contract is not explicitly stated in the provided context, which only mentions the execution dates and milestone payments. Therefore, while the Effective Date is clear, the expiration date remains unspecified, implying that further details would be needed to determine the duration of the agreement.",
        "response":"The Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. has an Effective Date of September 30, 2019, but the expiration date is not specified in the provided context.",
        "retrieved_contexts":[
            "IN WITNESS WHEREOF, the parties have caused this Development Agreement to be duly executed as of the respective   dates written below.   HOWMEDICA OSTEONICS CORP. CONFORMIS, INC.   By: \/s\/ Spencer Stiles By: \/s\/ Mark A. Augusti Name: Spencer Stiles Name: Mark A. Augusti Title: President Title: President and CEO Date: September 26, 2019 Date: 9-30-2019   [Signature Page to Development Agreement]   Source: CONFORMIS INC, 10-Q, 11\/1\/2019",
            ". Stryker shall pay to Conformis the following milestone payments for the development   work to be conducted hereunder if and when the following milestones are met, as follows:   (a) Milestone #1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient-   Specific Instrumentation delivered to it by Conformis in accordance with the R&D Work Plan, Stryker shall pay to Conformis a   total of two million U.S",
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            "Execution Version Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.   DEVELOPMENT AGREEMENT   This Development Agreement (\"this Agreement\") is entered into and effective as of September 30, 2019 (\"Effective   Date\") by and between Howmedica Osteonics Corp",
            "(b) Milestone #2 - Within thirty (30) days following the date on which there is a design freeze of the Patient-Specific   Instrumentation for the KIB Product in accordance with the R&D Work Plan, Stryker shall pay to Conformis a total of three   million U.S dollars ($3,000,000).   3.6 Payment. Stryker shall make all payments to Conformis required herein by wire transfer in accordance with the Wire   Instructions"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; What is the governing law for this contract?",
        "thought":"The context provided does not explicitly state the governing law for the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. It primarily discusses the execution of the agreement and related terms but lacks any reference to the legal jurisdiction or governing law clause. Therefore, I cannot determine the governing law based on the available information.",
        "response":"I don't know.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            "IN WITNESS WHEREOF, the parties have caused this Development Agreement to be duly executed as of the respective   dates written below.   HOWMEDICA OSTEONICS CORP. CONFORMIS, INC.   By: \/s\/ Spencer Stiles By: \/s\/ Mark A. Augusti Name: Spencer Stiles Name: Mark A. Augusti Title: President Title: President and CEO Date: September 26, 2019 Date: 9-30-2019   [Signature Page to Development Agreement]   Source: CONFORMIS INC, 10-Q, 11\/1\/2019",
            ".\"   WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain   Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a   Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such   agreements are referred to herein as the \"Other Agreements\")",
            ". Stryker shall pay to Conformis the following milestone payments for the development   work to be conducted hereunder if and when the following milestones are met, as follows:   (a) Milestone #1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient-   Specific Instrumentation delivered to it by Conformis in accordance with the R&D Work Plan, Stryker shall pay to Conformis a   total of two million U.S",
            ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Are there any exceptions to competitive restrictions in this contract?",
        "thought":"The context indicates that Conformis is generally restricted from developing Patient-Specific Instrumentation for Off-The-Shelf Knee Implants for third parties until January 1, 2032. However, it also states that Conformis may develop such instrumentation for its own Off-The-Shelf Implants or those of an Acquirer, which implies an exception to the competitive restrictions. Therefore, the exceptions to the competitive restrictions in the Development Agreement include the ability for Conformis and its Acquirers to develop Patient-Specific Instrumentation for their own products.",
        "response":"Yes, there are exceptions to the competitive restrictions in the Development Agreement; specifically, Conformis may develop Patient-Specific Instrumentation for its own Off-The-Shelf Implants or those of an Acquirer, despite the general prohibition on developing for third parties until January 1, 2032.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3",
            ". Stryker shall pay to Conformis the following milestone payments for the development   work to be conducted hereunder if and when the following milestones are met, as follows:   (a) Milestone #1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient-   Specific Instrumentation delivered to it by Conformis in accordance with the R&D Work Plan, Stryker shall pay to Conformis a   total of two million U.S",
            ". For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.   ARTICLE V   INTELLECTUAL PROPERTY   5.1 Inventions",
            ".\"   WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain   Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a   Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such   agreements are referred to herein as the \"Other Agreements\")"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does this contract include an exclusivity agreement?",
        "thought":"The context discusses various agreements between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc., including a Distribution Agreement that restricts Conformis from developing Patient-Specific Instrumentation for Off-The-Shelf Knee Implants for third parties until January 1, 2032. This implies a level of exclusivity in the context of the Distribution Agreement, as it limits Conformis's ability to engage with other parties in that specific field. However, the context does not explicitly state that there is a formal exclusivity agreement; it only suggests restrictions on development activities.",
        "response":"The context implies that the Distribution Agreement includes restrictions that could be interpreted as exclusivity, as it prohibits Conformis from developing Patient-Specific Instrumentation for Off-The-Shelf Knee Implants for third parties until January 1, 2032. However, it does not explicitly define these restrictions as an exclusivity agreement. Therefore, while there are limitations on Conformis's activities, it is not clearly stated that an exclusivity agreement exists.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ".\"   WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain   Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a   Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such   agreements are referred to herein as the \"Other Agreements\")",
            ". For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.   ARTICLE V   INTELLECTUAL PROPERTY   5.1 Inventions",
            ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3",
            "use only under this Agreement. Conformis waives any right it may have in law or equity to withhold Stryker's property.   (b) All Equipment furnished by Conformis to Stryker in connection with this Agreement: (i) shall only be used in the performance   of the R&D Program; (ii) shall remain the property of Conformis; and (iii) shall be disposed of or returned in good repair, normal   wear and tear excepted, by Stryker to Conformis at Conformis' direction and expense upon Conformis' request"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "thought":"The context mentions various types of contracts, including those that grant rights of first refusal and rights of first negotiation. However, it does not explicitly state whether the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. includes such rights. Therefore, while the context implies that such rights could exist in contracts, it does not confirm their presence in the specific Development Agreement in question.",
        "response":"The Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. does not explicitly state whether it includes any right of first refusal, right of first offer, or right of first negotiation, based on the provided context.",
        "retrieved_contexts":[
            "(xii) any stockholders agreements, voting agreements, registrations rights agreements, co-sale agreements and any other similar Contracts between the Company and any holder of Company capital stock\u037e \n\n\n(xiii) the Joint Venture Agreements for the Material Clinic Joint Ventures\u037e \n\n\n(xiv) any Contract between the Company or any of its Subsidiaries and any Governmental Entity and that is material to the Company and its Subsidiaries, taken as a whole\u037e",
            "IN WITNESS WHEREOF, the parties have caused this Development Agreement to be duly executed as of the respective   dates written below.   HOWMEDICA OSTEONICS CORP. CONFORMIS, INC.   By: \/s\/ Spencer Stiles By: \/s\/ Mark A. Augusti Name: Spencer Stiles Name: Mark A. Augusti Title: President Title: President and CEO Date: September 26, 2019 Date: 9-30-2019   [Signature Page to Development Agreement]   Source: CONFORMIS INC, 10-Q, 11\/1\/2019",
            "(viii)          any material Contract with any Person (A) pursuant to which Parent or any of its Subsidiaries may be required to pay milestones, royalties or other contingent payments based on any research, testing, development, regulatory filings or approval, sale, distribution, commercial manufacture or other similar occurrences, developments, activities or events, or (B) under which Parent or any of its Subsidiaries grants to any Person any right of first refusal, right of first negotiation",
            "rights under this Agreement.",
            "(viii) any Contract with any Person (A) pursuant to which the Company or its Subsidiaries may be required to pay milestones, royalties or other contingent payments based on any research, testing, development, regulatory filings or approval, sale, distribution, commercial manufacture or other similar occurrences, developments, activities or events, or (B) under which the Company or its Subsidiaries grants to any Person any right of first refusal, right of first negotiation, option to purchase"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does this contract provide for joint intellectual property ownership?",
        "thought":"The context indicates that both Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. have rights to Joint Intellectual Property (Joint IP) as they are equally responsible for the costs and expenses associated with preparing, filing, prosecuting, and maintaining such Joint IP Rights. This implies that while each party retains ownership of their respective Background IP, they share ownership of the Joint IP created under the Development Agreement. Therefore, the contract does provide for joint intellectual property ownership between the parties.",
        "response":"Yes, the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. provides for joint intellectual property ownership, as both parties are equally responsible for the costs and maintenance of the Joint IP Rights.",
        "retrieved_contexts":[
            ".   (b) Stryker acknowledges and agrees that, as between the Parties, Conformis owns all right, title and interest, including all   Intellectual Property rights, in and to Conformis Background IP and Conformis' Confidential Information, including any Conformis   Confidential Information underlying the Joint IP, and that, under this Agreement, Stryker shall acquire no right, title",
            ".   (a) Conformis acknowledges and agrees that, as between the Parties, Stryker owns all right, title and interest, including all   Intellectual Property rights, within the Stryker Background IP and Stryker's Confidential Information, including any Stryker   Confidential Information underlying the Joint IP, and that, under this Agreement, except as expressly set forth herein, Conformis   shall acquire no right, title, or interest in or to any of the foregoing",
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ". Subject to the limitations set forth in this Agreement, the Joint IP may be used freely by either Party or   its Affiliates and licensed to Third Parties by Conformis and its Affiliates, on the one hand, outside of the Buyer Field or by Stryker   and its Affiliates, on the other hand, within the Buyer Field, in each case, without the consent of, or duty to account to or notify, the   other Party, but",
            "and maintenance of the Joint IP Rights. In this regard, the prosecuting Party agrees to provide reasonable time for the non-   prosecuting party to review and comment prior to any deadline associated with such Patent. Conformis and Stryker shall be   equally responsible for costs and expenses of preparing, filing, prosecuting and maintaining any such Joint IP Rights"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; What licenses are granted under this contract?",
        "thought":"The context discusses various agreements related to the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc., specifically mentioning licenses and restrictions on developing Patient-Specific Instrumentation. It indicates that Conformis may develop such instrumentation for its own products and outlines limitations on developing for third parties. The relevant licenses appear to be those allowing Conformis to develop Patient-Specific Instrumentation for its Off-The-Shelf Implants, while also noting restrictions on third-party development until a specified date.",
        "response":"Under the Development Agreement, Conformis is granted licenses to develop Patient-Specific Instrumentation for its Off-The-Shelf Implants, while being prohibited from developing for third parties in orthopedics until January 1, 2032. This implies that Conformis retains certain rights to its products but faces limitations on external collaborations.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ".\"   WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain   Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a   Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such   agreements are referred to herein as the \"Other Agreements\")",
            ".2 of the License Agreement,   constitutes as Stryker's sole remedy and Conformis' exclusive liability in the event of any such rejection or failure by Conformis to   deliver materially conforming Deliverables hereunder so long as such rejection or failure does not arise from Conformis' fraud,   willful misconduct, gross negligence or bad faith",
            ". For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.   ARTICLE V   INTELLECTUAL PROPERTY   5.1 Inventions",
            ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does the licensee's affiliates have any licensing rights under this contract?",
        "thought":"The context indicates that Conformis, including its affiliates, is allowed to develop Patient-Specific Instrumentation for Off-The-Shelf Implants, which implies that the licensee's affiliates do have some rights under the contract. However, the context also specifies limitations on Conformis' ability to develop such instrumentation for third parties in orthopedics until a certain date. Therefore, while affiliates may have rights, those rights are subject to specific conditions and restrictions.",
        "response":"Yes, the licensee's affiliates (Conformis and its Acquirers) have licensing rights under the Development Agreement, allowing them to develop Patient-Specific Instrumentation, but these rights are limited by restrictions on developing for third parties in orthopedics until January 1, 2032.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ". For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.   ARTICLE V   INTELLECTUAL PROPERTY   5.1 Inventions",
            ".2 of the License Agreement,   constitutes as Stryker's sole remedy and Conformis' exclusive liability in the event of any such rejection or failure by Conformis to   deliver materially conforming Deliverables hereunder so long as such rejection or failure does not arise from Conformis' fraud,   willful misconduct, gross negligence or bad faith",
            ". Subject to the limitations set forth in this Agreement, the Joint IP may be used freely by either Party or   its Affiliates and licensed to Third Parties by Conformis and its Affiliates, on the one hand, outside of the Buyer Field or by Stryker   and its Affiliates, on the other hand, within the Buyer Field, in each case, without the consent of, or duty to account to or notify, the   other Party, but",
            ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Is there uncapped liability under this contract?",
        "thought":"The context indicates that Stryker's liability is limited to specific remedies outlined in the Distribution Agreement, particularly regarding breaches related to Product or Stryker Product. The indemnification clauses suggest that both parties have defined responsibilities and liabilities, which implies that there may not be uncapped liability under the contract. However, the exact terms of liability are contingent upon the provisions in the Distribution Agreement, which are not fully detailed in the provided context.",
        "response":"Based on the context, Stryker's liability appears to be limited to specific remedies as stated in the Distribution Agreement, suggesting there is no uncapped liability. The indemnification obligations indicate a shared responsibility for claims, further implying that liabilities are not unlimited. Therefore, it can be concluded that there is no uncapped liability under the Development Agreement.",
        "retrieved_contexts":[
            ". Notwithstanding   anything to the contrary, Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a   Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement.   (b) Indemnification by Stryker. Stryker shall indemnify and hold harmless Conformis, its directors, officers, employees, Agents   and   20   Source: CONFORMIS INC, 10-Q, 11\/1\/2019",
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ". To the extent that Stryker, on the one hand, and Conformis, on the other hand, each has indemnification   obligations to the other in connection with a single Claim, they will contribute to the aggregate damages, liabilities, costs and   expenses arising from such Claim in a proportion reflecting the relative and comparative responsibilities and determined liability of   the Parties for such damages, liabilities, costs and expenses, as well as any other relevant equitable considerations",
            ". Conformis shall indemnify and hold harmless Stryker, its directors, officers, employees, Agents   and Affiliates and   19   Source: CONFORMIS INC, 10-Q, 11\/1\/2019",
            ". For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.   ARTICLE V   INTELLECTUAL PROPERTY   5.1 Inventions"
        ]
    },
    {
        "user_input":"Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Is there a cap on liability under this contract?",
        "thought":"The context mentions Stryker's sole remedy and Conformis' exclusive liability for breach of a specific section, which implies that there are limitations on liability as outlined in the Distribution Agreement. However, it does not explicitly state a cap on liability, only that remedies and liabilities are defined in a particular section. Therefore, while there are limitations, the exact nature of a cap on liability is not clearly provided in the context.",
        "response":"The context implies that there are limitations on liability between Stryker and Conformis as per the Distribution Agreement, but it does not explicitly state a cap on liability.",
        "retrieved_contexts":[
            ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
            ". Stryker shall pay to Conformis the following milestone payments for the development   work to be conducted hereunder if and when the following milestones are met, as follows:   (a) Milestone #1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient-   Specific Instrumentation delivered to it by Conformis in accordance with the R&D Work Plan, Stryker shall pay to Conformis a   total of two million U.S",
            ". Notwithstanding   anything to the contrary, Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a   Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement.   (b) Indemnification by Stryker. Stryker shall indemnify and hold harmless Conformis, its directors, officers, employees, Agents   and   20   Source: CONFORMIS INC, 10-Q, 11\/1\/2019",
            ". To the extent that Stryker, on the one hand, and Conformis, on the other hand, each has indemnification   obligations to the other in connection with a single Claim, they will contribute to the aggregate damages, liabilities, costs and   expenses arising from such Claim in a proportion reflecting the relative and comparative responsibilities and determined liability of   the Parties for such damages, liabilities, costs and expenses, as well as any other relevant equitable considerations",
            ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What is the expiration date of this contract?",
        "thought":"The context provides information about the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc., including the Execution Date of June 12, 2019. However, it does not specify the expiration date of the contract or any terms that would indicate when the agreement would terminate. Therefore, while the context discusses the agreement, it does not contain relevant information to directly answer the question regarding the expiration date.",
        "response":"The context does not provide the expiration date of the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.",
        "retrieved_contexts":[
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            ".1 ETON shall enter into a commercial supply agreement with a contract manufacturing organization and Aucta shall enter into a commercial supply agreement with an active pharmaceutical ingredient supplier within ninety (90) days from the Execution Date unless otherwise agreed to by the parties in writing. 4.2 If the terms of Aucta's commercial supply agreement with the active pharmaceutical ingredient supplier in Section 4",
            ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11",
            ". Field Pkwy, Suite 235 Deer Park, Illinois, USA Attention: Legal if to Aucta, to: Aucta Pharmaceuticals, Inc. 71 Suttons Lane Piscataway, NJ 08854 Attention: CEO 15.4 Relationship of Parties. The status of the Parties under this Agreement shall be that of independent contractors, without the authority to act on behalf of or bind each other. Nothing in this Agreement shall be construed as establishing a partnership or joint venture relationship between the Parties hereto"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What is the governing law for this contract?",
        "thought":"The context provided does not explicitly mention the governing law for the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. Governing law typically refers to the jurisdiction whose laws will govern the interpretation and enforcement of the contract, but this information is absent in the retrieved context.",
        "response":"I don't know.",
        "retrieved_contexts":[
            ".3, then (a) ETON shall have the right to, and Aucta shall hereby grant ETON a license to, Market or otherwise dispose of any existing inventory of any Products then in ETON's possession subject to paying all Royalties and other amounts due hereunder for such sales",
            ", (b) Aucta may keep all the payments under Section 6 paid by ETON up to the point of termination and for ETON's disposal of remaining inventory and Aucta is free to commercialize or relicense the Product with no further obligations owed to ETON, (c) ETON shall refrain from holding itself out as Aucta's distributor, in particular, eliminate any reference to the Product and Aucta from its business, trade style and promotional material, and (d) ETON shall transfer all rights",
            ".1 Aucta, for itself and its Affiliates, hereby grants to ETON in accordance with the terms and conditions of this Agreement, an exclusive (even as to and against Aucta in the Territory) right and license, including the right to sublicense, to the Products (or any components thereof), Dossiers, and all current and future Aucta Background Intellectual Property that is owned or controlled by Aucta or its Affiliates for ETON to develop, manufacture, import, use, promote, distribute, market",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there a non-compete clause in this contract?",
        "thought":"The context mentions a non-competition provision within the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. Specifically, it states that Aucta is restricted from engaging in certain activities related to products containing Lamotrigine during the term of the agreement and for two years thereafter, indicating the presence of a non-compete clause. Additionally, the context emphasizes that these non-competition provisions are essential to the agreement, confirming their significance.",
        "response":"Yes, the Exclusive License and Product Development Agreement contains a non-compete clause that restricts Aucta Pharmaceuticals, Inc. from engaging in specific activities related to products containing Lamotrigine during the term of the agreement and for two years thereafter.",
        "retrieved_contexts":[
            "(iv) other than the Joint Venture Agreements, any Contract of the Company, any of its Subsidiaries or, to the knowledge of the Company, the Clinic Joint Ventures, that limits the ability of the Company, any of its Subsidiaries or a Clinic Joint Venture to compete in any line of business or with any Person or in any geographic area or during any period of time, in each case in any respect material to the Company, its Subsidiaries and the Clinic Joint Ventures, taken as a whole. \n\n\n15",
            ". 3.5 Competitive Products. During the Term of this Agreement, and for a period of two (2) years thereafter, Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine; nor will Aucta directly or indirectly assist any other Person or entity in carrying or any such activities. [ * * * ] 4. MANUFACTURE AND SUPPLY 4",
            "The non-competition provisions of this Agreement are an essential and material part of the total agreement, by which the Parties agree they shall not use any advantages derivable from such confidential information in their own business or affairs, unless the same is done pursuant to a new agreement executed by all signatories to this document.\n5. NON-CIRCUMVENTION",
            "(b)    is a non-competition or other agreement (including any exclusive license to, or covenant not to sue or assert claims based on, any Company Intellectual Property) that prohibits or otherwise restricts, in any material respect, the Company or any of its Subsidiaries from freely engaging in any business material to the Company and its Subsidiaries, taken as a whole, anywhere in the world;",
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Does this contract include an exclusivity agreement?",
        "thought":"The context clearly states that Eton Pharmaceuticals, Inc. is granted an exclusive license by Aucta Pharmaceuticals, Inc. for the Products, which implies that this agreement includes exclusivity. The term 'exclusive license' indicates that Eton has rights that are not shared with Aucta or any other party in the specified territory, thus confirming the presence of an exclusivity agreement.",
        "response":"Yes, the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. includes an exclusivity agreement, as Eton is granted an exclusive license to the Products, meaning no other party, including Aucta, can use those rights in the specified territory.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            "; WHEREAS, ETON desires to obtain an exclusive license to the Products, the Dossiers (later defined), and Aucta Background Intellectual Property (later defined) for Marketing the Products in the Territory, and Aucta is willing to grant such an exclusive license to ETON under the terms and conditions set forth herein; WHEREAS, ETON will pay Aucta certain milestone, royalty and licensing payments based on the sale of Products in the Territory under the terms and conditions set forth herein",
            ".1 Aucta, for itself and its Affiliates, hereby grants to ETON in accordance with the terms and conditions of this Agreement, an exclusive (even as to and against Aucta in the Territory) right and license, including the right to sublicense, to the Products (or any components thereof), Dossiers, and all current and future Aucta Background Intellectual Property that is owned or controlled by Aucta or its Affiliates for ETON to develop, manufacture, import, use, promote, distribute, market",
            ". As of the Agreement Date, none of the Top Suppliers that grants or licenses any material rights in or to use any Intellectual Property that is incorporated into any Company Product has cancelled or otherwise terminated or materially and adversely altered the terms (including with respect to pricing) of or, to the Company\u2019s knowledge, threatened to cancel or otherwise terminate or materially and adversely alter the terms (including with respect to pricing) of"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Can this contract be terminated for convenience, and under what conditions?",
        "thought":"The context indicates that Eton Pharmaceuticals, Inc. (ETON) has the right to terminate the Exclusive License and Product Development Agreement with Aucta Pharmaceuticals, Inc. (Aucta) at its sole discretion after providing 180 days' written notice. This implies that ETON can terminate the contract for convenience, as it does not require a specific reason beyond the notice period. The mention of mutual consent and other termination clauses suggests that there are various conditions under which termination can occur, but the specific right for ETON to terminate for convenience is clearly outlined.",
        "response":"Yes, the contract can be terminated for convenience by Eton Pharmaceuticals, Inc. (ETON) after providing 180 days' written notice to Aucta Pharmaceuticals, Inc. (Aucta). This termination right is at ETON's sole discretion, indicating that no specific reason is required beyond the notice period.",
        "retrieved_contexts":[
            ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11",
            ".4(b), ETON shall continue to market the Products as before notice of termination, receive revenue and pay associated costs for selling the Product(s) during any notice period. After termination is effective and Aucta assumes control of the Product, ETON will provide, to the extent practicable, transition services to Aucta to include assistance with Product distribution, processing of rebates, drug safety, etc",
            ". This Agreement may be terminated, in the case of clauses (a), (b), (e), (f) or (g) below, at any time prior to the Effective Time, whether before or after receipt of the Company Stockholder Approval or, in the case of clauses (c) or (d) below, at any time prior to receipt of the Company Stockholder Approval, as follows:   (a)            by mutual written consent of Parent and the Company;   (b)            by either Parent or the Company:",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            ". The objective of this clause is to provide reasonable assurance that a termination does not disrupt the supply of Product)s) to the market if possible and both parties shall work in good faith to try and avoid any disruption in the marketing or supply of Products during termination and transfer of Products sales back to Aucta. 11.5 Effect of Termination or Expiration: Surviving Obligations. 11.5.1 If this Agreement is terminated by ETON (i) under Section 11"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
        "thought":"The context indicates that either party in the Exclusive License and Product Development Agreement can assign their rights and obligations to affiliates or in the event of a change of control, such as a merger or acquisition, without needing the other party's approval. This means that if Eton Pharmaceuticals, Inc. or Aucta Pharmaceuticals, Inc. undergoes a change of control, they can transfer their rights under the agreement to a new entity. Therefore, the agreement allows for continuity in the contractual relationship despite changes in ownership.",
        "response":"In the event of a change of control of either Eton Pharmaceuticals, Inc. or Aucta Pharmaceuticals, Inc., the agreement permits the affected party to assign its rights and obligations to an affiliate or to a purchaser of its business without requiring the other party's approval.",
        "retrieved_contexts":[
            ".4(b), ETON shall continue to market the Products as before notice of termination, receive revenue and pay associated costs for selling the Product(s) during any notice period. After termination is effective and Aucta assumes control of the Product, ETON will provide, to the extent practicable, transition services to Aucta to include assistance with Product distribution, processing of rebates, drug safety, etc",
            ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11",
            ", and (ii) Licensor may assign its rights and obligations in this Agreement to its Affiliates or subsidiaries and either party may assign this Agreement in its entirety to any purchaser of all or substantially all of its business or assets pertaining to the line of business to which this Agreement relates or to any Affiliate of the party without the other party's approval",
            ". To the   extent applicable, it is the intent of the Parties that ownership of all developments under this Agreement shall vest in the respective   Party by operation of law or by assignment prior to assignment to the other Party pursuant to Article V.   18   Source: CONFORMIS INC, 10-Q, 11\/1\/2019",
            "(b)          No Party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the prior written consent of each other Party hereto, except that any of Parent or Merger Sub may transfer or assign its rights and obligations under this Agreement, in whole or from time to time in part, to one or more of its Affiliates at any time, in which case all references herein to Parent or Merger Sub, as applicable"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there an anti-assignment clause in this contract?",
        "thought":"The context explicitly states that neither Eton Pharmaceuticals, Inc. nor Aucta Pharmaceuticals, Inc. can assign the Agreement or any rights under it without prior written consent from the other party. This indicates the presence of an anti-assignment clause, as it restricts the ability to transfer rights or obligations under the contract without mutual agreement. Therefore, the context directly supports the conclusion that there is indeed an anti-assignment clause in the contract.",
        "response":"Yes, the Exclusive License and Product Development Agreement contains an anti-assignment clause, as it prohibits either party from assigning their rights or obligations without the prior written consent of the other party.",
        "retrieved_contexts":[
            ".9 No Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties (whether by operation of Law or otherwise) without the prior written consent of the other parties. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns",
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void",
            ". 3.5 Competitive Products. During the Term of this Agreement, and for a period of two (2) years thereafter, Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine; nor will Aucta directly or indirectly assist any other Person or entity in carrying or any such activities. [ * * * ] 4. MANUFACTURE AND SUPPLY 4",
            "(iv) other than the Joint Venture Agreements, any Contract of the Company, any of its Subsidiaries or, to the knowledge of the Company, the Clinic Joint Ventures, that limits the ability of the Company, any of its Subsidiaries or a Clinic Joint Venture to compete in any line of business or with any Person or in any geographic area or during any period of time, in each case in any respect material to the Company, its Subsidiaries and the Clinic Joint Ventures, taken as a whole. \n\n\n15"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
        "thought":"The context indicates that Eton Pharmaceuticals, Inc. (referred to as Eton) is obligated to pay Aucta Pharmaceuticals, Inc. (referred to as Aucta) certain licensing fees, milestone payments, and royalties based on the sales of products. Specifically, Aucta is entitled to receive 15% of Net Sales Royalty as long as Eton sells the products in the designated territory. This implies that the contract does include revenue-sharing arrangements through these royalties.",
        "response":"Yes, the Exclusive License and Product Development Agreement includes revenue-sharing arrangements, as Aucta is entitled to receive 15% of Net Sales Royalty from Eton for the products sold in the territory.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            ".3 ETON shall have the sole and exclusive right to determine all terms and conditions of sale of the Products to its or its prospective consumers. 5.4 [ * * * ] 6. MILESTONES AND OTHER PAYMENTS 6.1 Licensing Fees. ETON shall pay to Aucta licensing fees of up to an amount of five million dollars ($5,000,000) based on the following payment schedule: (a) An amount of two million dollars ($2,000,000) within five (5) days of the Effective Date of this Agreement",
            ". For avoidance of doubt, all rights conferred to ETON under this Agreement for the purpose of allowing ETON to Market the Product in the Territory shall continue until a Party terminates this Agreement. Aucta should continue to receive 15% of Net Sales Royalty for as long as ETON is selling the Product(s) in the Territory, unless otherwise agreed to under this Agreement",
            "; WHEREAS, ETON desires to obtain an exclusive license to the Products, the Dossiers (later defined), and Aucta Background Intellectual Property (later defined) for Marketing the Products in the Territory, and Aucta is willing to grant such an exclusive license to ETON under the terms and conditions set forth herein; WHEREAS, ETON will pay Aucta certain milestone, royalty and licensing payments based on the sale of Products in the Territory under the terms and conditions set forth herein"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there a minimum commitment required under this contract?",
        "thought":"The context does not explicitly mention a minimum commitment required under the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. It discusses obligations related to commercial supply agreements and termination rights but does not clarify any minimum commitment. Therefore, the relevant information does not imply a minimum commitment requirement under this contract.",
        "response":"The context does not provide information regarding a minimum commitment required under the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            ".1 ETON shall enter into a commercial supply agreement with a contract manufacturing organization and Aucta shall enter into a commercial supply agreement with an active pharmaceutical ingredient supplier within ninety (90) days from the Execution Date unless otherwise agreed to by the parties in writing. 4.2 If the terms of Aucta's commercial supply agreement with the active pharmaceutical ingredient supplier in Section 4",
            "(f) Except as contained in a Joint Venture Agreement or as would not be material to the Company and its Subsidiaries and Clinic Joint Ventures, taken as a whole, neither the Company nor any Subsidiary of the Company nor any Clinic Joint Venture may be required, by reason of (i) the execution, delivery and performance of this Agreement or the anticipated consummation of the transactions contemplated hereby or (ii) the passage of time, to purchase or redeem or to offer to purchase or redeem",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Does this contract include any volume restrictions?",
        "thought":"The context specifies that Aucta Pharmaceuticals, Inc. is restricted from researching, developing, manufacturing, selling, marketing, or distributing more than two products containing the active ingredient Lamotrigine during the term of the agreement and for two years thereafter. This indicates a limitation on the volume of products Aucta can engage with, which can be interpreted as a volume restriction. However, the context does not explicitly mention any overall volume restrictions on sales or production quantities beyond this specific limitation.",
        "response":"Yes, the Exclusive License and Product Development Agreement includes a volume restriction as Aucta Pharmaceuticals, Inc. is limited to not developing or distributing more than two products containing Lamotrigine during the term of the agreement and for two years thereafter.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            ".1 ETON shall enter into a commercial supply agreement with a contract manufacturing organization and Aucta shall enter into a commercial supply agreement with an active pharmaceutical ingredient supplier within ninety (90) days from the Execution Date unless otherwise agreed to by the parties in writing. 4.2 If the terms of Aucta's commercial supply agreement with the active pharmaceutical ingredient supplier in Section 4",
            ". 3.5 Competitive Products. During the Term of this Agreement, and for a period of two (2) years thereafter, Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine; nor will Aucta directly or indirectly assist any other Person or entity in carrying or any such activities. [ * * * ] 4. MANUFACTURE AND SUPPLY 4",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            ".3 ETON shall have the sole and exclusive right to determine all terms and conditions of sale of the Products to its or its prospective consumers. 5.4 [ * * * ] 6. MILESTONES AND OTHER PAYMENTS 6.1 Licensing Fees. ETON shall pay to Aucta licensing fees of up to an amount of five million dollars ($5,000,000) based on the following payment schedule: (a) An amount of two million dollars ($2,000,000) within five (5) days of the Effective Date of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What licenses are granted under this contract?",
        "thought":"The context outlines that Aucta Pharmaceuticals, Inc. grants Eton Pharmaceuticals, Inc. an exclusive license to develop, manufacture, import, use, promote, distribute, and market certain products, along with associated Dossiers and Aucta's Background Intellectual Property. The term 'exclusive license' indicates that Eton has rights that are not shared with Aucta or any other entity in the specified territory. Therefore, the licenses granted under the contract include rights to the Products, Dossiers, and Background Intellectual Property necessary for Eton's marketing and development efforts.",
        "response":"Under the Exclusive License and Product Development Agreement, Aucta Pharmaceuticals, Inc. grants Eton Pharmaceuticals, Inc. an exclusive license to develop, manufacture, import, use, promote, distribute, and market the Products, along with associated Dossiers and Aucta's Background Intellectual Property.",
        "retrieved_contexts":[
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            ".1 Aucta, for itself and its Affiliates, hereby grants to ETON in accordance with the terms and conditions of this Agreement, an exclusive (even as to and against Aucta in the Territory) right and license, including the right to sublicense, to the Products (or any components thereof), Dossiers, and all current and future Aucta Background Intellectual Property that is owned or controlled by Aucta or its Affiliates for ETON to develop, manufacture, import, use, promote, distribute, market",
            "; WHEREAS, ETON desires to obtain an exclusive license to the Products, the Dossiers (later defined), and Aucta Background Intellectual Property (later defined) for Marketing the Products in the Territory, and Aucta is willing to grant such an exclusive license to ETON under the terms and conditions set forth herein; WHEREAS, ETON will pay Aucta certain milestone, royalty and licensing payments based on the sale of Products in the Territory under the terms and conditions set forth herein",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            ".3, then (a) ETON shall have the right to, and Aucta shall hereby grant ETON a license to, Market or otherwise dispose of any existing inventory of any Products then in ETON's possession subject to paying all Royalties and other amounts due hereunder for such sales"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Are there any services to be provided after the termination of this contract?",
        "thought":"The context indicates that after the termination of the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc., Eton is obligated to provide transition services to Aucta. These services include assistance with product distribution, processing of rebates, and drug safety, which implies that Eton will continue to support Aucta in certain operational aspects even after the contract ends.",
        "response":"Yes, after the termination of the contract, Eton Pharmaceuticals, Inc. is required to provide transition services to Aucta Pharmaceuticals, Inc., which includes assistance with product distribution and other operational matters.",
        "retrieved_contexts":[
            ".4(b), ETON shall continue to market the Products as before notice of termination, receive revenue and pay associated costs for selling the Product(s) during any notice period. After termination is effective and Aucta assumes control of the Product, ETON will provide, to the extent practicable, transition services to Aucta to include assistance with Product distribution, processing of rebates, drug safety, etc",
            ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            ".1 ETON shall enter into a commercial supply agreement with a contract manufacturing organization and Aucta shall enter into a commercial supply agreement with an active pharmaceutical ingredient supplier within ninety (90) days from the Execution Date unless otherwise agreed to by the parties in writing. 4.2 If the terms of Aucta's commercial supply agreement with the active pharmaceutical ingredient supplier in Section 4",
            ", (b) Aucta may keep all the payments under Section 6 paid by ETON up to the point of termination and for ETON's disposal of remaining inventory and Aucta is free to commercialize or relicense the Product with no further obligations owed to ETON, (c) ETON shall refrain from holding itself out as Aucta's distributor, in particular, eliminate any reference to the Product and Aucta from its business, trade style and promotional material, and (d) ETON shall transfer all rights"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What are the audit rights under this contract?",
        "thought":"The context provides specific information about the audit rights under the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. It states that the AS Parties (which likely refers to Aucta and its affiliates) have the right to inspect MusclePharm's books and records, but it does not mention Eton or Aucta directly in relation to the audit rights. Therefore, the relevant information implies that the audit rights are limited to a specific party (MusclePharm) and may not directly apply to the agreement between Eton and Aucta.",
        "response":"The audit rights under the Exclusive License and Product Development Agreement allow the AS Parties to inspect the books and records of MusclePharm with at least five days' written notice, but this does not directly pertain to Eton Pharmaceuticals, Inc. or Aucta Pharmaceuticals, Inc. as the context primarily discusses MusclePharm's records.",
        "retrieved_contexts":[
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            ". Audit Rights:   (a) The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm",
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W",
            ", (b) Aucta may keep all the payments under Section 6 paid by ETON up to the point of termination and for ETON's disposal of remaining inventory and Aucta is free to commercialize or relicense the Product with no further obligations owed to ETON, (c) ETON shall refrain from holding itself out as Aucta's distributor, in particular, eliminate any reference to the Product and Aucta from its business, trade style and promotional material, and (d) ETON shall transfer all rights",
            ".1 Aucta, for itself and its Affiliates, hereby grants to ETON in accordance with the terms and conditions of this Agreement, an exclusive (even as to and against Aucta in the Territory) right and license, including the right to sublicense, to the Products (or any components thereof), Dossiers, and all current and future Aucta Background Intellectual Property that is owned or controlled by Aucta or its Affiliates for ETON to develop, manufacture, import, use, promote, distribute, market"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there a cap on liability under this contract?",
        "thought":"The context explicitly states in Section 9.2 that each party's liability arising out of or related to the agreement will not exceed the aggregate amounts paid or payable to the Licensor in the twelve months preceding the claim. This indicates that there is indeed a cap on liability under the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. Additionally, it notes exceptions to this cap, such as indemnification obligations and cases of gross negligence or willful misconduct.",
        "response":"Yes, there is a cap on liability under the Exclusive License and Product Development Agreement, which limits each party's liability to the aggregate amounts paid or payable to the Licensor in the twelve months preceding the claim, as stated in Section 9.2.",
        "retrieved_contexts":[
            ".1 At its sole cost and expense, Aucta shall be solely responsible and liable for any litigation in connection with the Product's development, and the Aucta Background Intellectual Property other than ANDA Litigation covered below in Section 7.5. 7.2 At its sole cost and expense, ETON shall be solely responsible and liable for any non-patent litigation in connection with its sales and marketing activities. 9",
            "; (ii) ETON's marketing, distribution, or sale of any Product on or after the Effective Date, including, without limitation, any Claim for personal injury or death, to the extent such Third Party Claims arise from the period time commencing on or after the Effective Date and to the extent such is not attributable to Aucta's breach of this Agreement or any Applicable Law",
            ".3 ETON shall have the sole and exclusive right to determine all terms and conditions of sale of the Products to its or its prospective consumers. 5.4 [ * * * ] 6. MILESTONES AND OTHER PAYMENTS 6.1 Licensing Fees. ETON shall pay to Aucta licensing fees of up to an amount of five million dollars ($5,000,000) based on the following payment schedule: (a) An amount of two million dollars ($2,000,000) within five (5) days of the Effective Date of this Agreement",
            "; (ii) Aucta's manufacture, registration, handling, storage, use, transportation of any Product on or after the Effective Date, including, without limitation, any Claim for personal injury or death, to the extent such Third Party Claims arise from the period of time commencing on or after the Effective Date and to the extent such is not attributable to ETON's breach of this Agreement or any Applicable Laws",
            "9.2 Cap on Monetary Damages. EACH PARTY'S LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT WILL NOT EXCEED AN AMOUNT EQUAL TO THE AGGREGATE AMOUNTS PAID OR PAYABLE TO LICENSOR IN THE TWELVE (12) MONTHS PRECEDING THE COMMENCEMENT OF THE CLAIM.   9.3 Exceptions. The provisions of Section 9.1 and Section 9.2 will not apply to limit the Licensee's indemnification obligations under Section 8.2, or in the case of Licensee's gross negligence or wilful misconduct.   10. Confidentiality"
        ]
    },
    {
        "user_input":"Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What are the insurance requirements under this contract?",
        "thought":"The context specifies that both Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. are required to maintain general liability insurance from the first commercial sale of any product until five years after the final sale. The insurance amounts must be reasonable and customary in the pharmaceutical industry, with a minimum of five million dollars per occurrence and ten million dollars in total. This information directly addresses the insurance requirements under the Exclusive License and Product Development Agreement between the two parties.",
        "response":"Under the Exclusive License and Product Development Agreement, Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc. must maintain general liability insurance of at least five million dollars per occurrence and ten million dollars total, from the first commercial sale of any product until five years after the final sale.",
        "retrieved_contexts":[
            ". INSURANCE At all times from the first commercial sale of any Product(s) or after the Effective Date through the date which is five (5) years after the final sale of such Product(s), the Parties will maintain general liability insurance in amounts that are reasonable and customary in the pharmaceutical industry, provided in no event shall the general liability insurance amounts be less than five million dollars ($5,000,000) per occurrence and ten million dollars ($10,000",
            "; (ii) ETON's marketing, distribution, or sale of any Product on or after the Effective Date, including, without limitation, any Claim for personal injury or death, to the extent such Third Party Claims arise from the period time commencing on or after the Effective Date and to the extent such is not attributable to Aucta's breach of this Agreement or any Applicable Law",
            "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11\/14\/2019",
            "; (ii) Aucta's manufacture, registration, handling, storage, use, transportation of any Product on or after the Effective Date, including, without limitation, any Claim for personal injury or death, to the extent such Third Party Claims arise from the period of time commencing on or after the Effective Date and to the extent such is not attributable to ETON's breach of this Agreement or any Applicable Laws",
            "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What is the expiration date of this contract?",
        "thought":"The context does not provide a specific expiration date for the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. It mentions the term of the agreement and conditions for invoicing but lacks explicit information about when the agreement itself expires. Therefore, I cannot determine the expiration date based on the provided context.",
        "response":"I don't know.",
        "retrieved_contexts":[
            "i. By the fifteenth (15th) day of the last month of the Term of the Agreement, ExxonMobil will have been invoiced for the actual charges incurred in all of the prior months of the Term of the Agreement, but the most recently issued invoice will not be due. Therefore, at such time ExxonMobil will not have yet paid for the last two (2) months of the Term of the Agreement",
            "c) Subsequent Monthly Invoices. Within fifteen (15) days after the end of each calendar month that occurs during the remainder of the Term of the Agreement, subject to Paragraph 10.01(e), FCE will calculate and invoice ExxonMobil for the actual amounts incurred (for charges permitted in accordance with the respective Project Description(s)) during the immediately preceding calendar month.\n\nPage 11 of 31\n\nSource: FUELCELL ENERGY INC, 8-K, 11\/6\/2019\n\n\n\n\n\nd) End of Term of the Program.",
            "ii. Within fifteen (15) days after the end of the Term of the Agreement, FCE will issue an invoice (\"9th Inning Invoice\") for the actual charges incurred during the last month of the Term of the Agreement, subject to Paragraph 10.01(a). FCE will apply any balance of the Initial Payment remaining after the 8th Inning Invoice as a credit towards the amount due on the 9th Inning Invoice",
            "12.02 Early Termination. The Parties recognize that circumstances may arise where this Agreement's early termination would be desirable. Accordingly, either Party may terminate this Agreement or all\/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice. In the event of early termination of a Project or this Agreement",
            ". Such books, records and accounts will be maintained for a period of at least three (3) years following the termination or expiration of this Agreement, provided there are no pending disputes between the Parties. In the case of a dispute, the books, records, and accounts will be maintained for one (1) year following resolution of such dispute."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What is the governing law for this contract?",
        "thought":"The context specifies that the governing law for the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company is the laws of the State of New York. This is directly relevant to the question as it explicitly addresses the governing law without ambiguity. The mention of 'without recourse to its conflicts of law rules' clarifies that New York law will apply regardless of any potential conflicts with laws from other jurisdictions.",
        "response":"The governing law for the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company is the laws of the State of New York.",
        "retrieved_contexts":[
            "13.01 Governing Law. The validity and interpretation of this Agreement and the legal relations of the Parties to it will be governed by the laws of the State of New York without recourse to its conflicts of law rules.",
            "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue.",
            "(ii) its legal obligations to third parties wherein nothing in this Agreement is intended to impair a party's contribution and indemnity rights under law with respect to third party claims.\n\nARTICLE 12 - TERM AND TERMINATION\n\n12.01 Term. Unless sooner terminated in accordance with this Article, this Agreement will continue in full force beginning on the Effective Date and ending two (2) years thereafter (\"Term\").",
            ". The invalidity or unenforceability of any provision of this Agreement will not affect the validity or enforceability of any other provision hereof which can be given effect without the invalid or unenforceable provision, and to this end the provisions of this Agreement are declared to be severable and the balance of this Agreement will be construed and enforced as if this Agreement did not contain such invalid or unenforceable provision.",
            ", INDEMNITIES AND LIABILITIES 13 ARTICLE 12 - TERM AND TERMINATION 14 ARTICLE 13 - ARBITRATION AND GOVERNING LAW 17 ARTICLE 14 - ASSIGNMENT 18 ARTICLE 15 - FORCE MAJEURE 18 ARTICLE 16 - ADDRESSES AND NOTICES 18 ARTICLE 17 - COMPLIANCE 19 ARTICLE 18 - RECORDS AND AUDIT 20 ARTICLE 19 - TAXES 20 ARTICLE 20 - ADDITIONAL PROVISIONS 20 APPENDIX A - DEFINITIONS 24 APPENDIX B - SAMPLE PROJECT DESCRIPTION FORMAT 30"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are there any exceptions to competitive restrictions in this contract?",
        "thought":"The context outlines exceptions to confidentiality and competitive restrictions in the Joint Development Agreement between FuelCell Energy, Inc. (FCE) and ExxonMobil Research and Engineering Company. Specifically, it mentions that the obligations do not apply if a Major Competitor acquires a significant ownership stake in FCE or if FCE sells its business related to the agreement to a Major Competitor. These exceptions indicate that competitive restrictions may not apply under certain circumstances involving Major Competitors, which are defined in the context.",
        "response":"Yes, the Joint Development Agreement includes exceptions to competitive restrictions, specifically if a Major Competitor acquires ten percent or more of FCE's voting securities or if FCE sells substantially all of its related business to a Major Competitor.",
        "retrieved_contexts":[
            "4.05 Exceptions. For the purposes of this Agreement, the obligations of confidentiality and restricted use herein shall not apply to any information or materials to the extent the Receiving Party can establish by documentary evidence that one or more of the following exceptions apply:",
            "The later occurrence of any one of the aforementioned exceptions will not excuse any failure to adequately protect Confidential Information pursuant to this Agreement prior to the existence of the exception. More specific Confidential Information will not be deemed to be within the foregoing exceptions merely because it is embraced by more general information that is publicly available or in the possession of Receiving Party pursuant to one of the exceptions",
            "b) any Major Competitor is or becomes the beneficial owner by purchasing directly from FCE, voting securities representing ten percent (10%) or greater than the actual voting power of any such entity;\n\nc) the sale to any Major Competitor of all or substantially all of the business of FCE to which this Agreement relates (whether by merger, consolidation, sale of stock, sale of assets or other similar transaction);",
            "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue.",
            ".05, shall be applicable to both FCE and any Affiliate assignee of FCE, and (iii) no assignment pursuant to this sentence will relieve the Parties of their obligations under this Agreement."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there a non-compete clause in this contract?",
        "thought":"The context provided does not mention any non-compete clause or similar restrictions between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. The sections discussed focus on the nature of the relationship between the parties, assignment of the agreement, and future work implications, none of which imply a non-compete clause. Therefore, it can be concluded that there is no indication of a non-compete clause in the Joint Development Agreement based on the provided information.",
        "response":"The Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company does not contain a non-compete clause, as the relevant sections do not address any such restrictions.",
        "retrieved_contexts":[
            "20.02 Independent Contractors. The relationship between the Parties is that of independent contractors. Nothing contained in this Agreement, or any course of action by either Party pursuant to this Agreement, will be construed or deemed to constitute or create a joint venture, partnership, agency or employment relationship between the Parties or between either Party and the employees or other representatives of the other Party.",
            "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void",
            ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort",
            "20.04 Future Work. This Agreement shall not constitute or imply any promise or intention: (a) to enter into any other agreement of any nature, (b) to make any purchase of products or services by either Party or its Affiliates, or (c) to make any commitment by either Party, its Affiliates, or licensees with respect to present or future marketing or supply of any product or service.",
            "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Can this contract be terminated for convenience, and under what conditions?",
        "thought":"The Joint Development Agreement allows either FuelCell Energy, Inc. (FCE) or ExxonMobil Research and Engineering Company (ExxonMobil) to terminate the agreement for convenience by providing sixty (60) days prior written notice. Additionally, ExxonMobil has specific rights to terminate the agreement with fifteen (15) days notice under certain conditions, such as FCE entering bankruptcy or undergoing a Change in Control. Therefore, the contract can indeed be terminated for convenience under the specified conditions.",
        "response":"Yes, the Joint Development Agreement can be terminated for convenience by either party with sixty (60) days prior written notice. Additionally, ExxonMobil can terminate with fifteen (15) days notice under specific conditions such as FCE's bankruptcy or Change in Control.",
        "retrieved_contexts":[
            "12.02 Early Termination. The Parties recognize that circumstances may arise where this Agreement's early termination would be desirable. Accordingly, either Party may terminate this Agreement or all\/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice. In the event of early termination of a Project or this Agreement",
            "(B) To the maximum extent permitted under law, ExxonMobil may terminate this Agreement upon fifteen (15) days written notice, without penalty, payment or prejudice to claims and obligations then accrued, if FCE commences a voluntary case under the Bankruptcy Code or a similar voluntary bankruptcy or insolvency proceeding in a non- U.S",
            "12.04 Other Termination. ExxonMobil may terminate this Agreement upon fifteen (15) days written notice, without penalty, payment or prejudice to claims and obligations then accrued, if FCE undergoes a Change in Control",
            ". Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Agreement will operate or be construed as a waiver thereof; nor will any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege.",
            ". In the event of termination under this Paragraph 12.05 and subject to ExxonMobil's waiver (in its sole discretion), any licenses granted to FCE under this Agreement that would otherwise survive termination will automatically terminate and any licenses granted to ExxonMobil under this Agreement that would otherwise survive termination will continue to survive termination."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
        "thought":"The context provided does not mention any specific clauses related to a right of first refusal, right of first offer, or right of first negotiation in the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. The articles and paragraphs listed focus on various contractual aspects such as exclusivity, termination, and arbitration, but do not indicate the presence of any rights that would imply a first refusal or negotiation. Therefore, the absence of relevant terms in the context suggests that these rights are not included in the agreement.",
        "response":"The Joint Development Agreement does not explicitly mention any right of first refusal, right of first offer, or right of first negotiation, based on the provided context.",
        "retrieved_contexts":[
            "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue.",
            "o Article 12 (Term and Termination) to the extent any clause therein speaks to post termination rights and obligations;\n\no Article 13 (Arbitration and Governing Law);\n\no Article 14 (Assignment);\n\no Article 16 (Addresses and Notices);\n\nPage 16 of 31\n\nSource: FUELCELL ENERGY INC, 8-K, 11\/6\/2019\n\n\n\n\n\no Paragraph 17.03 (Export Controls and Trade Sanctions);\n\no Article 18 (Records and Audit);\n\no Article 19 (Taxes);",
            "1. the execution, delivery and performance of this Agreement by such Party does not conflict with any agreement, instrument or undertaking, oral or written, to which it is a party or by which it may be bound, and\n\n2. all necessary consents, approvals and authorizations of all governmental authorities and third parties required to be obtained by such Party in connection with the execution, delivery, and performance of this Agreement have been or will be obtained;",
            "10.02 Up-Front Exclusivity and Technology Access Payment. In exchange for FCE working exclusively with ExxonMobil during the Term of the Agreement, pursuant to Paragraph 2.03 (Work Exclusivity\/Independent Work), and ExxonMobil's access to FCE Background Patents, pursuant to Paragraph 8",
            "\"Agreement\" means this agreement, together with the appendices attached to this agreement and any Project Descriptions, extensions, renewals, or amendments hereof agreed to in writing and signed by the Parties."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What happens in the event of a change of control of one of the parties in this contract?",
        "thought":"The context discusses the survival of rights and obligations after termination or expiration of the Joint Development Agreement, and it specifies that the Agreement is not assignable without prior written consent from the other party. The mention of 'Change in Control' indicates that such an event does not alter the obligations under section 14.01, which prohibits assignment without consent. Therefore, in the event of a change of control of either FuelCell Energy, Inc. or ExxonMobil Research and Engineering Company, the Agreement remains intact and cannot be assigned without mutual consent.",
        "response":"In the event of a change of control of either FuelCell Energy, Inc. or ExxonMobil Research and Engineering Company, the Joint Development Agreement remains unaffected as it explicitly states that such a change does not alter the obligations under section 14.01, which prohibits assignment without consent. This implies that the rights and obligations of the parties will continue to exist and cannot be transferred without mutual agreement.",
        "retrieved_contexts":[
            "Any rights and obligations that have accrued to either Party against the other prior to the effective date of termination or expiration of this Agreement in any respect will survive such termination or expiration, and rights that have accrued to an Affiliate of a Party will continue regardless of any change in Affiliate status during the Term of this Agreement or thereafter.\n\nARTICLE 13 - ARBITRATION AND GOVERNING LAW",
            "e) the approval by such entity's board of directors or shareholders of any reorganization or transaction that would cause any of the situations described in clauses (a) through (d) to occur; or\n\nf) the approval by the board of directors or other governing body or the shareholders or other equity holders of FCE of any plan or proposal for its liquidation or dissolution.\n\nThe occurrence or non-occurrence of a Change in Control does not alter or limit section 14.01 of this Agreement.",
            ". Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Agreement will operate or be construed as a waiver thereof; nor will any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege.",
            "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void",
            ". Both Parties agree and understand that each will be responsible for ongoing compliance with all such applicable laws, regulations, and requirements"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there an anti-assignment clause in this contract?",
        "thought":"The context clearly states that the Joint Development Agreement between FuelCell Energy, Inc. (FCE) and ExxonMobil Research and Engineering Company includes an anti-assignment clause in Article 14.01, which prohibits either party from assigning the agreement without prior written consent from the other party. This means that any assignment not made in accordance with the specified conditions will be void, indicating a strict anti-assignment provision.",
        "response":"Yes, the Joint Development Agreement contains an anti-assignment clause that prohibits either FuelCell Energy, Inc. or ExxonMobil Research and Engineering Company from assigning the contract without prior written consent from the other party.",
        "retrieved_contexts":[
            "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void",
            ".05, shall be applicable to both FCE and any Affiliate assignee of FCE, and (iii) no assignment pursuant to this sentence will relieve the Parties of their obligations under this Agreement.",
            "14.02 Assignees Bound. Any assignee permitted in Paragraph 14.01 (Assignment) will agree in writing to be bound by all the obligations of the assigning Party under this Agreement, and a copy of such written agreement will be promptly provided to the other Party. Any Party making an assignment of this Agreement as permitted in Paragraph 14.01 (Assignment) will remain bound by the continuing obligations of confidentiality and nonuse applicable to such Party prior to the assignment.",
            "20.06 No Third Party Beneficiaries. No third parties are intended to be third party beneficiaries under this Agreement. None of the provisions of this Agreement will be enforceable by a third party. For the avoidance of doubt, permitted assignees of a Party pursuant to Article 14 (Assignment) will not be considered third parties for purposes of this Paragraph.",
            ". Neither Party makes any representations as to the number, frequency, or monetary value of the Projects, except as otherwise set forth herein or in any Project Description."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; How is intellectual property ownership assigned in this contract?",
        "thought":"The Joint Development Agreement specifies that ExxonMobil will solely own the Program Results, which include Program Information, Program Patents, and copyrightable works, regardless of who conceived or developed them. This indicates that FuelCell Energy, Inc. (FCE) assigns ownership of these results to ExxonMobil. Additionally, each party retains ownership of their Background Information and Background Patents, which are separate from the Program Results.",
        "response":"In the Joint Development Agreement, intellectual property ownership is assigned to ExxonMobil for all Program Results, as FCE assigns these rights to ExxonMobil. Background Information and Background Patents remain owned by their respective parties, ensuring that only the results from the joint program are transferred.",
        "retrieved_contexts":[
            "(i) All rights and licenses granted to ExxonMobil and its Affiliates under or pursuant to this Agreement are, and will otherwise be deemed to be, for all purposes of Section 365(n) of the Bankruptcy Code, licenses of rights to \"intellectual property\" as defined in section 101 of the Bankruptcy Code.",
            "ARTICLE 6 - OWNERSHIP \/ PROCUREMENT OF PROGRAM RESULTS\n\n6.01 Ownership of Program Results. ExxonMobil will solely own Program Information, Program Patents, and copyrightable works resulting from the Program (collectively, \"Program Results\"), irrespective of whether the Program Results are conceived, created, developed or acquired by employees or other representatives of FCE, ExxonMobil, or both. FCE will assign, and hereby assigns, to ExxonMobil ownership of Program Results.",
            "6.06 Joint Research Agreement. The Parties acknowledge and agree that this Agreement is a \"joint research agreement\" as defined in 35 U.S.C. \u00a7100(h). The specification of any patent application filed pursuant to this Agreement may contain (or may be amended to contain) language required to invoke 35 U.S.C. \u00a7102(b)(2)(C) and \u00a7102(c) as applicable. Notwithstanding anything to the contrary in Paragraph 5",
            "(a) owned or controlled by the designated Party or its Affiliates (in the sense of having the right to license without accounting to others); and\n\n(b) conceived, created, developed, or acquired by the designated Party or its Affiliates:\n\n(1) prior to the Effective Date of this Agreement; or\n\n(2) at any time, but independently of any Project prior to the termination of this Agreement.\n\nBackground Information includes Background Samples but does not include Program Information.",
            "ARTICLE 8 - LICENSE TO BACKGROUND INFORMATION AND PATENTS\n\n8.01 Ownership Retained. Each Party will retain its title and ownership rights to its Background Information and Background Patents in all applicable jurisdictions.\n\n8.02 Grant of Rights to Background Information and Background Patents.\n\n(a) Grant to ExxonMobil."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What licenses are granted under this contract?",
        "thought":"The context outlines the rights and licenses granted under the Joint Development Agreement, specifically mentioning the use of Background Information and Program Information for research and development. It also indicates that the license includes rights to use, reproduce, and create derivative works, but is limited to non-commercial purposes and cannot be sub-licensed. The terms 'Background Information' and 'Program Information' refer to the intellectual property involved in the agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company.",
        "response":"Under the Joint Development Agreement, licenses are granted to use, reproduce, and create derivative works of Background Information and Program Information solely for research and development purposes, with restrictions on commercial use and sub-licensing.",
        "retrieved_contexts":[
            "(a) owned or controlled by the designated Party or its Affiliates (in the sense of having the right to license without accounting to others); and\n\n(b) conceived, created, developed, or acquired by the designated Party or its Affiliates:\n\n(1) prior to the Effective Date of this Agreement; or\n\n(2) at any time, but independently of any Project prior to the termination of this Agreement.\n\nBackground Information includes Background Samples but does not include Program Information.",
            ", and sub-licensees have agreed to be bound by confidentiality and limited use obligations no less protective of Disclosing Party's Confidential Information than the terms contained herein",
            ". More particularly, said right and license to practice includes the right to use, reproduce, and create derivative works of Program Information under applicable copyrights and to make, use, and import (but not sell or offer to sell) under the claims of Program Patents, in each case solely for research and development for the Program. Said right and license may be extended to contractors performing work on behalf of FCE but is not otherwise sub-licensable.",
            "\"License Agreement\" means the agreement between the Parties effective June 11, 2019 entitled License Agreement bearing ExxonMobil Document No. LAW-2019-3245.",
            "o Article 8 (License to Background Information and Patents), subject to Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy);\n\no Article 10 (Payment), but only to the extent there are continuing license and\/or royalty share obligations pertaining to the commercial use of Program Results, Background Information and\/or Background Patents;\n\no Article 11 (Representations, Warranties, Indemnities and Liabilities);"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are the licenses granted under this contract non-transferable?",
        "thought":"The context specifies that the rights and licenses granted under the Joint Development Agreement (JDA) may be extended to contractors working on behalf of FuelCell Energy, Inc. (FCE) but are explicitly stated to be 'not otherwise sub-licensable.' This indicates that the licenses are non-transferable to other parties outside of this specific arrangement. Therefore, the licenses granted under this contract are indeed non-transferable, as they cannot be sublicensed to third parties.",
        "response":"The licenses granted under the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company are non-transferable, as they cannot be sublicensed to parties outside of the contractors performing work on behalf of FCE.",
        "retrieved_contexts":[
            ", and sub-licensees have agreed to be bound by confidentiality and limited use obligations no less protective of Disclosing Party's Confidential Information than the terms contained herein",
            ". More particularly, said right and license to practice includes the right to use, reproduce, and create derivative works of Program Information under applicable copyrights and to make, use, and import (but not sell or offer to sell) under the claims of Program Patents, in each case solely for research and development for the Program. Said right and license may be extended to contractors performing work on behalf of FCE but is not otherwise sub-licensable.",
            ". All rights and licenses in this Paragraph (b)(1)(i) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable.",
            ". All rights and licenses in this Paragraph (b)(1)(ii) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable.",
            ". Any sale of a Prior JDA Project Patent to a Non-Affiliated Third Party is subject to the licenses granted and other obligations set forth in this Agreement."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Does the licensee's affiliates have any licensing rights under this contract?",
        "thought":"The context defines 'Affiliate(s)' as entities that are controlled by or under common control with a designated party, which in this case refers to FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company. The context indicates that rights and licenses can be extended to contractors working on behalf of FuelCell Energy but does not explicitly mention that affiliates of the licensee (ExxonMobil) have licensing rights under the Joint Development Agreement. Therefore, it implies that while affiliates may be involved, they do not automatically have licensing rights unless specified in the agreement.",
        "response":"The licensee's affiliates do not have licensing rights under the Joint Development Agreement unless explicitly stated, as the context only allows for rights to be extended to contractors working on behalf of FuelCell Energy.",
        "retrieved_contexts":[
            "4.06 Disclosure to Affiliates, Contractors, and Sub-licensees",
            "\"Affiliate(s)\" means any legal entity which, directly or indirectly, at the time in question, controls, is controlled by, or is under common control with the designated Party",
            ". All rights and licenses in this Paragraph (b)(1)(ii) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable.",
            ". All rights and licenses in this Paragraph (b)(1)(i) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable.",
            ", and sub-licensees have agreed to be bound by confidentiality and limited use obligations no less protective of Disclosing Party's Confidential Information than the terms contained herein"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are any of the licenses granted under this contract irrevocable or perpetual?",
        "thought":"The context discusses the termination of licenses under the Joint Development Agreement between FuelCell Energy, Inc. (FCE) and ExxonMobil Research and Engineering Company. It specifies that certain licenses may convert to royalty-bearing upon termination and that some licenses may terminate entirely, while others may survive termination. However, it does not explicitly state that any licenses are irrevocable or perpetual, only that some may survive termination under specific conditions.",
        "response":"The licenses granted under the Joint Development Agreement are not irrevocable or perpetual; they may convert to royalty-bearing or terminate upon certain conditions, as outlined in the agreement.",
        "retrieved_contexts":[
            ". In the event of termination under this Paragraph 12.03 where FCE is the defaulting Party, FCE's royalty-free licenses described in Paragraph 7.01(b)(1), 8.02(b)(1)(i), 8.02 (b)(1)(ii), 8.02(b)(1)(iii), and 8.02(b)(2)(i) will immediately convert to royalty-bearing licenses, with the royalty rate to be negotiated by the Parties in good faith.",
            ". In the event of termination under this Paragraph 12.05 and subject to ExxonMobil's waiver (in its sole discretion), any licenses granted to FCE under this Agreement that would otherwise survive termination will automatically terminate and any licenses granted to ExxonMobil under this Agreement that would otherwise survive termination will continue to survive termination.",
            "12.06 Continuing Rights and Obligations. Except as otherwise stated in this Agreement, the following Articles and Paragraphs will survive termination of this Agreement:\n\no Article 1 (Definitions);\n\no Article 4 (Disclosure, Confidentiality and Restricted Use);\n\no Article 6 (Procurement and Ownership of Program Results)\n\no Article 7 (License to Program Results), subject to Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy);",
            "20.08 Severability. The provisions of this Agreement are deemed severable",
            "o Article 8 (License to Background Information and Patents), subject to Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy);\n\no Article 10 (Payment), but only to the extent there are continuing license and\/or royalty share obligations pertaining to the commercial use of Program Results, Background Information and\/or Background Patents;\n\no Article 11 (Representations, Warranties, Indemnities and Liabilities);"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are there any services to be provided after the termination of this contract?",
        "thought":"The context discusses the early termination of the Joint Development Agreement between FuelCell Energy, Inc. (FCE) and ExxonMobil Research and Engineering Company, outlining the conditions under which either party can terminate the agreement and the obligations that arise upon termination. Specifically, it mentions that ExxonMobil must pay FCE for reasonable non-refundable expenses incurred prior to termination, which implies that there are financial obligations that continue post-termination. However, the context does not explicitly state any ongoing services to be provided after termination, focusing instead on financial settlements and legal obligations.",
        "response":"The context implies that after termination, ExxonMobil is obligated to pay FuelCell Energy for reasonable non-refundable expenses incurred prior to termination, but it does not explicitly state that any services will be provided post-termination.",
        "retrieved_contexts":[
            "12.02 Early Termination. The Parties recognize that circumstances may arise where this Agreement's early termination would be desirable. Accordingly, either Party may terminate this Agreement or all\/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice. In the event of early termination of a Project or this Agreement",
            ". The total amount paid FCE under this Agreement or for a Project, including all amounts paid following termination, will not exceed the maximum authorized charge specified in this Agreement or for a Project.",
            "(ii) its legal obligations to third parties wherein nothing in this Agreement is intended to impair a party's contribution and indemnity rights under law with respect to third party claims.\n\nARTICLE 12 - TERM AND TERMINATION\n\n12.01 Term. Unless sooner terminated in accordance with this Article, this Agreement will continue in full force beginning on the Effective Date and ending two (2) years thereafter (\"Term\").",
            ". In addition, if this Agreement is terminated by ExxonMobil, ExxonMobil will pay FCE reasonable non- refundable expenses incurred by FCE in satisfying authorized commitments entered into by FCE with third parties prior to receipt of the termination notice. FCE will uses its best efforts to minimize termination expenses and will give appropriate credit to ExxonMobil where applicable",
            "o Article 12 (Term and Termination) to the extent any clause therein speaks to post termination rights and obligations;\n\no Article 13 (Arbitration and Governing Law);\n\no Article 14 (Assignment);\n\no Article 16 (Addresses and Notices);\n\nPage 16 of 31\n\nSource: FUELCELL ENERGY INC, 8-K, 11\/6\/2019\n\n\n\n\n\no Paragraph 17.03 (Export Controls and Trade Sanctions);\n\no Article 18 (Records and Audit);\n\no Article 19 (Taxes);"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What are the audit rights under this contract?",
        "thought":"The context outlines the audit rights under the Joint Development Agreement between FuelCell Energy, Inc. (FCE) and ExxonMobil Research and Engineering Company. It specifies that ExxonMobil has the right to audit FCE's records and operations relevant to the agreement, with the costs of the audit borne by ExxonMobil. Additionally, it mentions that an independent accounting firm can be appointed by ExxonMobil to conduct these audits at reasonable intervals, ensuring compliance with the agreement's terms.",
        "response":"Under the Joint Development Agreement, ExxonMobil has the right to audit FuelCell Energy, Inc.'s records and operations relevant to the contract, with all audit expenses covered by ExxonMobil. An independent accounting firm, approved by FuelCell Energy, can conduct these audits at reasonable intervals during the term of the agreement and for three years thereafter.",
        "retrieved_contexts":[
            "18.02 Audit Rights",
            "(a) ExxonMobil and its employees or other representatives will have the right to reproduce for its internal records any of the documents kept by FCE in accordance with Paragraph 18.01 (Recordkeeping), such reproduced documents shall be subject to the confidentiality and use provisions contained in Article 4; and\n\n(b) all expenses of each such audit, including any pre-approved reasonable expenses incurred by FCE for such audit, will be for the account of ExxonMobil.",
            ", and accounts and any part of the applicable operations and facilities of FCE relevant to this Agreement, and to have access to FCE's knowledgeable personnel, as may be necessary to determine the completeness and accuracy of any accounting and payments required to be made under this Agreement and compliance with other terms of this Agreement, subject to the following",
            ", INDEMNITIES AND LIABILITIES 13 ARTICLE 12 - TERM AND TERMINATION 14 ARTICLE 13 - ARBITRATION AND GOVERNING LAW 17 ARTICLE 14 - ASSIGNMENT 18 ARTICLE 15 - FORCE MAJEURE 18 ARTICLE 16 - ADDRESSES AND NOTICES 18 ARTICLE 17 - COMPLIANCE 19 ARTICLE 18 - RECORDS AND AUDIT 20 ARTICLE 19 - TAXES 20 ARTICLE 20 - ADDITIONAL PROVISIONS 20 APPENDIX A - DEFINITIONS 24 APPENDIX B - SAMPLE PROJECT DESCRIPTION FORMAT 30",
            ". At the request of ExxonMobil, FCE will permit, at reasonable intervals and during regular business hours, during the Term of this Agreement and at least three (3) years thereafter, but no more than once per fiscal year, an independent certified public accounting firm of nationally recognized standing selected by ExxonMobil (and approved by FCE, which approval will not be unreasonably withheld) to inspect, during regular business hours, such books, records"
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there uncapped liability under this contract?",
        "thought":"The Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company specifies limitations on liability, stating that neither party will be liable for consequential or indirect damages. However, it also outlines exceptions where each party bears full responsibility for gross negligence or willful misconduct, indicating that there could be uncapped liability in those specific situations. Therefore, while general liability is capped, the exceptions imply that there are scenarios where liability may not be limited.",
        "response":"Under the Joint Development Agreement, there is generally limited liability for consequential damages; however, there is uncapped liability for gross negligence or willful misconduct by either party, meaning that in such cases, liability is not limited.",
        "retrieved_contexts":[
            ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort",
            "11.04 Exceptions to Limitations of Liability. Notwithstanding anything to the contrary in this Agreement, each Party will bear full responsibility, without limit, for the following:\n\n(i) Gross Negligence or Willful Misconduct attributable to its personnel, and, in no event, will a Party be required to release or indemnify the other Party for Gross Negligence or Willful Misconduct attributable to the other Party; and",
            ". The arbitrators will decide all questions and settle all disputes strictly in accordance with the provisions of this Agreement, including the relevant indemnities and liability limitations. The arbitrators will have no authority to award exemplary or punitive damages, and the arbitral panel will certify in the decision that no part of the award includes such damages",
            ".04 (EXCEPTIONS TO LIMITATIONS ON LIABILITY). NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, IS MADE REGARDING SUCH INFORMATION AND MATERIAL,  OR ITS COMPLETENESS, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE.",
            ". The Receiving Party will be liable to the Disclosing Party for any unauthorized disclosure or misuse of the Disclosing Party's Confidential Information by such Affiliates, contractors, and sub-licensees."
        ]
    },
    {
        "user_input":"Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there a cap on liability under this contract?",
        "thought":"The context specifies that neither party will be liable for consequential, indirect, special, incidental, punitive, or exemplary damages, which implies a limitation on liability. However, it also states that each party will bear full responsibility for gross negligence or willful misconduct, indicating exceptions to this limitation. Additionally, there is a mention of a maximum authorized charge that caps the total amount paid under the agreement, which further suggests a limit on liability.",
        "response":"Yes, the Joint Development Agreement includes a cap on liability, as it limits the total amount paid under the agreement to a maximum authorized charge. However, this cap does not apply to gross negligence or willful misconduct, for which each party remains fully responsible.",
        "retrieved_contexts":[
            ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort",
            "11.04 Exceptions to Limitations of Liability. Notwithstanding anything to the contrary in this Agreement, each Party will bear full responsibility, without limit, for the following:\n\n(i) Gross Negligence or Willful Misconduct attributable to its personnel, and, in no event, will a Party be required to release or indemnify the other Party for Gross Negligence or Willful Misconduct attributable to the other Party; and",
            ". The total amount paid FCE under this Agreement or for a Project, including all amounts paid following termination, will not exceed the maximum authorized charge specified in this Agreement or for a Project.",
            ".04 (EXCEPTIONS TO LIMITATIONS ON LIABILITY). NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, IS MADE REGARDING SUCH INFORMATION AND MATERIAL,  OR ITS COMPLETENESS, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE.",
            ".04 (Exceptions to Limitations of Liability)."
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; What is the expiration date of this contract?",
        "thought":"The context provides information about the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc., including the effective date of the agreement, which is October 11, 2019. However, it does not specify the expiration date of the contract or any terms that would indicate how long the agreement lasts. Therefore, the expiration date remains unknown based on the provided information.",
        "response":"The expiration date of the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. is not specified in the provided context.",
        "retrieved_contexts":[
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products",
            ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee",
            "The parties set forth below have executed this Agreement as of the Effective Date. REED'S: COMPANY: Reed's, Inc. B C Marketing Concepts Inc., dba Full Sail Brewing Company By: \/s\/ John Bello By: \/s\/ Cory Comstock Name: John Bello Name: Cory Comstock Title: CEO Title: CEO Address: Address: Reed's, Inc. B C Marketing Concepts Inc",
            "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; What is the governing law for this contract?",
        "thought":"The context provided does not explicitly state the governing law for the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. It contains details about the parties involved and their obligations but lacks any mention of the jurisdiction or legal framework that governs the contract. Therefore, without additional information regarding the governing law, I cannot provide a definitive answer.",
        "response":"I don't know.",
        "retrieved_contexts":[
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products",
            "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties",
            ". Each party shall ensure that all persons performing work under this Agreement on its behalf shall have the requisite experience, training, skill and other qualifications needed to develop the Recipes, Deliverables and Specifications. Company shall keep the Development Committee informed of the progress of the development of the Recipes and Deliverables and such other matters as any member of the Development Committee may reasonably request from time to time. 2"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Does this contract include an exclusivity agreement?",
        "thought":"The context discusses a Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for developing ginger-based alcohol beverages. However, it does not explicitly mention any exclusivity terms or conditions that would indicate an exclusivity agreement between the parties. Therefore, while the agreement outlines collaboration and rights, it does not imply that either party is restricted from engaging with other entities for similar products.",
        "response":"The Recipe Development Agreement does not explicitly include an exclusivity agreement between Reed's, Inc. and B C Marketing Concepts Inc. It outlines collaboration but does not restrict either party from working with others in the same market.",
        "retrieved_contexts":[
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products",
            ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee",
            "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties",
            ". This Agreement does not constitute and shall not be construed as constituting a partnership or joint venture or grant of a franchise between Reed's and Company. Neither party shall have the right to bind the other party to any obligations to third parties. 13. Assignment"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there an anti-assignment clause in this contract?",
        "thought":"The context explicitly states that 'Company may not assign or transfer its rights or obligations under this Agreement, whether by operation of law, contract or otherwise, without the prior written consent of Reed's.' This indicates that there is indeed an anti-assignment clause in the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc.",
        "response":"Yes, the Recipe Development Agreement contains an anti-assignment clause, which prohibits B C Marketing Concepts Inc. from assigning or transferring its rights or obligations without the prior written consent of Reed's, Inc.",
        "retrieved_contexts":[
            ". This Agreement does not constitute and shall not be construed as constituting a partnership or joint venture or grant of a franchise between Reed's and Company. Neither party shall have the right to bind the other party to any obligations to third parties. 13. Assignment",
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee",
            ". Company may not assign or transfer its rights or obligations under this Agreement, whether by operation of law, contract or otherwise, without the prior written consent of Reed's, which shall not be unreasonably withheld (it being understood that a purported assignment to a Reed's competitor identified or referred to in Exhibit D of the Manufacturing and Distribution Agreement shall be considered to be a reasonable basis for withholding consent)",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; How is intellectual property ownership assigned in this contract?",
        "thought":"The context outlines the ownership of intellectual property in the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. It specifies that Reed's will exclusively own all Deliverables created by the Company, which includes any jointly developed intellectual property rights. The terms 'Deliverables' refer to the recipes and processes developed under the agreement, and Reed's Intellectual Property includes anything developed prior to the agreement or independently by Reed's.",
        "response":"In the Recipe Development Agreement, Reed's, Inc. exclusively owns all Deliverables created by B C Marketing Concepts Inc., which includes any jointly developed intellectual property rights. This means that any recipes or processes developed during the collaboration will be assigned to Reed's in perpetuity.",
        "retrieved_contexts":[
            ". Company Intellectual Property includes but is not limited to Company's know-how and independently developed recipes and alcohol beverage production processes, including the Company's proprietary composition of or recipe for the neutral alcohol beverage base that contributes alcohol to the Products (\"Neutral Alcohol Beverage Base\")",
            ". (f) \"Reed's Intellectual Property\" means all Intellectual Property that: (i) was owned or developed by Reed's prior to the execution of this Agreement; (ii) was or is independently developed by Reed's without contribution or assistance from Company or Company's Intellectual Property; and (iii) the Recipe. (g) \"Specifications\" means the specifications for the Products to be developed by the Development Committee (as defined in Section 3). 2. Consideration",
            "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:",
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            ". 6. Intellectual Property. (a) Ownership of Intellectual Property. (i) Company will create and provide to Reed's the Deliverables. Reed's will exclusively own all Deliverables. Company will and hereby does, without further consideration, irrevocably assign to Reed's any and all worldwide right, title or interest that Company may now or hereafter possess in or to the Deliverables in perpetuity (or the maximum period permitted by Applicable Laws and Regulations) and Reed's accepts such assignment"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there uncapped liability under this contract?",
        "thought":"The context discusses a Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc., focusing on their collaboration for developing ginger-based alcohol beverages. However, it does not explicitly mention any terms related to liability, such as 'uncapped liability' or any limitations on liability. Therefore, the context does not provide sufficient information to determine if there is uncapped liability under this contract.",
        "response":"The context does not provide information regarding uncapped liability in the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. Therefore, I cannot ascertain if there is uncapped liability under this contract.",
        "retrieved_contexts":[
            "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties",
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products",
            ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee",
            ". Company shall be responsible for all costs relating to the development of the Recipes and Deliverables, except for costs and expenses relating to the involvement of Reed's personnel and contractors. 3. Development Committee. Representatives of Company and Reed's, as identified in Exhibit B, shall meet regularly to discuss and approve development milestones for the Products, the Recipes, Deliverables, Specifications and other topics as identified in Exhibit B (the \"Development Committee\")"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there a cap on liability under this contract?",
        "thought":"The context provided does not explicitly mention any limitations or caps on liability under the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. The focus is primarily on the responsibilities of the parties regarding the development of recipes and the roles of the Development Committee. Therefore, without specific language addressing liability caps, it cannot be concluded that there is one.",
        "response":"The context does not provide any information regarding a cap on liability under the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. Therefore, it is unclear if such a limitation exists.",
        "retrieved_contexts":[
            "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products",
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee",
            ". Company shall be responsible for all costs relating to the development of the Recipes and Deliverables, except for costs and expenses relating to the involvement of Reed's personnel and contractors. 3. Development Committee. Representatives of Company and Reed's, as identified in Exhibit B, shall meet regularly to discuss and approve development milestones for the Products, the Recipes, Deliverables, Specifications and other topics as identified in Exhibit B (the \"Development Committee\")"
        ]
    },
    {
        "user_input":"Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there a covenant not to sue included in this contract?",
        "thought":"The context discusses a Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. but does not explicitly mention a covenant not to sue. The terms 'covenant not to sue' typically refer to an agreement where one party agrees not to initiate legal action against the other, which is not addressed in the provided text. Therefore, the absence of this specific term implies that there may not be a covenant not to sue included in the contract.",
        "response":"The Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. does not explicitly mention a covenant not to sue. Therefore, it implies that such a covenant may not be included in the contract.",
        "retrieved_contexts":[
            ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions",
            ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee",
            "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products",
            "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties",
            ". This Agreement does not constitute and shall not be construed as constituting a partnership or joint venture or grant of a franchise between Reed's and Company. Neither party shall have the right to bind the other party to any obligations to third parties. 13. Assignment"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the expiration date of this contract?",
        "thought":"The context provides the effective date of the Distributorship Agreement as 29\/3\/18 and states that the agreement lasts for a period of three years. Therefore, the expiration date can be calculated by adding three years to the effective date, leading to an expiration date of 29\/3\/21. The option for renewal is also mentioned, but it does not affect the initial expiration date.",
        "response":"The Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC expires on 29\/3\/21, which is three years from the effective date of 29\/3\/18.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            ". Either party may terminate this Agreement upon written notice if the Manufacturing and Distribution Agreement terminates prior to the first anniversary of the Effective Date. 9. Indemnification",
            ". Notwithstanding the foregoing, in the event the expiration of this Agreement or termination of this Agreement by Musclepharm pursuant to paragraph 9(a), MusclePharm shall be entitled to sell-off the remaining Licensed Products for six (6) months after such expiration of this Agreement pursuant to paragraph 4(d) herein and shall continue to pay Endorser the Royalty set forth in paragraph 7 herein"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the renewal term for this contract?",
        "thought":"The context provides specific details about the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC, particularly regarding the duration and renewal terms. It states that the initial term of the agreement is three years, with an option for the distributor to renew for an additional three years by giving written notice within 90 days before the end of the initial term. Additionally, it mentions that the agreement will automatically renew for another three-year period unless either party provides written notice of non-renewal at least 90 days prior to the expiration of the initial term.",
        "response":"The renewal term for the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC is an additional three (3) years, which can be activated by the distributor providing written notice within ninety (90) days before the end of the initial three-year term.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5",
            ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the notice period required to terminate the renewal?",
        "thought":"The context specifies that either party can terminate the Distributorship Agreement upon thirty (30) days written notice at the expiration of its term or any renewal term. This indicates that for the renewal period, a notice period of thirty (30) days is required for termination. The relevant parties are Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC, and the terminology 'termination' refers to ending the agreement after the renewal period.",
        "response":"The notice period required to terminate the renewal of the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC is thirty (30) days written notice.",
        "retrieved_contexts":[
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            ". Either party may terminate this Agreement upon written notice if the Manufacturing and Distribution Agreement terminates prior to the first anniversary of the Effective Date. 9. Indemnification",
            "This Agreement may be terminated by either party at the expiration of its term or any renewal term upon thirty (30) days written notice to the other party",
            ". 8. RIGHTS OF PARTIES AT TERMINATION. (a) Obligations After Termination. In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter. (b) Survival"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the governing law for this contract?",
        "thought":"The context provided is a Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC, but it does not specify the governing law for the contract. Governing law typically refers to the jurisdiction whose laws will be applied in interpreting the contract, and this information is crucial for understanding legal obligations. Since the context does not contain this specific information, I cannot determine the governing law from the provided text.",
        "response":"I don't know.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier",
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement",
            ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein",
            "16.2 If the Distributor seeks the Supplier's consent to any proposed dealing under clause 16.1, the Distributor must: -\n\n(a) disclose fully in writing all material facts relating to the dealing\n\n(b) comply fully with any conditions or requirements set down by the Supplier which attach to any Suppliers consent that is given.\n\n16.3 Each party that has rights under this agreement is acting on its own behalf and not for the benefit of another person.\n\n17. Freedom to contract"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; Is there an anti-assignment clause in this contract?",
        "thought":"The context clearly states that the Distributor (CPM Medical Consultants LLC) is prohibited from assigning, transferring, or dealing with the agreement or its rights and obligations without consent, except to a Permitted Assignee. This indicates that there is indeed an anti-assignment clause in the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC. The terms 'Distributor' and 'Supplier' refer to CPM Medical Consultants LLC and Signature Orthopaedics Pty Ltd, respectively, in this context.",
        "response":"Yes, the Distributorship Agreement contains an anti-assignment clause that prohibits the Distributor from assigning or transferring the agreement without consent, except to a Permitted Assignee.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier",
            "; provided that (i) any compensation to such sub-agent, sub-distributor, sub-representative or other person to act on Distributor's behalf or to otherwise perform any of Distributor's obligations shall be solely Distributor's responsibility, and (ii) such appointment does not deprive Company of the essential rights to which it is entitled under this Agreement",
            "The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement.\n\nAgreed terms\n\n1. Definitions and interpretation\n\n1.1 The definitions and rules of interpretation in this clause apply in this agreement.",
            ". The Distributor shall not sub-contract or delegate in any manner any or all of its obligations under this agreement to any third party or agent."
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What licenses are granted under this contract?",
        "thought":"The context outlines a Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC, indicating that the Distributor (CPM Medical Consultants LLC) is granted exclusive rights to sell and distribute medical products within the United States. It also mentions that licenses may be granted in connection with distribution agreements and other business activities, but does not specify the exact licenses granted under this particular contract. Therefore, while it implies that exclusive distribution rights are granted, it does not provide explicit details on the specific licenses involved.",
        "response":"Under the Distributorship Agreement, CPM Medical Consultants LLC is granted the exclusive right to sell and distribute medical products in the United States. The context implies that additional licenses may be granted in connection with distribution agreements, but does not specify the exact licenses granted under this contract.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            ", and covenants not to sue (other than non-exclusive licenses granted to other Persons in the Ordinary Course of Business consistent with past practice and licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business)",
            ", and (ii) Licensor may assign its rights and obligations in this Agreement to its Affiliates or subsidiaries and either party may assign this Agreement in its entirety to any purchaser of all or substantially all of its business or assets pertaining to the line of business to which this Agreement relates or to any Affiliate of the party without the other party's approval",
            "; (B) licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business; (C) licenses granted in connection with talent agreements and the development of in-store displays, creative visual merchandising, marketing and advertising assets, and related branded content entered into in the Ordinary Course of Business; (D) licenses granted in connection with the production of co-branded or third-party products in the Ordinary Course of Business",
            ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; Are there any services to be provided after the termination of this contract?",
        "thought":"The context outlines the obligations of Signature Orthopaedics Pty Ltd (the Company) and CPM Medical Consultants LLC (the Distributor) upon termination of their Distributorship Agreement. Specifically, it states that the Company has no further responsibilities to the Distributor after termination, except for processing orders accepted prior to termination or within 90 days thereafter. This implies that there are limited services provided post-termination, primarily related to order processing.",
        "response":"After the termination of the Distributorship Agreement, Signature Orthopaedics Pty Ltd is only obligated to process orders accepted prior to termination or within 90 days thereafter, implying that no additional services are provided beyond this.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            ". 8. RIGHTS OF PARTIES AT TERMINATION. (a) Obligations After Termination. In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter. (b) Survival",
            "12.1 Termination of this agreement for any reason shall not affect any rights or liabilities accrued at the date of termination.\n\n10\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\n12.2 At the Supplier's option, on termination of this agreement:",
            "(n) Without affecting any other rights that it may be entitled to, the Supplier may give notice in writing to the Distributor terminating this agreement immediately if the Distributor purports to assign its rights or obligations under this agreement to an entity that is not (1) affiliated with, (2) related to, or (3) sharing common ownership with the Distributor (a Permitted Assignee).\n\n12. Effectsof termination",
            ". Either party may terminate this Agreement upon written notice if the Manufacturing and Distribution Agreement terminates prior to the first anniversary of the Effective Date. 9. Indemnification"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What are the insurance requirements under this contract?",
        "thought":"The context provides specific insurance requirements under the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC. It states that the Supplier (Signature Orthopaedics) must maintain product liability insurance of no less than AU$10 million for any claims related to faulty or defective products. This directly addresses the insurance requirements under the contract, clarifying the responsibilities of the Supplier regarding insurance coverage.",
        "response":"Under the Distributorship Agreement, Signature Orthopaedics Pty Ltd (the Supplier) is required to maintain product liability insurance of at least AU$10 million for any claims related to faulty or defective products. The Supplier must also provide a copy of the insurance policy to CPM Medical Consultants LLC (the Distributor) upon request.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            ". The Supplier shall add the distributor to their current insurance certificate.",
            "10.3 During the Term, the Supplier shall maintain product liability insurance with a reputable insurer of no less than AU$10 million for any one occurrence for any and all liability (however arising) for a claim that the Products are faulty or defective. The Supplier shall provide a copy of the insurance policy to the Distributor on request.\n\n8\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019",
            "(ix)  that is between the Company or any of its Subsidiaries, on the one hand, and the Company or another one of its Subsidiaries, on the other hand, or that otherwise would be required to be filed as an intercompany or\n\n\n\n\n\n\n\n\n________________\n\n\naffiliate agreement with an Insurance Regulator; \n\n\n(x) that involve or could reasonably be expected to involve aggregate payments or receipts by or to the Company or any of its Subsidiaries in excess of $3,000,000 in any twelve-month period;",
            ". The Distributor and Company, as applicable, make the following representations, warranties and covenants"
        ]
    },
    {
        "user_input":"Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; Is there a covenant not to sue included in this contract?",
        "thought":"The context indicates that the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC includes a covenant not to sue, specifically mentioning that such covenants are part of the agreement, albeit with certain exceptions for non-exclusive licenses in the ordinary course of business. The term 'covenant not to sue' refers to an agreement where one party agrees not to initiate legal action against the other, which is explicitly stated in the context. Therefore, the context directly supports the conclusion that there is a covenant not to sue included in the contract.",
        "response":"Yes, the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC includes a covenant not to sue, as stated in the context.",
        "retrieved_contexts":[
            "EXHIBIT 10.43 Dated 29\/3\/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3\/21\/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground",
            ", and covenants not to sue (other than non-exclusive licenses granted to other Persons in the Ordinary Course of Business consistent with past practice and licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business)",
            ", covenant not to sue or other rights under any Company IP, other than any non-exclusive outbound license entered into in the ordinary course of business, in the case of each of the foregoing clauses (A) and (B), in each case, that could not be replaced on commercially reasonable terms, excluding any standard non- disclosure, end-user, customer, confidentiality or consulting agreements, in each case as entered into in the ordinary course of business",
            ". Representations, Warranties and Covenants",
            ". Each Party agrees that (a) its respective representations, warranties, covenants and agreements set forth herein are solely for the benefit of the other Parties, in accordance with and subject to the terms of this Agreement, and (b) this Agreement is not intended to, and does not, confer upon any Person other than the Parties any rights or remedies, including the right to rely upon the representations and warranties set forth herein"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the expiration date of this contract?",
        "thought":"The context specifies that the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor became effective on August 1, 2019, and has a duration of three years. Therefore, the expiration date of the contract would be three years from the effective date, which is August 1, 2022. Additionally, the Distributor has an option to renew the agreement for another three years, but this renewal is contingent upon providing written notice within 90 days of the initial expiration.",
        "response":"The Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor expires on August 1, 2022, unless renewed by the Distributor.",
        "retrieved_contexts":[
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            "12\n\nSource: GENTECH HOLDINGS, INC., 1-A, 8\/8\/2019\n\n\n\n\n\nIN WITNESS WHEREOF, this Agreement was signed by the Parties under the hands of their duly authorised officers and made effective as of the date first written above. Luiz Augusto Matavelli Bacetti B & C General Warehouse Corporation LLC Date: 04th, August, 2019. xxxxxxxx xxxxxxxx Date:\n\nSource: GENTECH HOLDINGS, INC., 1-A, 8\/8\/2019",
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement",
            ". NO ACTIONS, REGARDLESS OF FORM, ARISING OUT OF THIS AGREEMENT, MAY BE BROUGHT BY DISTRIBUTOR MORE THAN ONE (1) YEAR AFTER THE CAUSE OF ACTION HAS ARISEN. 14. NOTICES 14.1 All notices required or permitted hereunder shall be in writing and shall be delivered (a) by facsimile, (b) personally, or (c) mailed by certified or registered mail, return receipt requested and postage prepaid, addressed to the addressed below"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the renewal term for this contract?",
        "thought":"The context specifies that the Distributor Agreement between B & C General Warehouse Corporation LLC (referred to as 'Company') and the Distributor has an initial term of three years, with an option for the Distributor to renew for an additional three-year period. It also mentions that the agreement will renew automatically for one additional three-year term unless either party provides written notice of non-renewal at least ninety days before the expiration of the initial term. Therefore, the renewal term for this contract is three years, contingent upon proper notice being given.",
        "response":"The renewal term for the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor is an additional three (3) years, provided that the Distributor gives written notice to the Company at least ninety (90) days before the end of the initial term.",
        "retrieved_contexts":[
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5",
            ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the governing law for this contract?",
        "thought":"The context provided does not explicitly mention the governing law for the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor. It focuses on the rights and obligations of the parties involved and does not include any clauses related to the jurisdiction or governing law. Therefore, I cannot determine the governing law based on the available information.",
        "response":"I don't know.",
        "retrieved_contexts":[
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier",
            ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein",
            ". (g) This Agreement is the binding legal obligation of each Party and is enforceable in accordance with its terms. 4. RESPONSIBILITIES OF DISTRIBUTOR. Distributor agrees that it will diligently perform the services and obligations detailed in this Agreement. The operations of Distributor are under its sole and exclusive control, including without limitation supervision of, and liability for expenses incurred with respect to, employees"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a most favored nation clause in this contract?",
        "thought":"The context mentions 'most favored nation' rights and obligations multiple times, indicating that such provisions may exist in the Distributor Agreement. However, it also specifies that these rights are only applicable if they are material to the Company and its Subsidiaries. Therefore, while the term is present, it implies that the existence of a most favored nation clause would depend on its materiality to the parties involved.",
        "response":"The Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products may contain a most favored nation clause, but its applicability is contingent upon whether such rights are deemed material to the Company and its Subsidiaries.",
        "retrieved_contexts":[
            ", (C) contains any provision that requires the purchase of all or any portion of the Company\u2019s or any of its Subsidiaries\u2019 requirements from any Third Party or (D) grants \u201cmost favored nation\u201d rights, except in the case of each of clauses (A), (B), (C) and (D) for such rights and provisions that are not material to the Company and its Subsidiaries, taken as a whole",
            ":   (i)                 a Contract granting a \u201cmost favored nation\u201d or most favored customer pricing to any Person, or any Contract providing for the grant of exclusive material sales, distribution, marketing or other exclusive rights, rights of first refusal, rights of first negotiation or similar rights and\/or terms to any Person, or materially limiting the right of the Company or any of its Subsidiaries to engage in any line of business or in any geographic area",
            ", (B) contains material exclusivity or \u201cmost favored nation\u201d obligations or restrictions or (C) contains any other provisions that restrict the ability of the Company or any of its Subsidiaries to sell, market, distribute, promote, manufacture, develop, commercialize, or test or research any Company Product, directly or indirectly through third parties, in any material respect, or that would so limit or purport to limit the ability of Parent or any of its Affiliates to sell, market, distribute",
            ", (B) contains material exclusivity or \u201cmost favored nation\u201d obligations or restrictions or (C) contains any other provisions that restrict the ability of the Company or any of its Subsidiaries to sell, market, distribute, promote, manufacture, develop, commercialize, or test or research any Company Product, directly or indirectly through Third Parties, in any material respect, or that would so limit or purport to limit the ability of Parent or any of its Affiliates to sell, market, distribute",
            ", any Routine Services Contracts entered into in the ordinary course of business), (D) provides for \u201cexclusivity\u201d or any similar requirement in favor of any Person or group of Persons or in any geographical area or (E) requiring the Company or any of its Affiliates (including, following the Closing, Parent or any of its Affiliates) to conduct any business on a \u201cmost favored nations\u201d basis with any Person"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Does this contract include an exclusivity agreement?",
        "thought":"The context indicates that the Distributor Agreement grants the Distributor exclusive rights to sell and distribute the Products, which implies an exclusivity agreement. However, there is also a mention of a non-exclusive distributor arrangement in another part of the context, suggesting potential ambiguity. Therefore, while the primary excerpt supports the existence of exclusivity, the overall context presents conflicting information regarding the nature of the distribution rights.",
        "response":"The Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor implies an exclusivity agreement, as it grants the Distributor exclusive rights to sell and distribute the Products. However, there is conflicting information regarding a non-exclusive arrangement, which may create ambiguity in the interpretation of exclusivity.",
        "retrieved_contexts":[
            ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein",
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement",
            "The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement.\n\nAgreed terms\n\n1. Definitions and interpretation\n\n1.1 The definitions and rules of interpretation in this clause apply in this agreement.",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            "(iv)          any material Contract other than exclusive distributor agreements and employee agreements that (A) limits or purports to limit, in any material respect, the freedom of Parent or any of its Subsidiaries to engage or compete in any line of business or with any Person or in any area, (B) contains material exclusivity or \u201cmost favored nation\u201d obligations or restrictions or (C) contains any other provisions that restrict the ability of Parent or any of its Subsidiaries to sell, market"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a clause preventing the solicitation of customers in this contract?",
        "thought":"The context includes a clause stating that the Company shall not contact any of the Distributor's customers without prior written approval from the Distributor. This implies that there is a restriction on solicitation of customers by the Company, which aligns with the question about whether such a clause exists in the Distributor Agreement. The terms 'Company' and 'Distributor' refer to the parties involved in the agreement, and the clause directly addresses the solicitation of customers.",
        "response":"Yes, the Distributor Agreement contains a clause preventing the Company from contacting any of the Distributor's customers without prior written approval from the Distributor, which effectively restricts solicitation.",
        "retrieved_contexts":[
            ". The Company shall not contact any of Distributor's Customer's for any reason, without the prior written approval of Distributor.",
            ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein",
            "16.2 If the Distributor seeks the Supplier's consent to any proposed dealing under clause 16.1, the Distributor must: -\n\n(a) disclose fully in writing all material facts relating to the dealing\n\n(b) comply fully with any conditions or requirements set down by the Supplier which attach to any Suppliers consent that is given.\n\n16.3 Each party that has rights under this agreement is acting on its own behalf and not for the benefit of another person.\n\n17. Freedom to contract",
            "The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement.\n\nAgreed terms\n\n1. Definitions and interpretation\n\n1.1 The definitions and rules of interpretation in this clause apply in this agreement.",
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there an anti-assignment clause in this contract?",
        "thought":"The context explicitly states that the Distributor shall not assign or transfer the agreement or its rights and obligations without the consent of the Supplier, except to a Permitted Assignee. This indicates that there is indeed an anti-assignment clause in the Distributor Agreement, as it restricts the Distributor's ability to assign the contract without consent. The term 'anti-assignment clause' refers to this specific provision that limits the assignment of rights under the agreement.",
        "response":"Yes, the Distributor Agreement contains an anti-assignment clause that prohibits the Distributor from assigning or transferring the agreement without the Supplier's consent, except to a Permitted Assignee.",
        "retrieved_contexts":[
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier",
            "; provided that (i) any compensation to such sub-agent, sub-distributor, sub-representative or other person to act on Distributor's behalf or to otherwise perform any of Distributor's obligations shall be solely Distributor's responsibility, and (ii) such appointment does not deprive Company of the essential rights to which it is entitled under this Agreement",
            ". The Distributor shall not sub-contract or delegate in any manner any or all of its obligations under this agreement to any third party or agent.",
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Are there any price restrictions or controls specified in this contract?",
        "thought":"The context specifies that the Distributor has the freedom to set resale prices for the Products without any control or liability from the Company, which indicates that there are no price restrictions or controls imposed by the Distributor Agreement. The terms 'Distributor' and 'Company' refer to the same parties mentioned in the question, B & C General Warehouse Corporation LLC being the Company and the other party being the Distributor. Therefore, the context directly addresses the question regarding price restrictions in the contract.",
        "response":"The Distributor Agreement allows the Distributor to set resale prices at its sole discretion, with no price restrictions or controls specified by B & C General Warehouse Corporation LLC, the Company. This implies that the Distributor has complete autonomy over pricing.",
        "retrieved_contexts":[
            ". Distributor shall be free to resell the Products for such prices and upon such terms and conditions as Distributor may see fit in its sole discretion. Company shall have no control over or any liability in connection with the price at which Distributor resells the Products, and Distributor shall hold Company harmless and indemnify and defend Company from and against any liability resulting therefrom. 3. REPRESENTATIONS",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein",
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement",
            "The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement.\n\nAgreed terms\n\n1. Definitions and interpretation\n\n1.1 The definitions and rules of interpretation in this clause apply in this agreement."
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Does this contract include any volume restrictions?",
        "thought":"The context provided does not explicitly mention any volume restrictions related to the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor for Coffee Products. The terms focus on the rights and obligations of the parties involved, but there is no indication of limitations on the volume of products that can be distributed. Therefore, it can only be implied that the contract does not include volume restrictions unless stated otherwise in another section of the agreement.",
        "response":"The Distributor Agreement does not explicitly mention any volume restrictions regarding the distribution of coffee products. Therefore, it can only be implied that there are no such restrictions unless otherwise stated in the agreement.",
        "retrieved_contexts":[
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier",
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement",
            ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein",
            ". The Distributor shall not sub-contract or delegate in any manner any or all of its obligations under this agreement to any third party or agent."
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; How is intellectual property ownership assigned in this contract?",
        "thought":"The context indicates that the Distributor must assign any rights in the trademarks of the Company to the Company without charge, which implies that the Company retains ownership of its intellectual property. Additionally, the Distributor cannot initiate any proceedings regarding the Company's trademarks without permission, reinforcing the Company's control over its intellectual property. The mention of Joint IP suggests that if there are any jointly developed intellectual properties, each party would have a shared ownership, but the primary ownership of the trademarks remains with the Company.",
        "response":"In the Distributor Agreement, intellectual property ownership is assigned to the Company, as the Distributor must assign any rights in the Company's trademarks to the Company without charge and cannot act on the trademarks without permission. This indicates that the Company retains ownership of its intellectual property, while any jointly developed intellectual property would be shared equally.",
        "retrieved_contexts":[
            ". Distributor will not institute any proceedings with respect to the trademarks of Company either in Distributor's own name or on behalf of Company without express written permission of Company. Distributor shall assign to Company, without charge, any rights in the trademarks of Company that may inure to the benefit of Distributor pursuant to this Agreement or otherwise. Distributor shall execute any documents or do any acts that may be required to accomplish the intent of this Section. 12",
            "(f) This Agreement shall be binding upon and inure to the benefit of each party\u2019s respective successors and lawful assigns; provided, however, that Vendor may not assign this Agreement (whether by operation of law, sale of securities or assets, merger or otherwise), in whole or in part, without the prior written approval of IBC. Any purported assignment in violation of this Section shall be void",
            "(b) Territory. The rights granted Distributor hereunder are granted for the following geographical areas and markets. USA. (c) Products. The Products manufactured and sold by Company to Distributor for distribution hereunder are as follows: \u25cf Arte Caf\u00e9 Especial \u25cf Arte Caf\u00e9 Gourmet \u25cf Arte Caf\u00e9 Laurina \u25cf Arte Caf\u00e9 Organico \u25cf And all another new brand and or kind of coffee. (d) Subagents",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            ". Each Party to whom ownership is to vest in Joint IP by operation of law or by assignment by its employees or Agents agrees   to assign and hereby assigns to the other Party an undivided one-half right, title and interest in and to all Joint IP; and to facilitate   such assignment, the Party possessing such ownership agrees (i) to regularly ensure that its employees and consultants timely make   any appropriate assignments to it"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Are there any services to be provided after the termination of this contract?",
        "thought":"The context indicates that upon termination of the Distributor Agreement between B & C General Warehouse Corporation LLC (the Company) and the Distributor, the Company has no further responsibilities except to process orders accepted prior to termination. This implies that there are limited services provided after termination, specifically related to processing existing orders. The context does not mention any ongoing services beyond this obligation, which clarifies the extent of post-termination responsibilities.",
        "response":"After the termination of the Distributor Agreement, B & C General Warehouse Corporation LLC is only obligated to process orders accepted prior to termination, implying no additional services are provided thereafter.",
        "retrieved_contexts":[
            ". 8. RIGHTS OF PARTIES AT TERMINATION. (a) Obligations After Termination. In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter. (b) Survival",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            "(n) Without affecting any other rights that it may be entitled to, the Supplier may give notice in writing to the Distributor terminating this agreement immediately if the Distributor purports to assign its rights or obligations under this agreement to an entity that is not (1) affiliated with, (2) related to, or (3) sharing common ownership with the Distributor (a Permitted Assignee).\n\n12. Effectsof termination",
            ". (g) This Agreement is the binding legal obligation of each Party and is enforceable in accordance with its terms. 4. RESPONSIBILITIES OF DISTRIBUTOR. Distributor agrees that it will diligently perform the services and obligations detailed in this Agreement. The operations of Distributor are under its sole and exclusive control, including without limitation supervision of, and liability for expenses incurred with respect to, employees",
            "(b) the Distributor may dispose of the balance of the Products in its possession and account to the Supplier for the Price for those Products; and\n\n(c) subject to clause 12.2(b), the Distributor must cease using any intellectual property of the Supplier or of another person that relates to the distributorship and the Distributor must sign any instrument and do any other act that is necessary to achieve this purpose;"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a cap on liability under this contract?",
        "thought":"The context mentions a limitation of liabilities clause that states JRVS's liability shall not exceed the amount received from the Distributor for the product causing the liability. However, it does not explicitly state that this clause applies to the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor for Coffee Products. Therefore, while there is a cap on liability mentioned in the context, it is unclear if it directly pertains to the specific agreement in question.",
        "response":"The context implies that there is a cap on liability, as JRVS's liability is limited to the amount received from the Distributor for the relevant product; however, it is not explicitly stated that this applies to the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor for Coffee Products.",
        "retrieved_contexts":[
            ", except to the extent the liability arises as a result of the wilful misconduct of the Distributor",
            "13. LIMITATION OF LIABILITIES 13.1 Limitation of Liabilities. IN NO EVENT SHALL JRVS'S LIABILITY ARISING OUT OF THIS AGREEMENT EXCEED THE AMOUNT RECEIVED BY JRVS FROM THE DISTRIBUTOR HEREUNDER FOR THE PRODUCT GIVING RISE TO THE LIABILITY",
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            ". Distributor shall be free to resell the Products for such prices and upon such terms and conditions as Distributor may see fit in its sole discretion. Company shall have no control over or any liability in connection with the price at which Distributor resells the Products, and Distributor shall hold Company harmless and indemnify and defend Company from and against any liability resulting therefrom. 3. REPRESENTATIONS"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the duration of any warranties provided in this contract?",
        "thought":"The question asks about the duration of any warranties in the Distributor Agreement between B & C General Warehouse Corporation LLC and the Distributor for Coffee Products. The relevant section in the context mentions that the Distributor must inspect the Products upon receipt and notify the Company of any defects within seven days, implying a warranty period of seven days for reporting defects. However, the overall duration of the agreement is three years, with an option to renew, but this does not directly pertain to the warranty duration.",
        "response":"The warranty period for reporting defects in the Distributor Agreement is seven days from the receipt of the Products, as stated in the context.",
        "retrieved_contexts":[
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination",
            "(a) the Supplier may buy from the Distributor all or any stocks of Products for the current market value for those Products. The Distributor must deliver such Products to the Supplier within 14 days of receiving the Supplier's notice, and the Supplier must pay for the Products in full within 30 days of their delivery. The Supplier shall be responsible for the costs of packaging, insurance and carriage of the Products; or",
            "5. Producer's Representations and Warranties",
            ". Distributor will promptly inspect the Products upon receipt at Distributor's facility to determine whether any Products included in the shipment are in short supply, defective, or otherwise not in conformance with this Agreement. Within Seven (7) days of receipt of such Products, Distributor will notify Company of any shortages, defects, non-conformance, and Company will promptly replace such Products free of charge. Title to the Products shall pass to Distributor upon delivery"
        ]
    },
    {
        "user_input":"Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a covenant not to sue included in this contract?",
        "thought":"The context mentions a covenant not to sue included in the Distributor Agreement, specifically stating that the Distributor covenants not to sue except in certain circumstances. This indicates that there is indeed a provision related to not suing, which is relevant to the question about the presence of such a covenant in the contract between B & C General Warehouse Corporation LLC and the Distributor for Coffee Products.",
        "response":"Yes, the Distributor Agreement includes a covenant not to sue, which allows for exceptions under specific circumstances.",
        "retrieved_contexts":[
            ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement",
            ", except to the extent the liability arises as a result of the wilful misconduct of the Distributor",
            "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")",
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier",
            ", and covenants not to sue (other than non-exclusive licenses granted to other Persons in the Ordinary Course of Business consistent with past practice and licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business)"
        ]
    },
    {
        "user_input":"Consider the Non-Exclusive Distributor Agreement between iMine Corporation and Sunwai Technology for Cryptocurrency Mining Rigs; What is the expiration date of this contract?",
        "thought":"The context provides information about the Non-Exclusive Distributor Agreement between iMine Corporation (referred to as JRVS) and Sunwai Technology. It states that the agreement is effective as of July 19, 2018, and has a duration of three years, implying that it will expire on July 19, 2021, unless renewed. The option for renewal is mentioned, but the expiration date of the initial term is clear.",
        "response":"The Non-Exclusive Distributor Agreement between iMine Corporation (JRVS) and Sunwai Technology is set to expire on July 19, 2021, unless renewed.",
        "retrieved_contexts":[
            "EXHIBIT 10.5 NON-EXCLUSIVE DISTRIBUTOR AGREEMENT This Non-Exclusive Distributor Agreement (the \"Agreement\") is made and entered into as of this 19th day of July 2018, by and between iMine Corporation, (hereinafter referred to as \"JRVS\") and SUNWAI Technology, a Taiwanese company, with its principal office at 6th Floor, No. 258, Section 3, Nanjing East Road, Songshan District, Taipei 10051 (hereinafter referred to as the \"Distributor\")",
            "Source: IMINE CORP, S-1, 7\/25\/2018\n\n\n\n\n\nIN WITNESS WHEREOF, THE PARTIES HERETO HAVE EXECUTED THIS AGREEMENT AS OF THE DATE FIRST WRITTEN ABOVE. Sunwai Technology iMine Corporation\n\n\/s\/ Sei-Peng Tu \/s\/ Daniel Tsai By: Sei-Peng Tu By: Daniel Tsai Title: President Title: Chief Executive Officer 9\n\nSource: IMINE CORP, S-1, 7\/25\/2018",
            ". RECITAL WHEREAS, Distributor desires to be, a nonexclusive distributor of JRVS for certain cryptocurrency mining rig products; JRVS wishes to sell its products through Distributor on a continuing basis on the terms and conditions set forth below. AGREEMENT NOW, THEREFORE, in consideration of the mutual agreements and covenants, JRVS and the Distributor agree as follows: 1. DEFINITIONS 1",
            ". or international intellectual property, unfair competition or trade secret laws. 1.7 \"Products\" shall mean the products offered by JRVS for sale to the Distributor; the Products shall include iMine cryptocurrency mining rigs and its parts and components. 1.8 \"Territory\" shall mean the geographic area of Taiwan. 2. APPOINTMENT 2.1 Appointment of Nonexclusive Distributor",
            "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
        ]
    },
    {
        "user_input":"Consider the Non-Exclusive Distributor Agreement between iMine Corporation and Sunwai Technology for Cryptocurrency Mining Rigs; What is the governing law for this contract?",
        "thought":"The context provided does not explicitly state the governing law for the Non-Exclusive Distributor Agreement between iMine Corporation (referred to as JRVS in the context) and Sunwai Technology. It primarily discusses the appointment of the distributor and the definitions of terms related to the agreement. Without specific mention of governing law, I cannot determine the applicable legal jurisdiction for this contract.",
        "response":"I don't know.",
        "retrieved_contexts":[
            ". RECITAL WHEREAS, Distributor desires to be, a nonexclusive distributor of JRVS for certain cryptocurrency mining rig products; JRVS wishes to sell its products through Distributor on a continuing basis on the terms and conditions set forth below. AGREEMENT NOW, THEREFORE, in consideration of the mutual agreements and covenants, JRVS and the Distributor agree as follows: 1. DEFINITIONS 1",
            ". or international intellectual property, unfair competition or trade secret laws. 1.7 \"Products\" shall mean the products offered by JRVS for sale to the Distributor; the Products shall include iMine cryptocurrency mining rigs and its parts and components. 1.8 \"Territory\" shall mean the geographic area of Taiwan. 2. APPOINTMENT 2.1 Appointment of Nonexclusive Distributor",
            "EXHIBIT 10.5 NON-EXCLUSIVE DISTRIBUTOR AGREEMENT This Non-Exclusive Distributor Agreement (the \"Agreement\") is made and entered into as of this 19th day of July 2018, by and between iMine Corporation, (hereinafter referred to as \"JRVS\") and SUNWAI Technology, a Taiwanese company, with its principal office at 6th Floor, No. 258, Section 3, Nanjing East Road, Songshan District, Taipei 10051 (hereinafter referred to as the \"Distributor\")",
            "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier",
            ". The Distributor shall not, during the term of this Agreement, directly or indirectly market, sell, distribute, solicit orders within the Territory for any products which are competitive with the iMine Products unless JRVS consents thereto in writing in advance, based upon the Distributor's full disclosure of the material facts in seeking such consent. Any such marketing, sale, distribution or solicitation of the competitive products is considered to be a material breach of this Agreement. 3"
        ]
    }
]